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ABSTRACT
Placental efficiency (PE) describes the relationship between placental and fetal
weights and is defined as fetal weight divided by placental weight. Within pig litters, PE
can vary drastically, resulting in similarly sized pigs associated with very different
placenta, up to a 50% weight difference. However, the means enabling the smaller
placenta to grow a similarly sized littermate is unknown. The main objectives of this
study were to (1) determine the concentration of glucose and cortisol in venous umbilical
blood of pigs at birth and evaluate if a relationship existed between concentration and PE,
and (2) determine the expression level of genes in placental and associated endometrial
tissues of high PE and low PE feto-placental units. For the first objective, terminal
Yorkshire crossed pigs (n = 15) were monitored during farrowing to tag umbilical cords
and ear notch pigs to ensure feto-placental units were properly matched and PE could be
calculated. Neonatal growth measurements were taken to compare high PE and low PE
feto-placental units. Umbilical blood samples were taken for quantification of glucose
and cortisol. The basis of high PE, a smaller but more efficient placenta, was confirmed
as placental weight was reduced, but fetal weight was not different in the high PE group.
Given that birth weight, crown-rump length, girth, and body weights up to day 21 did not
differ by PE, the survival and postnatal growth performance of pigs grown of high PE
placentas should not be reduced. Furthermore, glucose and cortisol concentrations did not
differ by PE suggesting high PE placentas have some other means enabling the transport
of similar nutrient and hormone quantities despite a reduction in size. For the second
objective, maternal line gilts (n = 8) were ovario-hysterectomized on day 95 of gestation
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to obtain corresponding placental and endometrial samples from each feto-placental unit.
PE was calculated to identify the most efficient and least efficient unit in each litter;
placental and endometrial samples from these units formed the high PE and low PE
comparison groups. RNA sequencing was performed to identify differentially expressed
genes (DEG) in high PE compared to low PE placental and endometrial samples. In the
placenta, 214 DEG were identified, while zero DEG were identified in the endometrium.
Of those DEG in the placenta, 103 were upregulated and 111 were downregulated.
Although a portion of the DEG identified in the pig placenta encoded nutrient
transporters and gene products with angiogenic or growth factor activity, DEG with
alternative functions were also identified, indicating the complexity of the relationship
between placental and fetal weights. Overall the results of this study provide new insights
into the regulation of PE; however, further research is required to make PE production
applicable.
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CHAPTER ONE
LITERATURE REVIEW
Introduction
Litter size varies among swine breeds; for example, the Chinese Meishan is
highly prolific and farrows 3 to 4 more piglets per litter than U.S. and European breeds
(Wilson et al., 1998). Currently, the hog litter rate (pigs/litter) in the U.S. is 10.5 piglets
per litter (NASS, 2017). For swine producers, litter size is directly proportional to
profitability; therefore, a considerable amount of research has been devoted to increasing
litter size (Wilson et al., 1998; Biensen et al., 1998; Vonnahme and Ford, 2004; Vallet
and Freking, 2007; Kwon et al., 2016). In addition, recent reports indicate that the world
population will increase from 7.3 billion in 2015 to a staggering 9.7 billion in 2050
(Zeigler and Steensland, 2015). Consequently, these predictions have prompted food
security concerns. Companies have come together to create initiatives, like the Global
Harvest Initiative, that focus on solutions to meet the rising demand for food and
agriculture products. Currently, Global Harvest’s 2015 Gap report indicates the TFP, or
ratio of agricultural outputs to inputs, is “not accelerating fast enough to double
agricultural output by 2050 (Zeigler and Steensland, 2015).” These reports are alarming;
however, in response there have been calls for sustainable and efficient increases in
agriculture production. Since the swine industry is vertically integrated, the industry is a
prime candidate for adopting practices that increase both the sustainability and efficiency
of meat production. In addition, compared to other livestock species like the cow, pigs
have a relatively short gestation length and require a shorter period of time for growth.
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Thus, there is renewed interest in increasing the sustainability and efficiency of the swine
industry to help meet the increase in demand. Of particular interest is the reproductive
efficiency of pigs.
Early attempts to increase litter size considered ovulation rate, uterine capacity,
and uterine length. However, it was determined that increasing these parameters did not
result in a significant increase in litter size (Fenton et al., 1972; Webel and Dziuk, 1974;
Christenson et al., 1987; Gama and Johnson, 1993; Johnson et al., 1999). Alternatively,
the current research indicates placental efficiency (PE) is a significant factor in litter size.
The placenta plays a vital role in the development of the piglet. Placental functions
include nutrient and gas exchange, metabolism, and hormone production (Bauer et al.,
1998b). Placental efficiency is quantified by the “ratio of fetal weight to placental
weight” and indicates the amount of fetal tissue that can be produced per gram of
placenta (Christenson et al., 1987). Variations in PE were first seen between breeds. It
was discovered that the highly prolific Chinese Meishan exhibits high PE, as the
placentas are small and highly vascularized, while Yorkshires exhibit low PE, as the
placentas are larger and less vascularized. However, variations in PE are not restricted to
breeds; placental variation is also found within breeds and even within litters. In fact, it is
common to find placentas that are drastically different in size yet yield piglets that are
approximately the same size. Thus, there is a clear difference in the functionality of the
two placentas. In an attempt to elucidate differences in functionality, several studies have
investigated the variation in PE within breeds and within litters. With regard to increasing
litter size in U.S. production breeds, these studies have focused on placental vascular
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density, nutrient transport, and more recently, genetic differences. The objective of this
review is to consider the current body of knowledge surrounding PE in the pig and litter
size.

Development of the Pig Placenta
The fertilized oocyte, containing the fused male and female pronuclei, surrounded
by a characteristic translucent protein coat known as the zona pellucida, is the zygote.
After fertilization, the zygote undergoes a series of cleavage events as it travels through
the oviduct into the uterus (Steven, 1975). The first cleavage or mitotic division results
in two cells, also known as blastomeres, within the zona pellucida. Then, the blastomeres
continue to cleave, transforming into what looks like a ball of cells contained within a
zona pellucida; at this stage the structure is termed a morula. The morula then develops
into a blastocyst, which is characterized by a fluid filled cavity or blastocoele and two
cell layers near the wall: the ectoderm and endoderm (Figure 1.1a) (Perry, 1981). The
thicker portion of the ectoderm is the embryonic disc, which later develops into the
embryo. The rest of the ectoderm is the trophoblast, which eventually contributes to the
extraembryonic membranes (Mossman, 1937; Perry, 1981). The formation of the
endoderm begins with tangential cell divisions originating from the embryonic disc to
form the first endodermal cells (Perry, 1981). Then, those initial endodermal cells
continue to multiply and disperse along the inner surface of the ectoderm to form the
inner cell layer or endoderm and enclose the blastocoele (Figure 1.1b & 1.1c) (Mossman,
1937; Perry, 1981). The blastocyst continues to grow and hatches or breaks out of the
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zona pellucida. At this stage, the hatched blastocyst can float within the uterus (Steven,
1975; Perry, 1981).

Figure 1.1 Depiction of blastocyst (a) and formation of endoderm (b) within blastocyst
prior to hatching (c). (Perry, 1981)
In the pig, embryos are in the 4-cell stage and enter the uterus approximately 48
hours after ovulation. The embryos continue to divide developing into morulas and then
blastocysts. By day 6, the blastocysts lack a zona pellucida and migrate from the tip of
the uterine horn into the body of the uterus, and by day 9 some of the blastocysts have
migrated into the opposite uterine horn. The movement and distribution of the blastocysts
throughout the uterus is achieved by peristaltic contractions of the uterus. However, by
day 12 blastocysts line both uterine horns, are spaced evenly apart, and stick to the
uterine lining in an adhesive manner (Dziuk, 1985).
During this same time period, the blastocysts undergo rapid elongation
transforming from a spherical ball into a tubular structure before becoming filamentous
(Perry, 1981). Specifically, on day 9/10 the blastocysts are spherical in shape and 1 to 5
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mm long. By day 12, the blastocysts are tubular in shape and range from 12 to 80 cm
long, and by day 13 the blastocysts are filamentous with lengths up to 1 m long (Figure
1.2) (Perry and Rowlands, 1962; Anderson, 1978). However, since the endometrium is
heavily folded only about 20 to 30 cm of the uterine horn is occupied by each filamentous
blastocyst and elongation continues until the blastocysts are in close proximity to each
other (Perry, 1981).

Figure 1.2 Day 13 elongated pig blastocyst. (Perry and Rowlands, 1962)
After elongation, the blastocyst, which consists of the embryonic disc, the
endoderm, and the ectoderm or trophoblast, continues to develop forming the fetal
membranes. Cells from the ectoderm of the embryonic disc begin to “bud” off and form
the mesoderm between the embryonic disc and the endoderm. The mesoderm continues
to grow outward past the embryonic disc before separating into two layers to create the
exocoele cavity. Then, the outer mesodermal layer and ectoderm grow upward and
around the embryonic disc on both sides, creating two amniotic folds. The amniotic folds
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continue to grow until the folds fuse, forming the amnion around the embryonic disc. The
fusion of the amniotic folds also separates the amnion from the chorion, which is the
outer layer of the mesoderm and the ectoderm. The allantois is formed via an outgrowth
of the gut and is covered by mesoderm (Figure 1.3) (Perry, 1981). The allantois begins to
grow and expands into the exocoele as the yolk sac regresses, except in one area, near the
embryo, where the amnion and chorion will fuse. The mesoderm covering the allantois
then fuses with the chorion forming the allantochorion. Thus, the allantochorion consists
of an outer ectodermal layer (trophoblast), middle mesodermal layer, and inner
endodermal layer (Figure 1.4) (Perry, 1981). The trophoblast of the allantochorion begins
to attach to the uterine epithelium via interlocking microvilli on day 18 and within 1 d
attachment is complete (Perry, 1981).
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Figure 1.3 Illustration of the fetal membranes of a pig at day 18 of gestation.
(Perry, 1981)

Figure 1.4 Illustration of the fetal membranes of a pig at day 21 of gestation.
(Perry, 1981)
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Classification of the Pig Placenta
The placenta of the pig is described as a diffuse epitheliochorial placenta. The
first classification, diffuse, is a classification based on placental shape and area of
attachment. Diffuse describes how the entire placenta attaches to the adjacent
endometrium, except at the tips and directly across from uterine glands (Perry, 1981).
Following attachment, the surface area of the interlocking chorion and
endometrium increases as the area becomes folded. By day 20, primary and secondary
folds have formed in the endometrium. By day 35, primary ridges or rugae and troughs
have also formed in the endometrium, with secondary ridges clearly visible by day 100.
Likewise, complementary ridges and troughs are present in the chorion, except at uterine
glands (Dantzer, 1984). As gestation progresses, fetal capillaries protrude into the
trophoblast of the chorionic ridges at the summit and lateral sides and maternal capillaries
protrude into the uterine epithelial cells. Accordingly, the distance separating maternal
and fetal blood decreases throughout gestation, often measuring less than 2 µm by term.
Thus, Freiss and others (1980) concluded gaseous exchange occurs at the summit of the
chorionic ridges as well as the lateral sides (Friess et al., 1980). Conversely, fetal
capillaries do not protrude into the chorionic troughs. Instead, intercellular channels in
this region and pinocytotic vesicles in the fetal epithelium facilitate the transport of less
diffusible substances from the dam to the fetus (Friess et al., 1980).
The chorion is not interlocked with the endometrium around uterine glands.
Instead, regular or irregular areolae begin forming around day 30 when the chorion cups
over the opening of one or more uterine glands, creating an “areola-uterine gland unit”
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(Crombie, 1972; Friess et al., 1980). The differentiation between regular and irregular
areolae is due to folding. Regular areolae are characterized by heavy folding of the
trophoblast cells with little modification of the uterine epithelium. Conversely, irregular
areolae are characterized by heavy folding of the uterine epithelium with little
modification of the trophoblast cells (Crombie, 1972). Essentially, both regular and
irregular areolae are specialized regions of the chorion that take up histotroph (uterine
milk) secreted by the uterine glands (Friess et al., 1982).
The second classification, epitheliochorial, is a classification based on the number
of placental tissue layers separating maternal and fetal blood. Epitheliochorial designates
the presence of six tissues layers and of those six tissue layers, three are maternal and
three are fetal. Specifically, the tissue layers are the maternal capillary endothelium,
maternal connective tissue, maternal uterine epithelium, fetal chorionic epithelium, fetal
connective tissue, and fetal capillary endothelium (Steven, 1975). Thus, nutrients from
maternal blood must pass through all six tissue layers to reach fetal blood.

Placental Vascularity
Placental vasculature originates from the inner mesodermal layer of the exocoele,
which also covers the yolk sac. It begins with the formation of blood islands and then
blood vessels (Perry, 1981). Once the allantois reaches the chorion, blood vessels from
the mesoderm covering the allantois advance into the chorion. By day 30 of gestation, the
entire allantochorion, except at the necrotic tips, is highly vascularized (Friess et al.,
1980; Perry, 1981).
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As the placenta grows, the complementary ridges and troughs in the folded
bilayer become vascularized. Leiser and Danzter (1988) reported net like structures,
made up of maternal and fetal capillaries, are located on the maternal side and fetal side
of the bilayer. In addition, the authors concluded that maternal-fetal blood flow in the pig
should be described as cross-counter current because the vascular architecture
exemplified properties of both crosscurrent and countercurrent flow. This, however, was
in direct opposition to other authors who suggested the blood flow was concurrent (Leiser
and Dantzer, 1988). In concurrent blood flow, the maternal and fetal vessels would run
parallel to each other with blood flowing in the same direction (Wooding and Burton,
2008). However, this arrangement would provide the least amount of placental exchange,
which is inconsistent with the high nutrient exchange rates required for fetal growth
during the end of gestation. Instead, in countercurrent blood flow the fetal and maternal
vessels run parallel to each other with blood flowing in opposite direction, providing up
to 100% exchange. Additionally, in crosscurrent blood flow, the maternal and fetal
vessels run perpendicular to each other and blood flow is in one direction. Thus, crosscountercurrent blood flow would increase the exchange capacity of the placenta, which is
consistent with the high nutrient exchange rate required for fetal growth (Leiser and
Dantzer, 1988).

Function of the Placenta
The placenta is an organ that creates an interface for exchange between maternal
and fetal circulation. Functions of the placenta include nutrient and gas exchange,
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metabolism, and hormone production (Bauer et al., 1998b). Nutrients from the maternal
circulation can cross the placenta into the fetal circulation by different transport
mechanisms. These mechanisms include simple diffusion, facilitated diffusion, and active
transport (Steven, 1975). Transport by simple diffusion means a substance can readily
pass through a membrane, from an area of high concentration to an area of low
concentration, without the aid of carrier proteins or the expenditure of energy. A
modification of simple diffusion is facilitated diffusion, where a substance is transported
across a membrane passively with the aid of carrier proteins. Similarly, active transport
involves carrier proteins but requires energy to transport a substance against a
concentration gradient (Bauer et al., 1998b).
Nonetheless, the specific mechanism of transport utilized depends on the nutrient
being transported. For example, water is transported across the placenta by diffusion,
glucose is transported by facilitated diffusion, and most amino acids are transported by
active transport. Likewise, gases, such as oxygen and carbon dioxide, are transported by
simple diffusion (Steven, 1975).
Beyond nutrient and gas exchange, the placenta also has functions in metabolism
and hormone synthesis. For instance, the pig placenta produces some lactate and fructose
from glucose, illustrating the placenta’s role in metabolism (Père, 1995). Furthermore,
the pig placenta produces the hormones progesterone and estrogen. Progesterone is
referred to as the “pregnancy maintenance hormone” and is involved in uterine
receptivity of the conceptus. Conversely, the hormone estrogen is involved in maternal

11

recognition of pregnancy in pigs, as well as eliciting maternal metabolic changes and
physiological changes during pregnancy (Harding and Bocking, 2001).

Nutrient Transport and Utilization
Carbohydrates
In pigs, as in other animals, glucose is the main energy substrate utilized by the
fetus for metabolism and growth (Sinclair and Warshaw, 1975; Père, 1995; Hay Jr,
2006). However, gluconeogenesis is meager in the fetal pig when the dam is in the fed
state (Fowden et al., 1997). Thus, glucose is the primary carbohydrate transported by the
placenta to the fetus (Hay Jr, 1994). Since sugars, like glucose, are polar compounds,
sugars do not readily diffuse across the placenta. Instead, facilitative transporter proteins,
mainly from the GLUT transporter family, transport glucose down a concentration
gradient. GLUT-1 and GLUT-3 are the main glucose transporters in several species.
GLUT-1 is a facilitative glucose transporter present in the placenta of all species (Hay Jr,
2006). GLUT-3 is a facilitative glucose transporter present in other mammalian species
such as rats, mice, and sheep (Illsley, 2000). However, the abundance and localization of
GLUT transporter proteins in the pig placenta is not well known. Bazer and others (2010,
2012) used in situ hybridization to localize GLUT-1 through GLUT-4 (SLC2A1-SLC2A4)
mRNA in the placenta and endometrium of pigs. The results indicated GLUT-1
(SLC2A1) was expressed by the trophoblast and endometrial epithelial cells, GLUT-2
(SLC2A2) was expressed in the areolae and the apical regions of the folded bilayer,
GLUT-3 (SLC2A3) was weakly or not expressed by the trophoblast or endometrial
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epithelial cells, and GLUT4 (SLC2A4) was expressed in the trophoblast and endometrial
epithelial cells, especially from day 15 to 80 (Bazer et al., 2010; Bazer et al., 2012). Thus,
it appears GLUT-1, as in other species, is the main glucose transporter and facilitates the
bi-directional transport of glucose as it is found on both the maternal and fetal facing
portions of the placenta (Hay Jr, 2006). The results also indicated GLUT-2, another
isoform of the transporter protein, and GLUT-4, an isoform that is insulin responsive,
may be involved in glucose transport across the pig placenta. Conversely, the results
indicated GLUT-3, which is abundant in the placentas of several mammalian species, is
not involved in glucose transport across the pig placenta. However, the available reports
on the presence of glucose transporter proteins in the pig placenta are inconsistent. After
examining the swine gene index, Vallet and others (2009) reported expressed sequence
tags corresponding to GLUT-1, GLUT-2, and GLUT-3 were isolated from the placenta,
while expressed sequence tags corresponding to GLUT-1, GLUT-3, and GLUT-5 were
isolated from the uterus (Vallet et al., 2009). Therefore, further investigation into the
localization and abundance of GLUT transporter proteins in the pig placenta and
endometrium is warranted.
In many species, the transplacental transport of glucose is regulated by the
difference in maternal and fetal blood glucose concentrations (Hay Jr, 2006). In the pig,
Père (2001) reported fetal glycemia was 2.2 to 2.5 times lower than maternal glycemia
(Père, 2001). In addition, Reynolds and others (1985) reported that the mean glucose
concentration from umbilical blood was 58% of the mean glucose concentration from
uterine blood in pigs (Reynolds et al., 1985). Together, this data indicates that in pigs,
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glucose concentrations are lower in the fetal blood than in the maternal blood and glucose
transport across the placenta is regulated by maternal fetal concentration differences.
Moreover, the fetus does not utilize all of the glucose taken up by the fetoplacental unit. Some of the glucose is utilized by the placenta as metabolic fuel (Battaglia
and Meschia, 1988). In a glucose tracer study, it was reported that 78.1% of the labeled
glucose infused into the vena cava of fetal piglets was taken up by the uteroplacental
tissues, confirming that these tissues take up a portion of the glucose not utilized by the
fetus (Fowden et al., 1997).
In addition, the placenta produces lactate and fructose from glucose (Père, 1995).
The monocarboxylate cotransporter family (MCT) aids in the transport of lactate across
cell membranes (Halestrap, 2013). Correspondingly, the gene SLC16A7, which codes for
the protein MCT2, was identified in a transcriptomic analysis of the pig placenta (Vallet
et al., 2014). Therefore, it is likely that MCT isoforms transport lactate across the pig
placenta. In contrast, fructose is transported across the placenta by GLUT isoforms.
Specifically, the isoforms GLUT-2 and GLUT-5 are known fructose transporters (Vallet
et al., 2009).
In an attempt to understand how the feto-placental unit utilizes lactate and
fructose, several studies have investigated the relative concentrations in the umbilical
vein and arteries. Père and others (2001) reported lactate concentrations were higher in
the fetus than in the sow and higher in the umbilical vein than the artery, suggesting
lactate is taken up by the fetal piglet (Père, 2001). Likewise, Fowden and others (1997)
also reported higher blood lactate concentrations in the umbilical vein than the artery and
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consequently a significant fetal uptake of lactate. Therefore, the authors suggested that
lactate might serve as a fetal carbohydrate conserving mechanism, since the placenta is
more permeable to glucose than to lactate (Fowden et al., 1997). Thus, lactate, as in other
animals, is an important energetic fuel for fetal metabolism (Fowden et al., 1997; Père,
2001).
Similarly, blood fructose concentrations are higher in the fetal pig; however,
blood fructose is almost absent in the sow. Additionally, fetal pig blood fructose
concentrations are 2 times higher than glucose concentrations. Thus, quantitatively
fructose is the main carbohydrate in the fetal pig. However, since fructose concentrations
do not differ between the umbilical vein and arteries it seems the fetal pig does not utilize
fructose as an energetic fuel (Père, 1995). Alternatively, fructose may serve to increase
glucose transport to the fetus. White and others (1979) confirmed glucose is converted to
fructose within the fetal compartment and reported fructose transport back to the maternal
blood does not occur. Therefore, fructose would decrease glucose concentrations in the
fetus, thereby increasing the maternal-fetal glucose concentration gradient, and, in turn,
glucose transport to the fetus (White et al., 1979). Although this may be true, White and
others (1982) reported fructose might be involved in nucleic acid synthesis and, therefore,
fetal growth and development. Thus, roles of fructose in fetal pig metabolism are still
being determined (White et al., 1982; Vallet et al., 2009).
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Amino Acids
Amino acids are the building blocks of proteins in cells and, thus, are essential to
the growing fetus. However, the fetus does not use amino acids solely for the formation
of new tissue. In fact, amino acids are also precursors for the synthesis of nitric oxide,
polyamines, neurotransmitters, purine and pyrimidine nucleotides, and several other nonprotein substances (Self et al., 2004). In addition, amino acids can be used as fuel for
oxidative metabolism, however, to what degree, depends on the species. In pigs, the fetus
produces urea, the predominant deamination product of amino acid catabolism. However,
urea concentrations in utero are low, α-amino nitrogen concentrations in the fetus are also
low (Fowden et al., 1997), and of the α-amino nitrogen taken up by the gravid uterus only
13% is catabolized to urea (Ford et al., 1984). Additionally, the urea and α-amino
nitrogen fetal-maternal differences are smaller in the pig than in the sheep (Silver, 1981),
indicating fewer amino acids are used as fuel for oxidative metabolism in piglets
(Fowden et al., 1997).
The transport of amino acids across the placenta is complex. Transporter proteins
mediate the transport of amino acids across the placenta. Amino acid uptake by cell
membranes occurs via accumulative transporters and exchangers. Accumulative
transporters increase the concentration of amino acids within the cell by co-transporting
them, usually with Na

against the concentration gradient (Lager and Powell, 2012).

Thus, amino acids are actively transported across the placenta, which is in agreement
with the higher plasma fetal maternal ratios of most amino acids in the pig (Wu et al.,
1995; Grillo et al., 2008). Exchangers transport amino acids by exchanging one amino
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acid outside of the cell with one amino acid inside the cell. Conversely, the efflux of
amino acids occurs via facilitative transporters and exchangers. Furthermore, transport
systems are used to group amino acid transporters with similar characteristics, like
sodium dependency and substrate specificity (Lager and Powell, 2012).
Numerous transport systems have been identified in the human placenta, some of
which have now been identified in the pig placenta. Finch and others (2004) discovered
the presence of two neutral amino acid transport systems, similar to those of other
species, in the trophoblast portion of the pig placenta, system L and system B0 (Finch et
al., 2004). System L is a sodium independent exchanger that exchanges nonessential
amino acids for essential amino acids like leucine (Verrey, 2003). System B0 is a sodium
dependent transport system. Finch and others (2004) reported that the uptake of the
amino acid leucine by the pig placenta occurred via system L on days 45 and 65 of
gestation. However, by day 100 the uptake of leucine occurred via system L and B0 in the
normal pig placenta and only system L in the placentas of the smallest fetuses. The
absence of system B0 in the placentas of the smallest fetuses is of interest since leucine is
an essential amino acid and may impact growth (Finch et al., 2004).
Johnson and others (2010), reported SLC7A3, a gene encoding an arginine
transporter, was present in the chorion of the pig placenta and expression increased from
day 25 to 30 and then maintained until day 85 (Johnson et al., 2010). The gene SLC7A3
corresponds to the protein CAT3 and the y+ transporter system. CAT3 transports cationic
amino acids and also plays an important role in embryogenesis (Verrey et al., 2004).
These results are similar to those reported in sheep. Gao and others (2009) reported
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SLC7A1, SLC7A2, and SLC7A3, corresponding to CAT1, CAT2, and CAT3, were
expressed in the trophectoderm and endoderm of the ovine conceptus and concluded the
changes in expression, seen in the uterus and conceptus throughout pregnancy, were
important in the transport of arginine (Gao et al., 2009).
Arginine is an important amino acid. It is a substrate for protein synthesis and a
precursor for different metabolic substances such as nitric oxide and polyamines. Nitric
oxide is known to enhance blood flow and, therefore, the transfer rate of nutrients from
the maternal blood to the fetal blood. Polyamines are important for embryogenesis,
placental growth, protein synthesis, and cell proliferation and differentiation. Both nitric
oxide and polyamines play an important role in angiogenesis (Mateo et al., 2007). In
1996, Wu and others reported arginine concentrations in porcine allantoic fluid were
unusually high (Wu et al., 1996). Based on this finding and the roles of arginine, Mateo
and others (2007) hypothesized that diets supplemented with L-arginine would improve
the reproductive performance of pigs. The authors reported that dietary supplementation
of L-arginine increased the number of pigs born alive and the live litter birth weight by
22% and 24%, corresponding to an increase of 2 live born piglets per litter. Thus, Mateo
and others (2007) suggested that arginine supplementation increased fetal survival and
live litter birth weight in pigs by enhancing placental angiogenesis and, thus, the transport
of arginine from the dam to fetus (Mateo et al., 2007).
In addition, Vallet and others (2014) published a list of solute carrier (SLC) genes
expressed in trophoblast cells of the pig placenta. Although this list was not all-inclusive,
it indicated the presence of several genes coding for nutrient transporter proteins in the
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pig placenta. Among these were genes coding for amino acids transporters, including
genes in the SLC1, SLC3, SLC7, SLC16, SLC36, and SLC38 gene families. The genes
SLC1A3, SLC7A4, and SLC16A10 were the most highly expressed genes for amino acid
transporters (Vallet et al., 2014).
The gene SLC1A3 codes for the glutamate transporter protein GLAST and
corresponds to the transporter system X-AG (Kanai and Hediger, 2004; Vallet et al., 2014).
Glutamate is converted to glutamine by glutamine synthetase, which is highly expressed
in the short cuboidal and tall columnar trophoblast cells of the pig placenta (Self et al.,
2004; Vallet et al., 2014). Glutamine is a precursor in the synthesis of proteins,
aminosugars, purine and pyrimidine nucleotides, and some amino acids. The conversion
of glutamate to glutamine in the pig placenta is consistent with the high fetal maternal
ratio of glutamine and indicates glutamine is an important amino acid for porcine fetal
development (Self et al., 2004).
The gene SLC7A4 corresponds to CAT4, which is similar to the CAT proteins 1-3
of the y+ transporter system mentioned previously. However, the substrates transported
by CAT4 are unknown and, thus, the function of CAT4 is also unknown (Verrey et al.,
2004). Nonetheless, SLC7A2, coding for CAT2, was also expressed in the pig placenta
and functions to transport cationic amino acids (Vallet et al., 2014).
Lastly, the gene SLC16A10 codes for the nutrient transporter protein MCT10 (also
known as TAT1) of the T transporter system. The protein MCT10/TAT1 transports
aromatic amino acids like histidine, phenylalanine, tryptophan, and tyrosine (Halestrap,
2013). The plasma fetal maternal ratios of these amino acids indicate concentrations are
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higher in the maternal plasma than the fetal plasma (Wu et al., 1995). In addition, the
transport of substrates by MCT10 is not proton or sodium coupled (Halestrap, 2013).
Thus, the mechanism of transport appears to be facilitated diffusion instead of active
transport (Vallet et al., 2014).

Lipids
The transfer of nutrients across the placenta is vital for fetal growth.
Carbohydrates, mainly glucose, followed by amino acids are two of the most important
nutrients that cross the pig placenta. Conversely lipids, which contain fatty acids and are
higher energy substrates, reportedly do not cross the pig placenta or transport is very low
(Vallet et al., 2009). However, essential fatty acids, those that cannot be synthesized by
the animal, must be transferred from the dam to the fetus in mammals. On the contrary,
nonessential fatty acids can be de novo synthesized by the fetus (Battaglia and Meschia,
1978). In pigs, free fatty acid (FFA) concentrations are lower in the fetal plasma than the
maternal plasma. Additionally, maternal plasma FFA concentrations decreased after sows
ate a meal; however, this was not correlated with an increase in fetal plasma FFA
concentrations, suggesting maternal FFA are not readily transported across the pig
placenta (Père, 2001). In support of this concept, after pregnant sows were injected with
labeled fatty acids, only minute amounts were found in fetal plasma lipids (Thulin et al.,
1989). Moreover, Elphick and others (1980) reported that the majority of the umbilical
uptake of fatty acids did not directly originate from maternal FFA (Elphick et al., 1980).
Instead, the placenta is capable of fatty acid synthesis and esterification (Martin and
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Hausman, 1981). However, some essential fatty acids, like linoleic acid, are transferred
across the placenta. Seerley and others (1974) reported piglets gestated in sows fed corn
oil had more carcass lipids and more liver and muscle tissue linoleic acid as a result of
the linoleic acid in the corn oil (Seerley et al., 1974). Altogether, these results provide
evidence for the transport of essential fatty acids across the pig placenta and the de novo
synthesis of nonessential fatty acids. However, both are relatively low, which is in
agreement with the very low fat reserves of newborn piglets (Battaglia and Meschia,
1978).
Lipid transport across pig placenta is not well understood. Most fatty acids in the
maternal blood are in the form of triglycerides, which must be broken down into nonesterified fatty acids (NEFA) to be transported across the placenta (Leskanich and Noble,
1999). Triglycerides are broken down by triglyceride lipases, like lipoprotein lipase
(Leskanich and Noble, 1999), whose activity is present in the pig placenta (Ramsay et al.,
1991). In humans and rats, proteins have been identified that mediate the transport of
fatty acids across the placenta, including fatty acid transporter protein (FATP), fatty acid
translocase (FAT), plasma membrane fatty acid binding protein (FABPpm), and fatty
acid binding protein (FABP) (Knipp et al., 1999). In the pig, the SLC genes SLC27A4 and
SLC27A6 were expressed by placental trophoblast cells (Vallet et al., 2014). The gene
SLC27A4 codes for the transport protein FATP4, a long chain fatty acid transporter. The
gene SLC27A6 codes for the transport protein FATP6, which is also a long chain fatty
acid transporter (Stahl, 2004). However, these genes were not highly expressed by the
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trophoblast cells, indicating free fatty acid transport by the pig placenta is indeed poor
(Vallet et al., 2014).
Alternatively, it has been proposed that lipids may be transported to the fetus as
triglycerides bound to lipoproteins (Vallet et al., 2009; Vallet et al., 2014). Lipids are
commonly bound to lipoproteins and cells have receptors for these lipoprotein-lipid
complexes. In addition, Vallet and others (2014) reported trophoblast cells express
receptors for lipoprotein complexes, specifically LRP6 (Vallet et al., 2014). Thus, it
appears lipoproteins may also be involved in lipid transport across the pig placenta.
However, ultimately the mechanisms for lipid transport still remain unclear.

Vitamins and Minerals
Vitamins and minerals are also transported across the pig placenta. The transport
mechanisms of each vitamin or mineral are most likely different. Therefore, the specific
transport mechanism of each nutrient is still unknown (Vallet et al., 2009). However, the
placental transport mechanisms of key vitamins and minerals have been explored in the
pig. Uteroferrin is an iron containing glycoprotein that aids in the transport of iron from
the dam to the fetus in pigs (Roberts and Bazer, 1988). In 1985, Raub and others
identified uteroferrin in the endometrial glands, the lumen of glands and areolae, and the
chorionic epithelial cells of the areolae. Uteroferrin was not found in the surface
epithelium between areolae. In addition, the contents of the chorionic epithelial cells of
the areolae suggested areolae pick up uteroferrin by pinocytosis (Raub et al., 1985). Thus,
iron is transported across the placenta via endometrial gland secretions containing

22

uteroferrin and areolae pickup of those secretions. Uteroferrin then enters fetal circulation
and travels via the umbilical cord vein to the fetal liver (Renegar et al., 1982). Uteroferrin
binds to the fetal liver via mannose specific cell receptors and iron is removed for use by
the fetus (Saunders et al., 1985). Uteroferrin that is not bound by the fetal liver is filtered
by the kidney and excreted into the allantoic sac (Renegar et al., 1982). The iron from
uteroferrin within the allantoic sac is transferred to transferrin, which can leave the
allantoic sac to reach the fetus (Buhi et al., 1982). Thus, the allantoic sac serves as an iron
reservoir for the fetus (Buhi et al., 1983).
Similarly, retinol, a form of vitamin A, is transported adhered to retinol binding
protein. The endometrium synthesizes retinol-binding protein (Clawitter et al., 1990) and
it has been proposed retinol-binding protein transfers retinol to the fetus via the areolae
through a mechanism similar to uteroferrin (Dantzer and Winther, 2001).

Hormones
Hormones affect the transport of nutrients across the placenta and fetal growth.
Specifically, insulin-like growth factors (IGF) and glucocorticoid exposure are known to
affect placental growth, nutrient transport capacity, and fetal growth in several
mammalian species (Zhang et al., 2015). Insulin-like growth factors are single chained
polypeptides that are involved in feto-placental development and alter PE (Fowden et al.,
2009; Zhang et al., 2015). The IGF, IGF-1 and IGF-2, alter metabolism, mitogenesis, and
the differentiation of various cells. Insulin-like growth factors one and two are found in
fetal and placental tissues and expression is affected by the nutritional and hormonal
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status of the uterus. In general, IGF-1 regulates the growth of the fetus in relation to
nutrient availability, whereas IGF-2 stimulates fetal placental growth. Interestingly, the
glucocorticoid cortisol affects the expression of IGF. In sheep, when fetal cortisol levels
rise during the prepartum period IGF-2 expression levels decrease (Fowden, 2003).
Additionally, cortisol affects PE. Administering maternal cortisol in late gestation
increases PE in non-human primates, rats, and sheep. However, overexposure of cortisol
can negatively impact placental morphology and fetal weight. Moreover, glucocorticoids
affect placental production of hormones and affect glucocorticoid availability in fetoplacental tissues by altering the expression of an enzyme that converts glucocorticoids to
the inactive form. Lastly, cortisol affects nutrient transport across the placenta. In a
human placental cell line, cortisol increased system A amino acid transport and the
mRNA and protein expression of the amino acid transporter SNAT2. Conversely,
increasing glucocorticoid exposure in mice, by gene deletion, resulted in an increased
expression of MeAIB transport, increased expression of system A transporter isoforms,
and increased PE at day 15 of gestation. However, by day 18 of gestation the increased
expression was lost, PE was decreased, and glucose transporter expression was decreased
(Fowden et al., 2009). Thus, the effects of glucocorticoids on placental nutrient transfer
seem more variable. Nevertheless, IGF and glucocorticoids play a role in placental
growth, nutrient transport, PE, and ultimately fetal growth.
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Variation in Litter Size
Litter size varies among swine breeds; for example, the Chinese Meishan is
highly prolific and farrows 3 to 4 more piglets per litter than U.S. and European
counterparts (Wilson et al., 1998). For swine producers, litter size is directly proportional
to profitability; therefore, a considerable amount of research has been devoted to litter
size. Attempts to increase litter size in pigs began with ovulation rate and uterine
capacity. Johnson and others (1999) used genetic selection to attempt to increase
ovulation rate and as a result litter size. After 11 generations of selection, there was an
increase of 7.4 ovulations and 3.8 fetuses at day 50 of gestation, but at farrowing this
increase resulted in only 1.1 more live piglets. By generation 14, the overall increase was
1.4 live piglets per litter; however, the increase in litter size was accompanied by lower
birth weights and an increase in the number of stillborn pigs. Thus, increasing litter size
by selecting to increase ovulation rate was impractical. Overall, the authors concluded
that litter size in this selection line was increasingly limited by uterine capacity as the rate
of ovulation increased (Johnson et al., 1999).
Uterine capacity is defined as “the maximum number of fetuses that the dam is
able to support at a specific stage of gestation (Christenson et al., 1987).” Several studies
have demonstrated that uterine capacity is a major factor limiting increases in litter size
after day 30 of gestation. Among these are superovulation, superinduction, and unilateral
hysterectomy-ovariectomy (UHO) studies. Superovulation increases the number of ova
ovulated via exogenous hormones and superinduction is the transfer of additional
embryos to a pregnant uterus (Wilson et al., 1999). Both superovulation and
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superinduction increase the number of embryos up to day 30 of gestation; however,
neither result in larger litters (Fenton et al., 1972; Webel and Dziuk, 1974). Likewise,
UHO females ovulate approximately the same number of ova as controls but farrow
fewer pigs per litter than controls (Christenson et al., 1987). Thus, litter size in pigs is
ultimately limited by uterine capacity. However, attempts to increase uterine capacity via
selection lead to small and irregular increases in litter size (Gama and Johnson, 1993).
Additionally, the heritability of uterine capacity was low (0.09) (Young et al., 1996).
However, researchers attempting to increase litter size in domestic breeds also
focused on comparisons of the highly prolific Chinese Meishan and U.S. and European
breeds. Ford and others (1997) summarized the results of those comparisons. Most
notably, Meishans exhibiting equivalent uterine size and ovulation rates of less prolific
breeds farrow more piglets per litter than U.S. and European breeds. Additionally,
Meishan conceptuses have a reduced trophectoderm mitotic rate during preimplantation,
are shorter after elongation, secrete less estradiol, and are smaller throughout gestation
when compared to U.S. and European pig breeds (Ford et al., 1997). The authors
described this as one strategy for increased litter size in the Meishan as it allows more
conceptuses to survive past day 18. However, a second strategy for increased litter size
exists in Meishans that allows conceptus survival past day 30, when uterine capacity
becomes limiting (Ford, 1997).
In 1998, Wilson and others conducted a study that provided additional evidence
of that second strategy. In this study, Meishan and Yorkshire embryos were cogestated in
either Meishan or Yorkshire recipients to evaluate the effects of uterine type and
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conceptus genotype on development during gestation. In the first experiment, Meishan
and Yorkshire embryos were cogestated in Meishan and Yorkshire recipients until
slaughter on day 90 of gestation. Regardless of genotype, placentas and fetuses recovered
from Meishan recipients were smaller than those recovered from Yorkshire recipients,
Meishan and Yorkshire fetal weights were similar when recovered from Meishan
recipients, and Meishan fetal weights were lighter than Yorkshire littermate fetal weights
when recovered from Yorkshire recipients. Due to the variation in fetal weights when
conceptuses were gestated in Yorkshire recipients, a second experiment was conducted.
In the second experiment, Meishan and Yorkshire embryos were cogestated in Yorkshire
recipients until farrowing. In this experiment, Meishan and Yorkshire fetal weights were
similar, but Meishan placentas were smaller and redder than Yorkshire placentas. In
addition, comparisons of day 90 and term Meishan and Yorkshire placentas revealed that
the Meishan placentas were relatively the same size at day 90 and term, while the
Yorkshire placentas increased in size (70%) from day 90 to term. As a result, Wilson and
others (1998) suggested that near the end of gestation, when fetal demand for nutrients
increases, the Meishan placenta compensates by increasing vascularity, while the
Yorkshire placenta compensates by increasing size (Wilson et al., 1998). Thus, providing
evidence that the second strategy for increased litter size in Meishans is a smaller more
vascular placenta that occupies less uterine space (Ford, 1997).
In response to the above study, Biensen and others (1998) conducted a study to
compare and contrast placental and fetal growth in Yorkshire and Meishan conceptuses
gestated in Yorkshire or Meishan uteri. In this experiment, Meishans received embryo
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transfers from Yorkshires, and Yorkshires received embryo transfers from Meishans,
while other females of both breeds gestated personal embryos. The uteri were recovered
on day 70, 90, and 110 of gestation, and placental size and vascularity were evaluated.
The study concluded that from day 0 to 90 placental size is determined by the type of
uterus the conceptus is gestated in; however, after day 90 the type of uterus become
irrelevant and the specific genotype of the conceptus drives the changes in the placenta.
Hence, between day 90 and term (114 days), when fetal demand for nutrient uptake
increases, the smaller Meishan placenta compensates by coming more vascular, while the
Yorkshire placenta increases in size in order to maintain fetal growth (Biensen et al.,
1998).

Placental Efficiency in Pigs
The studies conducted by Wilson and others (1998) and Biensen and others
(1998) demonstrate a clear difference in PE between breeds exists. Placental efficiency is
defined as “the ratio of fetal weight to placental weight” and indicates the amount of fetal
tissue that can be produced per gram of placenta (Christenson et al., 1987). In general,
Meishans exhibit high PE, as the placentas are small and highly vascularized, while
Yorkshires exhibit low PE, as the placentas are larger and less vascularized (Biensen et
al., 1998; Wilson et al., 1998). However, this variation in placental size and efficiency is
not restricted to breeds; placental variation is also found within breeds and even within
litters.
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In 1999, Wilson and others conducted a study to determine if variations in
placental size and efficiency existed in the Yorkshire population used for research and if
selection for differences in placental size and efficiency would alter litter size. The results
of this study confirmed that variation in PE existed within the population of Yorkshire
pigs and even within individual litters. In addition, selection of pigs for higher (group A)
or lower (group B) than average PE and subsequent breeding indeed resulted in increased
litter size (approximately 3 piglets per litter), increased PE, and reduced placental weight
(40%) in parities belonging to group A. However, the increase in litter size was
accompanied by a 20% reduction in birth weight (Wilson et al., 1999). Although the
decrease in birth weight was small, it is of concern as numerous studies have
demonstrated the negative impact reduced birth weight has on neonatal survival,
postnatal growth, and meat quality (Rehfeldt and Kuhn, 2006).
In contrast, Mesa and others (2005) concluded that PE could not be used as a tool
to increase litter size. However, this study did not directly select for PE. Instead, a
selection index including placental weight, birth weight, and total born was used to
indirectly decrease PE in the low line or increase PE in the high line. The selection
resulted in two divergent lines. By generation 4, birth weight did not differ between lines,
placental weight was lower in the high line than the low line, and PE was higher in the
high line than the low line. However, there was no difference in litter size between the
two lines and for total born in the high line the genetic trend was negative. Therefore, the
authors concluded it was unlikely that litter size could be increased by selecting for
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increased PE (Mesa et al., 2005). However, the opposing results of this study may be due
to the selection method.
In a follow up study, generation 3 females from the selection index study above
were mated within line. At day 110 of gestation, fetal weights were less in the high PE
group than the low PE group, placental weights were less in the high PE group than the
low PE group, and PE did not differ between the high and low PE groups. Thus, the
authors concluded that unlike the Chinese Meishan, decreases in placental weight are not
accompanied by compensatory mechanisms in Western breeds (Mesa et al., 2012).
However, since the females used in this study were originally selected for an index of PE
before directly selecting for PE, these results may not be true for all Western breeds.
Interestingly, Vonnahme and Ford (2004) continued to select and breed the
population of Yorkshires selected for high or low PE by Wilson and others (1999) for
four more generations. These pigs were utilized in a study containing three experimental
groups: a high PE group, a low PE group, and an unselected control group. The goal of
this study was to compare placental and endometrial vascular density and placental
VEGF, VEGF-R1, and VEGF-R2 mRNA expression at days 70 and 90 in each group
(Vonnahme and Ford, 2004). Vascular endothelial growth factor (VEGF) is an
angiogenic factor that increases endothelial cell proliferation, migration, and capillary
permeability when it binds to specific receptors (Neufeld et al., 1994; Stacker and Achen,
1999). Although, the exact cascade of events that occurs is dependent upon which
receptor VEGF binds to, VEGF-R1 or VEGF-R2. Vascular endothelial growth factor,
receptor one affects vascular permeability and endothelial cell differentiation, while
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VEGF-R2 affects endothelial cell proliferation and migration. The results of this study
indicated that placental vascular density increased from day 70 to day 90 in all groups. In
addition, placentas from the high PE group expressed higher VEGF and VEGF-R1
mRNA levels than the low and control groups. However, no additional increase in
placental vascular density was seen in the high PE group to account for the increased
efficiency of those placentas. Therefore, the researchers concluded VEGF must increase
the efficiency of smaller placentas by some other means, possibly by increasing vascular
permeability or reducing the distance separating maternal and fetal blood (Vonnahme and
Ford, 2004).
Correspondingly, in a study by Vallet and Freking (2007) differences in the
placental bilayer structure were associated with small and large pig fetuses. This study
utilized UHO gilts to induce intrauterine crowding during gestation. Gilts were
slaughtered on days 45, 65, 85, and 105 of gestation and samples were taken in
association with the smallest and largest fetuses in a litter. In this study, PE, estimated by
the dividing fetal weight by placental weight, increased as gestation progressed and was
greater for the placentas of smaller fetuses. However, the authors indicated the ratio of
fetal weight to placental weight may not have been the best indicator of PE. Nonetheless,
the placentas associated with the smaller fetuses had increased placental bilayer fold
widths, increased placental bilayer lengths, and decreased widths of the placental stroma
above the folded bilayer. Therefore, the results suggested that the placentas of smaller
fetuses were more efficient because the placenta compensated for the decreased
intrauterine space by increasing the width of the placental bilayer providing more surface

31

area for nutrient exchange between the maternal and fetal blood supplies (Vallet and
Freking, 2007).

Genetics
The efficiency of a placenta not only depends on morphological characteristics,
like vascular density and bilayer width, it also depends on nutrient transporters. The
location, type, and number of nutrient transporters in the placenta are critical, as most
nutrients require transporter proteins to cross the placenta. In 2009, Wilmoth and others
hypothesized that the variations in placental size and efficiency seen within litters may be
due to an increase in nutrient transport by the most efficient feto-placental unit. Since
little was known about the expression of nutrient transporters in the pig, Wilmoth and
other conducted a study to determine if a relationship existed between the mRNA
expression of nutrient transporters in the placenta and adjacent endometrium and PE. In
order to do so, the researchers evaluated placental vascular density within a maternal line
(PIC 1025) and saw an increase in vascular density from day 90 to 110 of gestation
(Wilmoth, 2009). However, as seen by Vonhamme and others (2004), an increase in
placental vascularity does not solely account for the increase in efficiency of smaller
placentas (Vonnahme and Ford, 2004). But, since the viability of Meishan piglets is not
reduced, despite being grown on smaller but more vascular placenta (Wilson et al., 1998),
there may be a correlation between vascular density and nutrient transfer. Therefore,
Wilmoth and others selected specific nutrient transporter genes and determined the
expression of those genes in the placental and adjacent endometrial tissue of each fetus.
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The selected nutrient transporters included GLUT-3, FAT-1, FAT-2, CAT-1, ASCT-1,
yLAT-1 and rBAT-1. However, no differences were found in the mRNA expression of
the selected nutrient transporters using that methodology (Wilmoth, 2009).
During the same time period, Zhou and others (2009) were investigating the
molecular basis of placental development in two breeds with drastically different PE. In
this study, placental samples were collected from Erhualian and Large White gilts for
transcriptomic analysis. Specifically, placental samples were collected from three
Erhualian gilts on day 75 (E75) and day 90 (E90) of gestation and three Large White gilts
on day 75 (L75) and day 90 (L90) of gestation. Two female placental samples were
collected per gilt, used for RNA extraction, and pooled in equal volumes to create 12
pools. The porcine Affymetrix GeneChip was then used to hybridize the pooled samples.
Gene ontology was performed to elucidate the molecular function of all the genes
expressed in the placenta, differentially expressed genes (DEG) on day 75 of gestation,
and DEG on day 90 of gestation. The results of the transcriptome analysis revealed 226
DEG between E75 and L75. Of those, 94 showed increased expression levels in E75,
whereas 132 were more highly expressed in L75. Additionally, 577 genes were
differently expressed between E90 and L90. Of those, 277 showed increased expression
levels in E90, whereas 300 were more highly expressed in L90. The differential
expression of thirteen selected genes was confirmed by RT-PCR. Overall, the results
indicated the DEG were involved in angiogenesis, vascularity, nutrient transport, fetal
development, and hormone regulation. Additionally, the data confirmed that differences
in PE between Chinese breeds and Western breeds are in part attributed to differences in
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vascularity and nutrient transporter expression (Zhou et al., 2009). While this study
focused on variations in PE between breeds, it also confirmed on a genetic level that
placental development differs in Large White gilts. Thus, to address variations in PE
within Large White gilts studies should focus on the genetic expression of placentas from
Large White gilts. Additionally, this study provided a methodology for comparing gene
expression in placental samples and it provided insight on the molecular function of the
genes expressed by the placenta.
In 2014, Vallet and others conducted a study to determine the expression of
nutrient transporters in the pig placenta. In order to do so, placental samples were
collected from pigs on day 85 of gestation and samples from the average weight fetuses
were used to perform a transcriptomic analysis of placental trophoblast cells. Although
not inclusive, the transcriptomic analysis provided a list of solute carrier genes involved
in nutrient transport. The list indicated many genes are expressed in the placental
trophoblast cells that encode for glucose, amino acid, fat, and vitamin and mineral
transporter proteins. Although this study did not account for variations in PE, it provided
more information on the transporter proteins involved in nutrient transport across the pig
placenta (Vallet et al., 2014).
In another study, Su and others (2010) conducted an experiment to investigate if
the regulation of genes by microRNAs differs in the pig placenta at two time points
during gestation. MicroRNAs are small noncoding RNA molecules that posttranscriptionally regulate gene expression by inhibiting translation or causing mRNA
degradation. In this study, placental samples from Large White gilts were collected on
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gestational day 30 and 90, which correspond to two pivotal periods for conceptus loss.
Two placental samples were collected per gilt and the RNA samples were pooled.
MicroRNA array resulted in the discovery of 17 differentially expressed miRNAs, and
the differential expression of 8 miRNAs was confirmed by qRT-PCR. Target gene
prediction and pathway analysis indicated that the differently expressed miRNAs targeted
genes involved in adheren junctions, angiogenesis, trophoblast differentiation, and cell
growth. Thus, the authors concluded that the differentially expressed miRNAs might play
a role in placental growth and development (Su et al., 2010). Overall, this study gave
clues to the underlying genetic mechanisms governing the placenta’s ability to support
fetal development but it did not account for the variations in PE during each time period,
nor did it identify which genes have the greatest impact on litter size.
A more recent study identified DEG associated with litter size in pigs. In this
study, Berkshire pig placentas were divided into two groups based on litter size: a larger
litter size group (LLG) and a smaller litter size group (SLG). Transcriptomic analysis
using RNA sequencing identified 588 DEG. Of those, 98 were upregulated and 490 were
downregulated. Gene ontology enrichment analysis was conducted on the upregulated
and downregulated genes in the LLG. In addition, searching relevant terms in NCBI
PubMed identified DEG associated with litter size. The search revealed 129 of the DEG
were associated with litter size. Of those, 110 were downregulated and 19 were
upregulated. The results were then confirmed with RT-PCR. Lastly, while investigating
the molecular pathways involved in the upregulation of some of the DEG in the LLG,
specifically early growth response 2 (EGR2) and endothelial lipase (LIPG), it was
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discovered that upstream regulators of these genes might be involved. To further
investigate, the authors looked at the mRNA expression of genes associated with the Wnt
signaling pathway known to increase EGR2 expression and genes that regulate LIPG
expression. The results indicated the mRNA expression of a Wnt signaling pathway
molecule, WNT9B, and a regulator of LIPG, IL-6, were increased in the LLG compared to
the SLG. Wnt signaling is known to play a role in placental development and
differentiation and may be involved in trophoblast lipid transport. The gene LIPG
encodes a lipase involved in the hydrolysis of triglycerides and phospholipids. Based on
these results, the authors concluded that IL-6 and LIPG may be involved in increasing
nutrient transport across the pig placenta (Kwon et al., 2016). While this study identified
DEG associated with litter size within a breed and identified specific genes that may
function to increase nutrient transport across the placenta, it did not address variations in
PE between or within litters. To further understand the mechanisms at play, it would be
advantageous to include placental characteristics.

Conclusion
In summary, as the world population continues to grow, there is a need for
sustainable and efficient increases in food production. Several attributes make the swine
industry the perfect candidate, including the industry’s vertical integration, the short
gestation length of pigs, and the short grow out phase of pigs. The breeds used for
production in the U.S. farrow fewer piglets per litter than more prolific breeds like the
Chinese Meishan. Thus, attempts to increase litter size in these breeds have been long
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underway. Early attempts considered ovulation rate, uterine capacity, and uterine length.
However, it was determined increasing these parameters resulted in little to no increase in
litter size. Alternatively, more recent research indicates PE is a significant factor in litter
size. Placental efficiency, defined as “the ratio of fetal weight to placental weight,”
describes the amount of fetal tissue that can be produced per gram of placenta
(Christenson et al., 1987). Variations in PE were first seen between the Chinese Meishan
and the Yorkshire; however, these variations are not restricted to breeds. Instead,
variations in PE are seen within breeds and even within litters. Studies investigating
variations in PE within litters have indicated a difference in the functionality of the most
efficient and least efficient placenta in a litter exists. Research has focused on placental
vascularity, nutrient transport, and more recently, genetic differences. Collectively, the
research indicates that increases in PE may be associated with variations in gene
expression that positively affect fetal growth via various growth factors and improved
nutrient transport. Determining if a difference exists in the global expression of genes
between the least and most efficient placentas in a litter may help elucidate the role of PE
in litter size.
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CHAPTER TWO
PLACENTAL EFFICIENCY IN RELATION TO NEONATAL GROWTH
MEASUREMENTS, AND THE CONCENTRATION OF GLUCOSE
AND CORTISOL IN THE UMBILICAL BLOOD OF PIGS
Abstract
Within domestic pig litters, placentas can vary drastically in size yet yield piglets
of approximately the same size; however, the means enabling the smaller placenta to
grow a similarly sized littermate is still unknown. The ratio of fetal weight to placental
weight, termed placental efficiency (PE), has been used to quantify this variation.
Previous research indicates nutrient transport capacity, which relies partly on nutrient
transporter proteins and can be altered by hormone exposure, may play a role. Therefore,
the main objective of this study was to determine the concentration of glucose and
cortisol in the venous umbilical blood of pigs at birth and evaluate if a relationship
existed between concentration and PE. Terminal Yorkshire crossed pigs (n = 15) were
monitored during farrowing, between December 2015 and October 2016, to tag and
match each pig and associated placenta, take venous umbilical blood samples, and
neonatal measurements. Placental efficiency was determined and used to create a high PE
group (n = 23) and a low PE group (n = 21). Mean birth weight was not significantly
different between the high PE group and the low PE group (1537.24 ± 192.50 and
1531.38 ± 286.55, P = 0.8596), but mean placental weight was significantly lower (P <
0.0001) in the high PE group (240.86 ± 37.12) compared to the low PE group (441.55 ±
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112.85). Mean CRL and mean girth were not significantly different by PE (P = 0.9206, P
= 0.5644). Mean glucose concentration was higher in the high PE group (47.60 ± 29.69)
than the low PE group (38.91 ± 16.32), but this difference was not significant (P =
.2882). Similarly, mean cortisol was higher in the high PE group (23.39 ± 7.22)
compared to the low PE group (17.88 ± 7.57), but this difference was also not significant
(P = 0.1612). Additionally, mean body weight over time (0, 1, 2, 3, 7, 14, and 21 d) was
not significantly different by PE (P = 0.6800). The basis of high PE, a smaller but more
efficient placenta, was confirmed as placental weight was reduced but fetal size was not
different in the high PE group. Furthermore, glucose and cortisol concentrations did not
differ by PE, suggesting high PE placentas have some other means enabling the transport
of similar concentrations despite a reduction in size, such as increased transporter number
or type and altered enzyme activity or increased bilayer width, respectively.
Keywords: Pigs, Placental Efficiency, Glucose, Cortisol

Introduction
As the human population continues to increase, there is a need for efficient
increases in food production. Since pigs are a litter-bearing species, have a relatively
short gestation length, and the time to slaughter weight is less than that of larger meat
animals, increases in the reproductive efficiency of pigs would provide sustainable and
efficient increases in meat production. However, attempts to increase litter size have been
long underway and have resulted in little to no increase in litter size. These attempts
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considered ovulation rate, uterine capacity, and uterine length. Alternatively, current
research suggests placental efficiency (PE) may have a significant role in litter size.
The placenta plays a vital role in the development of the piglet. The placenta is an
organ that creates an interface for exchange between the mother and fetus; main functions
include nutrient and gas exchange, metabolism, and hormone production (Bauer et al.,
1998b). In swine, the placenta is characterized as diffuse epitheliochorial. The first
classification, diffuse, is a classification based on placental shape and area of attachment.
Diffuse describes how almost the entire placenta attaches to the adjacent endometrium,
which allows for nutrient transport to occur at any point along the placenta. The second
classification, epitheliochorial, is a classification based on the number of tissue layers
separating maternal and fetal blood. Epitheliochorial designates the presence of six tissue
layers; therefore, nutrients from the maternal blood must pass through all six tissue layers
to reach the fetal blood (Steven, 1975).
Placental efficiency is quantified by “the ratio of fetal weight to placental weight”
and indicates the amount of fetal tissue that can be produced per gram of placenta
(Christenson et al., 1987). Variations in PE were first seen between breeds (Biensen et
al., 1998; Wilson et al., 1998). However, variations in PE are not restricted to breeds;
placental variation is also found within breeds and even within litters. In fact, it is
common to find placentas that are drastically different in size yet yield piglets that are
approximately the same size.
Therefore, variations in PE may be attributed to differences in nutrient transport
capacity. Most nutrients are transported across the placenta with the aid of transport
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proteins. For example, glucose, the main energy substrate utilized by the fetus, is
transported across the placenta by facilitative transporter proteins (Hay Jr, 1994; Hay Jr,
2006). However, some key vitamins and minerals, such as iron, are transported from the
dam to the fetus via endometrial gland secretions and the resulting areolae pickup of
those secretions (Raub et al., 1985). Thus, fetal nutrient availability is dependent upon the
mechanism of transport across the placenta and the abundance of that mechanism.
Furthermore, exposure to hormones such as insulin-like growth factors (IGF) and
glucocorticoids are known to affect placental growth, nutrient transport capacity, and
fetal growth in several mammalian species (Zhang et al., 2015). For instance, in humans
and mice the glucocorticoid cortisol has been shown to alter the expression of nutrient
transporters in the placenta (Fowden et al., 2009). Additionally, IGF-1 is known to
regulate the growth of the fetus in relation to nutrient availability; however, cortisol
affects the expression of IGF (Fowden, 2003). Hence, it is plausible that a relationship
exists between PE and the abundance of various metabolites and hormones in fetal blood.
Therefore, the main objective of this study was to determine the concentration of glucose
and cortisol in the venous umbilical cord blood of pigs at farrowing and evaluate if a
relationship existed between the concentrations and PE.

Materials and Methods
Experimental Design
All procedures were approved by the Clemson University Animal Care and Use
Committee (AUP #2015-068).

41

Animal Management
Terminal Yorkshire crossed gilts and sows (n = 15) at Clemson University’s
Starkey Swine Center were checked for standing heat twice per day in the morning and
evening. Once estrus was detected, gilts/sows were bred by artificial insemination 12 h
and 24 h later. During gestation, females were housed in groups. The Monday before
estimated due dates, females were moved to crates in the farrowing barn and allowed to
farrow naturally. Farrowing assistance was provided when deemed necessary by the
farm’s standard operating procedures.

Sample Collection
Gilts and sows were monitored for signs of farrowing beginning 1 d prior to
estimated due dates. Females were checked every hour for the following signs of
farrowing: vulvar swelling, vulvar discharge, restlessness, rooting/nesting behavior,
contractions, and streaming milk. Once the first signs of farrowing were detected,
females were checked every 30 min. Upon initiation of farrowing, females were
monitored constantly until the last placenta was passed.
During farrowing, as each pig was expelled, the portion of the umbilical cord
closest to the dam’s vulva was tagged with a numbered mouse ear tag (umbilical tag).
The umbilical cord was then ruptured below the tag to ensure the tag remained with the
portion of the umbilical cord attached to the placenta. Next, each pig was given an
identification number corresponding to the order of birth, using the conventional ear
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notching system. Both numbers, umbilical tag number and pig ear notch number, were
recorded on a data sheet to ensure each pig and associated placenta could be matched.
Following pig identification, an umbilical cord blood sample was taken from each
pig using a 10 mL syringe and 22-gauge needle. Additionally, several neonatal
measurements were taken including birth weight, crown-rump length (CRL), and girth.
Sex, male (M) or female (F), was also recorded. This procedure was repeated for each
pig.
Next, placentas were collected as they were expelled. In the instance that more
than one placenta was expelled at a time, the placentas were carefully sorted by finding
the two entangled necrotic tips and peeling them apart. Care was taken to ensure the
placentas were not ripped apart. Once the placentas were sorted, each placenta was
matched to the appropriate pig by corresponding umbilical tag and ear notch numbers.
Next, each placenta was weighed and then PE for each feto-placental unit was calculated
by dividing birth weight by placental weight. After farrowing, each piglet was weighed 1
d, 2 d, 3 d, 7 d, 14 d, and 21 d after birth.

Glucose and Cortisol Quantification
Following collection, umbilical cord blood samples were allowed to clot at room
temperature for 2 h before overnight incubation at 4 °C. Samples were then centrifuged
at 3,000 rpm for 20 min at 4 °C. Serum was removed, stored in 0.5 mL microcentrifuge
tubes to avoid repeated freeze thaw cycles, and frozen at -20 °C until the assays could be
performed.
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Serum glucose concentrations were determined using a glucose colorimetric assay
kit from Caymen Chemical (Ann Arbor, MI). The assays were performed according to
the manufacturer’s assay procedures and it was determined a 1:5 dilution of the samples
was necessary. Absorbance was measured using a spectrophotometer (Powerwave X340,
BioTek, Winooski, VT) at 520 nm. Concentrations were generated using KC4 software
(BioTek, Winooski, VT).
Cortisol concentrations were determined in the serum samples using a Corti-Cote
RIA from MP Biomedicals LLC (Orangeburg, NY). The assays were performed
according to the manufacturer’s assay procedures in Clemson University’s Endocrine
Physiology Lab.

Statistical Analysis
To make comparisons based on PE, a high PE group and a low PE group were
selected from the litters collected (n = 15) based on the normal distribution of all PE
values obtained. Feto-placental units with PE values above the 75th quartile (> 5.7) were
included in the high PE group (n = 23) and feto-placental units with PE values below the
25th quartile (< 4.12) were included in the low PE group (n = 21). Statistical analyses
were conducted using JMP Pro version 12.2.0 (SAS Institute Inc., Cary, NC, 1989-2007).
A linear mixed effects model was used to analyze each dependent variable, with PE, sex,
and PE*sex as fixed effects, and a random effect to account for pig nested within dam.
Pig body weights over time were also analyzed as the dependent variable, but with PE,
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time, sex, and all possible interactions as fixed effects, and pig nested within dam as a
random effect. A significance level of 0.05 was used for all tests of significance.

Results
Descriptive statistics for the variables placental weight, birth weight, CRL, girth,
glucose concentrations, and cortisol concentrations are presented in Table 2.1. For these
variables of interest, there was not a significant effect of sex or an interaction between PE
and sex. Mean placental weight was lower in the high PE group than the low PE group
and this difference was significant (P < 0.0001, Figure 2.1). Conversely, mean birth
weight was slightly higher in the high PE group compared to the low PE group, but this
difference was not significant (Figure 2.1). Likewise, mean CRL was slightly higher in
the high PE group than the low PE group, but this difference was not significant (Figure
2.2). Mean girth was also slightly higher in the high PE group compared to the low PE
group, but again, this difference was not significant (Figure 2.3). Moreover, mean
glucose concentration was higher in the high PE group than the low PE group; however,
this difference was not significant (Figure 2.4). Similarly, mean cortisol concentration
was higher in the high PE group compared to the low PE group, but this difference was
also not significant (Figure 2.5).
Descriptive statistics for the variable body weight over time are presented in
Table 2.2. For this variable, there was not a significant effect of sex and there were no
significant interactions between PE and sex, PE and time, sex and time, or PE, time, and
sex. As expected, time, measured in days, was a significant effect as mean body weight
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increased with day (P < 0.0001, Figure 2.6). Furthermore, mean body weight was higher
in the high PE group compared to the low PE group on days 0, 1, 2, 3, and 21, while
mean body weight was higher in the low PE group compared to the high PE group on
days 7 and 14; however, these differences were not significant (Figure 2.6). Additionally,
although there were no significant interactions between PE and sex, Figure 2.7 illustrates
the numerical separation in mean body weights over time by PE and sex at day 21.
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Table 2.1 Descriptive statistics by placental efficiency (L or H) for the measurements
placental weight, birth weight, crown-rump length, girth, glucose concentration, and
cortisol concentration taken at birth in pigs.
Measurement
Placenta Wt, g
L
H
Birth Wt, g
L
H
CRL, cm
L
H
Girth, cm
L
H
Glucose, mg/dL
L
H
Cortisol, µg/dL
L
H

Statistic
Mean
SD
441.55
240.86

112.85
37.12

1531.38
1537.24

286.55
192.50

27.52
28.17

2.73
1.70

25.43
25.57

2.22
1.42

38.91
47.60

16.32
29.69

17.88
23.39

7.57
7.22

F
55.1838

PE
P-value
< .0001*

Effect
Sex
PE*Sex
F
P-value
F
P-value
1.3332 0.2555 1.5982 0.2139

0.0317

0.8596

0.0232

0.8797

0.7786

0.3832

0.0101

0.9206

0.8310

0.3681

1.3604

0.2512

0.3385

0.5644

2.1349

0.1531

0.0504

0.8237

1.1680

0.2882

2.2789

0.1416

0.0465

0.8308

2.06

0.1612

0.9873

0.3280

0.6645

0.4212

Means ± SD
Asterisk (*) indicates P < 0.05
PE denominator degrees of freedom between 30.69 and 39.70
Sex denominator degrees of freedom between 30.15 and 38.06
PE*Sex denominator degrees of freedom between 29.10 and 37.97
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Mean Placental Weight & Birth
Weight
2000
1800

Weight (g)

1600
1400
1200
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800

Low PE

*

High PE

600
400
200
0

Placental

Birth

Figure 2.1 Mean placental weight and birth weight of pigs in the low placental efficiency
group and high placental efficiency group. Mean ± SD,
P < 0.05 indicated by an asterisk (*).
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Mean Crown-Rump Length
35
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CRL (cm)

25
20
15

27.52

28.17
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High

10
5
0

Placental Ef9iciency
Figure 2.2 Mean crown-rump length of pigs at birth in the low placental efficiency group
and high placental efficiency group. Mean ± SD.

49

Mean Girth
28
27

Girth (cm)

26
25
24
23

25.43

25.57
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High

22
21
20

Placental Ef9iciency
Figure 2.3 Mean girth of pigs at birth in the low placental efficiency group and high
placental efficiency group. Mean ± SD.
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Mean Glucose Concentration
90

Glucose (mg/dL)
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20
10
0

38.91

47.6
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Placental Ef9iciency

Figure 2.4 Mean glucose concentration in the venous umbilical cord blood of pigs at
birth in the low placental efficiency group and high placental efficiency group.
Mean ± SD
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Mean Cortisol Concentration
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Cortisol (µg/dL)
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5
0
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High
Placental Ef9iciency

Figure 2.5 Mean cortisol concentration in the venous umbilical cord blood of pigs at
birth in the low placental efficiency group and high placental efficiency goup.
Mean ± SD
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Table 2.2 Descriptive statistics by placental efficiency (L or H) for the measurement
body weight at 0, 1, 2, 3, 7, 14, and 21 days after birth in pigs.
Statistic
Measurement
Mean
SD
Body Wt, g
0d
L
1531.38
286.55
H
1537.24
192.50
1d
L
1596.12
337.12
H
1639.33
214.46
2d
L
1760.86
416.28
H
1776.89
259.98
3d
L
1924.10
470.82
H
1942.93
325.52
7d
L
3094.68
607.03
H
3084.13
399.95
14d
L
5243.79 1119.31
H
5152.92
828.04
21d
L
7482.06 1573.90
H
7841.69 1214.37
Body Wt
Effects
F
P-value
PE
0.1727
0.6800
Sex
0.1689
0.6833
PE*Sex
1.9347
0.1719
Time
782.1386 < .0001*
PE*Time
0.6449
0.6942
Sex*Time
0.4649
0.8338
PE*Time*Sex 0.8795
0.5108
Means ± SD
Asterisk (*) indicates P < 0.05
PE, Sex, PE*Sex denominator degrees of freedom 40.20
Time, PE*Time, Sex*Time, and PE*Time*Sex degrees of
freedom 212.60
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Mean Body Weight Over Time
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Figure 2.6 Mean body weight of pigs after birth on days 0, 1, 2, 3, 7, 14, and 21 in the
low placental efficiency group and high placental efficiency group. Mean ± SD
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Mean Body Weight Over Time
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Time (d)
Figure 2.7 Mean body weight of pigs after birth on days 0, 1, 2, 3, 7, 14, and 21 in low
placental efficiency females, low placental efficiency males, high placental efficiency
females, and high placental efficiency males. Mean ± SD
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Discussion
Within domestic pig litters, placentas can vary drastically in size yet yield piglets
of approximately the same size. The ratio of fetal weight to placental weight, termed PE,
has been used to quantify this variation; however, the means enabling the smaller
placenta to grow a similarly sized littermate is still unknown. Previous research indicates
nutrient transport capacity, which relies partly on nutrient transporter proteins and can be
altered by hormone exposure, may play a role. Therefore, the main objective of this study
was to determine the concentration of glucose and cortisol in the venous umbilical blood
of pigs at birth and evaluate if a relationship existed between concentration and PE.
Another objective of this study was to evaluate the effect of PE on the postnatal growth
performance of pigs up to day 21.
Previous studies have reported high PE placentas are smaller than low PE
placentas, yet each grow a littermate of comparable size (Wilmoth, 2009; Wilmoth,
2012). Placental weight, as expected, was reduced in high PE placentas compared to low
PE placentas. Moreover, birth weight did not differ by PE; which is in agreement with the
results of previous studies.
Furthermore, birth weight is an indicator of neonatal survival, with lower birth
weights indicating decreased survival (Rehfeldt and Kuhn, 2006). Birth weight is also
commonly used as an indicator of postnatal growth performance in pigs (Douglas et al.,
2016). It is well known that the postnatal growth performance of low birth weight pigs is
reduced. Low birth weight pigs take longer to grow, have lower carcass quality, and as a
result, lower meat quality (Rehfeldt and Kuhn, 2006). However, since PE did not affect
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birth weight in this study, the survival and postnatal growth of pigs grown on high PE
placentas should not be reduced.
Crown-rump length is highly correlated to fetal age (Ullrey et al., 1965) and fetal
weight (Jang et al., 2014) during gestation. However, CRL can also be used to calculate
ponderal index (birth weight/(crown-rump length)3) and body mass index (birth
weight/(crown-rump length)2), which are often superior indicators of neonatal survival
(Baxter et al., 2008). Additionally, Baxter and others (2008) reported stillborn pigs had
longer CRL (≥ 29.80 cm) than surviving pigs and pigs that died during the neonatal
period had shorter CRL (≤ 25.70 cm) than surviving pigs. In other words, pigs with
longer than average or shorter than average CRL are at risk for reduced survival. In this
study, the mean CRL of high PE pigs (28.17 ± 1.70 cm) and low PE pigs (27.52 ± 2.73
cm) was between the critical lengths reported by Baxter and others (2008), and CRL was
not different between high and low PE pigs; therefore, the neonatal survivability of pigs
grown on high PE placentas should not be reduced. Additionally, the absence of a
difference in CRL between high and low PE pigs has previously been reported by
Wilmoth (2012).
Similar to CRL, girth can be used to predict body weight (Groesbeck et al., 2010);
and CRL, in addition to indicating neonatal survival, along with girth, can be used to
predict postnatal growth. Recent studies have suggested morphological measurements,
like CRL and girth, may be “more reflective of the intrauterine environment” and,
therefore, better determinants of postnatal growth (Douglas et al., 2016). In fact, Douglas
and others (2016) reported the best predictor of postnatal growth performance was not
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birth weight and, instead, reported morphological measurements were more predictive,
but which measurement was dependent upon birth weight and phase of growth. For
example, for normal birth weight pigs from day 1 to 28, abdominal circumference was
the best indicator of growth performance, while CRL was the best indicator of growth
performance from day 28 to 70 (Douglas et al., 2016). As previously stated, mean CRL
was not different between high and low PE pigs. Likewise, mean girth was not different
between high and low PE pigs. Therefore, the postnatal growth performance of pigs
grown on high PE placentas should not be reduced.
Accordingly, mean body weight over time (1 d, 2 d, 3 d, 7 d, 14 d, 21 d) was not
different between high and low PE pigs. This data demonstrates that, up to at least day
21, the postnatal growth performance of pigs grown on high PE placentas is not reduced.
However, although not statistically significant, there was a separation in the mean body
weight of high PE and low PE pigs, more so between high PE males and low PE males,
on day 21. Therefore, it is possible that a separation in the mean body weight of high and
low PE pigs occurs after day 21. Thus, future studies should record body weights until
slaughter weight is reached; however, it is important to note that in addition to uterine
effects, body weights beyond day 21 will also reflect environmental effects, like
hierarchy and heat stress.
The concentration of glucose and cortisol in the venous umbilical blood of high
PE and low PE pigs at birth was also determined. Allowing dams to farrow naturally
provided a less invasive way to collect data and another time point in gestation to
evaluate, but allowing dams to farrow naturally was also a limitation of this study. Some
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umbilical cords were broken before the pigs were farrowed, which prevented pairing of
those fetal-placental units (required to determine PE) and hindered umbilical cord blood
sampling. This limitation was managed by using the 25th and 75th quartile of all PE
values obtained, opposed to the highest and lowest PE values per litter, to create the high
PE group and the low PE group used for comparisons. However, further research is
warranted to determine which method of defining high and low PE is more appropriate.
Glucose, the main energy substrate of fetal pigs, was numerically higher in high
PE compared to low PE pigs, but this difference was not significant. Glucose standard
deviations were also large, particularly in the high PE group. Another limitation of this
study was that the feed intake of dams was not measured. Although dams were fed the
same amount of feed at the same time, pigs nearing farrowing may come off feed or
consume less. Therefore, the variation in venous umbilical cord glucose concentrations
may be attributed to differences in feed intake by dams, a variable future studies should
record.
Nonetheless, Wilmoth (2012) also reported umbilical cord venous-arterial blood
glucose concentration differences were not different between high and low PE pigs. The
lack of a difference in this major energy substrate is intriguing since high PE placentas
were smaller than low PE placentas but birth weight was not different between high and
low PE pigs. Thus, the lack of a difference in glucose between high and low PE pigs
suggests that high PE placentas have some other means allowing the smaller placenta to
transport comparable nutrient quantities and grow a similarly sized littermate. Vonnahme
and Ford (2004) reported increased placental vascularity was not solely accountable for
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the increased efficiency of smaller placentas (Vonnahme and Ford, 2004). However,
since the efficiency of the placenta is complex and has been reported to be dependent
upon several characteristics, such as placental vascularity, bilayer width, and nutrient
transporter proteins, it is plausible that the increased efficiency of smaller placentas is
related to an increase in the number, type, or location of nutrient transporter proteins in
the placenta. However, Wilmoth (2009) found no difference in the expression of selected
nutrient transporter genes between high and low PE placentas, but the expression of only
seven nutrient transporter genes was determined (Wilmoth, 2009). Future work should
focus on the expression of all nutrient transporters in the pig placenta and the localization
of those nutrients transporters at the endometrial placental bilayer in relation to PE and
the concentration of metabolites like glucose.
Lastly, the concentration of glucocorticoid cortisol was measured in the umbilical
blood of high PE and low PE feto-placental units. Cortisol is known to impact fetal
development. For example, near the end of gestation an increase in fetal cortisol
concentration occurs that is necessary for small intestine maturation (Lin et al., 2012) and
organ maturation, such as the lungs and the liver (McNeil et al., 2007). However, while a
natural increase in cortisol near the end of gestation occurs, previous studies have
reported an overexposure to cortisol retards fetal growth (McNeil et al., 2007). Likewise,
a reduction in venous umbilical cord cortisol concentration is associated with intrauterine
growth restriction (defined by low birth weight) in pigs (Lin et al., 2012).
Furthermore, both the adrenal gland of the fetus and maternally derived cortisol,
which can diffuse across the placenta, contribute to fetal cortisol concentrations.
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Although, the availability of cortisol is regulated by an enzyme, 11 β-hydroxysteroid
dehydrogenase-isoform 2 (11β HSD-2), which converts cortisol into cortisone, a
biologically less active compound. Correspondingly, placental 11β HSD-2 limits cortisol
diffusion across the placenta (McNeil et al., 2007). In this study, the mean venous
umbilical cord cortisol concentration between high and low PE groups did not differ.
Considering an overexposure or reduction in cortisol negatively impacts fetal growth and
birth weight, and neither cortisol concentration or birth weight differed by PE, the results
of this study are in agreement. However, high PE placentas were smaller than low PE
placentas; therefore, the mechanism by which the smaller more efficient placenta diffuses
similar amounts of cortisol is unknown.
There are several plausible explanations for the means enabling the smaller
placenta to diffuse similar quantities of cortisol. Vallet and Freaking (2007) reported high
PE placentas, associated with the smallest fetus in a litter, were more efficient due to an
increased placental bilayer width that provided more surface area for exchange (Vallet
and Freking, 2007). Thus, the smaller high efficiency placentas in this study may have
transferred equivalent amounts of cortisol to the fetus via an increased placental bilayer
width that provided more surface area for exchange. Additionally, the smaller more
efficient placenta (high PE) may inactivate less cortisol, via 11β HSD-2, in order to
transport a similar amount of cortisol to the fetus or the larger less efficient placenta (low
PE) may inactivate more cortisol, via 11β HSD-2, in order to prevent fetal overexposure
to cortisol. Lastly, research indicates by day 50 of gestation 77% of fetal cortisol
originates from the fetal adrenal gland, but by day 100 of gestation 94% of fetal cortisol
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originates from the fetal adrenal gland (McNeil et al., 2007). Therefore, at the end of
gestation the amount of maternal cortisol diffusing across the placenta should be minimal
due to the maternal fetal concentration gradient; hence, the smaller size of the high PE
placentas (less surface area for diffusion) may have no impact on cortisol diffusion across
the placenta at that time point. In order to address these possible explanations, future
work should evaluate placental bilayer widths and determine the activity of placental 11β
HSD-2, in relation to cortisol concentrations in high PE and low PE feto-placental units.
In addition to fetal development, cortisol also impacts the placenta. In non-human
primates, rats, and sheep, administering maternal cortisol during late gestation increased
PE; however, these increases in PE were accompanied not only by a reduction in
placental size, but also a reduction in fetal weight. Glucocorticoids are also known to
alter placental production of hormones. Moreover, glucocorticoids have been reported to
affect placental nutrient transport. In a placental cell line specific to humans, cortisol
increased system A amino acid transport via the SNAT2 transporter protein (Fowden et
al., 2009). In contrast, GLUT-1 and GLUT-3 transporter proteins were downregulated in
response to synthetic cortisol exposure in human placental trophoblast cells (Hahn et al.,
1999). In rat placentas, GLUT-1 and GLUT-3 transporter protein expression has been
reported to increase (Langdown and Sugden, 2001) and decrease (Hahn et al., 1999).
Additionally, increasing glucocorticoid exposure in mice, by deleting the gene coding for
the enzyme 11β HSD-2, initially upregulated MeAIB transport via system A amino acid
transporters; however, this increase was lost by day 18 and SLC2A3 glucose transporter
expression was decreased (Fowden et al., 2009). Although the response varies, it is
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apparent glucocorticoids impact the placenta. Nonetheless, this study measured cortisol
concentrations in the venous umbilical cord blood of pigs after diffusion across the
placenta; therefore, it is still possible that cortisol, at the placental level, may impact high
and low PE placentas differently. Accordingly, future studies should determine the
concentration of cortisol in the uterine artery and umbilical vein, and evaluate if a
relationship exists between cortisol concentrations and the expression of nutrient
transporters in high PE compared to low PE placentas.
In conclusion, the basis of high PE, a smaller more efficient placenta capable of
growing a similarly sized littermate, was confirmed. Additionally, the survival and
postnatal growth performance of pigs grown of high PE placentas should not be reduced,
as indicated by birth weight, CRL, girth, and body weights up to day 21. Although, it is
recommended that future studies follow body weight to slaughter weight to ensure the
postnatal growth performance of pigs is not affected by PE. The lack of a difference in
umbilical cord glucose and cortisol concentrations between high and low PE pigs
suggested that high PE placentas have some other means allowing the smaller placenta to
transport comparable nutrient/hormone quantities and grow a similarly sized littermate.
Previous research indicates an increase in transporter number or type in the placenta
(glucose) and altered placental enzyme activity or increased placental bilayer width
(cortisol) may contribute to the increased efficiency of high PE placentas. Therefore,
future work evaluating the relationship between metabolites and PE should consider
placental nutrient transporter abundance, placental enzyme activity, and placental bilayer
width. Moreover, to address the limitations of this study, future studies should record the
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feed intake of dams leading up to farrowing to determine if feed intake significantly
effects umbilical cord metabolite concentrations between high and low PE feto-placental
units, and determine the best way to define high and low PE (cutoff values).
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CHAPTER THREE
THE IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES
BETWEEN HIGH PLACENTAL EFFICIENCY AND LOW
PLACENTAL EFFICIENCY PLACENTAS IN SWINE
Abstract
Placental efficiency (PE) describes the relationship between placental and fetal
weights and is defined as fetal weight divided by placental weight. Within pig litters, PE
can vary drastically, resulting in similarly sized pigs associated with very different
placenta, up to a 50% weight difference. However, the means enabling the smaller
placenta to grow a similarly sized littermate is unknown. We hypothesized high PE
placentas would have differential gene expression that affects fetal growth via growth
factors and/or improved nutrient transport. Accordingly, the main objective of this study
was to determine the expression level of genes in placental and associated endometrial
tissues of high PE and low PE feto-placental units. Another objective of this study was to
obtain descriptive measurements of each feto-placental unit to compare high PE and low
PE units. Maternal line gilts (n = 8) were ovario-hysterectomized on day 95 of gestation
to obtain umbilical blood, fetal growth measurements, fetal organ and tissue weights, and
placental and endometrial samples. PE was calculated to identify the most efficient and
least efficient feto-placental unit in each litter; samples from these units were compared.
Placental and endometrial vascular density (VD) was measured. Glucose and nonesterified fatty acid (NEFA) concentrations in the umbilical blood were determined. RNA
sequencing was performed to identify differentially expressed genes (DEG) in high PE
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compared to low PE placental and endometrial tissues. Gene ontology (GO) enrichment
analysis was also performed. Fetal measurements, VD, glucose and NEFA were not
significantly different (P <0.05) between high PE and low PE feto-placental units. In
total, 214 DEG (false discovery rate P-value (FDR) < 0.10) were identified in the
placenta and zero DEG (FDR < 0.10) were identified in the endometrium. Of the DEG in
the placenta, 103 genes were upregulated (33 log fold change (logFC) ≥ 1; 70 0 < logFC
< 1.0) and 111 genes were downregulated (49 logFC ≤ -1.0; 62 -1.0 < logFC < 0). Gene
ontology enrichment analysis identified 4 significantly enriched terms (FDR < 0.05) in
the upregulated genes and zero significantly enriched terms (FDR < 0.05) in the
downregulated genes. The results indicate the reduction in placental size, characteristic of
high PE placentas, does not adversely affect the fetus. The lack of a difference in
placental VD, and glucose and NEFA in the umbilical blood of high PE and low PE fetoplacental units confirmed data indicating high PE placentas have another means enabling
the smaller placenta to grow a similarly sized littermate. The identification of DEG in
high PE compared to low PE pig placentas, and further analysis of those genes,
confirmed a portion of the DEG in the pig placenta encode nutrient transporters and gene
products with growth factor or angiogenic activity; however, DEG with alternative
functions were also identified, indicating the complexity of the relationship between
placental and fetal weights.
Keywords: Placental Efficiency, Pigs, Birth Weight, Gene Expression
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Introduction
Litter sizes of U.S. and European pig breeds differ from those of more prolific
breeds. For instance, the Chinese Meishan, a highly prolific breed, farrows 3 to 4 more
piglets per litter than commercial pig breeds (Wilson et al., 1998). Several attempts to
increase litter size in commercial pigs have been made; however, these attempts resulted
in little to no increase in litter size. Currently, increasing litter size in pigs is of renewed
interest as the human population continues to increase and, thus, the need for efficient
increases in food production becomes more urgent.
Previous research identified uterine capacity, or the number of conceptuses a
female can support during gestation, as the major factor limiting increases in litter size
(Christenson et al., 1987). However, selecting for increased uterine capacity resulted in
small and variable increases in litter size (Gama and Johnson, 1993). Nonetheless,
comparisons of the highly prolific Chinese Meishan to Yorkshires revealed differences in
the ratio of fetal weight to placental weight, termed placental efficiency (PE). Meishans
exhibited high PE, as the placentas were small and highly vascularized, while Yorkshires
exhibited low PE, as the placentas were larger and less vascularized (Biensen et al., 1998;
Wilson et al., 1998).
Moreover, the variation in PE identified between breeds was also found within
commercial breeds and within litters (Wilson et al., 1999). Often, littermates will be
approximately the same size but grown on placentas of drastically different sizes,
indicating there is a difference in the functionality of the placentas. The increased
efficiency of high PE placentas within commercial breeds may be partially attributed to
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increased vascular endothelial growth factor (Vonnahme and Ford, 2004) and/or
increased width of the placental bilayer providing more surface area for nutrient
exchange (Vallet and Freking, 2007). However, in pigs, nutrients from the maternal blood
must pass through six tissue layers to reach the fetal blood, and most of those nutrients
require nutrient transporters to cross the placenta (Steven, 1975). Hence, the variation in
PE seen within litters may be due to increased nutrient transport by the high PE placenta.
Yet, an analysis of selected nutrient transporters in high and low PE samples revealed no
differences in nutrient transporter expression (Wilmoth, 2009).
Conversely, a comparison of high PE and low PE placentas from different breeds
revealed differentially expressed genes (DEG) that were associated with placental
vascularity and nutrient transport (Zhou et al., 2009). Likewise, a transcriptomic analysis
of Berkshire placentas from large litters and small litters identified DEG associated with
litter size that may function to increase nutrient transport across the placenta (Kwon et al.,
2016). However, to the authors knowledge there is no research that has identified DEG
between high PE and low PE placental or endometrial tissue in commercial breed litters.
Therefore, the main objective of this study was to determine the global genetic expression
of genes in high PE and low PE placental and endometrial samples and evaluate if
increased PE is associated with variations in gene expression that positively affect fetal
growth via various growth factors and improved nutrient transport.
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Material and Methods
Experimental Design
All procedures were approved by the West Virginia Animal Care and Use
Committee (ACUC # 10-0505).

Animal Management
PIC maternal line gilts (n = 8) were bred by artificial insemination 12 h and 24 h
post estrus using PIC 1025 maternal line semen (Birchwood Genetics, West Manchester,
OH). Assignments for gestational day 95 ovario-hysterectomies were given at the time of
breeding. Following breeding, gilts were housed in groups and gestation proceeded as
normal until preparations for surgery began.

Surgical Procedure
At least two days before surgery, gilts were moved to the Food Animal Research
Facility at the West Virginia University Animal Science Farm (Morgantown, WV). Gilts
were also taken off feed 12 h before surgery. On the day of surgery, gilts were
anesthetized via jugular venipuncture using ketamine (3 mg/mL) and xylazine (2
mg/mL). In addition, atropine sulfate (0.05 mg/kg) was administered to reduce salivation
and isoflurane was used to maintain anesthesia. Gilts were placed in dorsal recumbency,
the surgical area was prepped, and surgical drape was used to keep the surgical site clean.
To begin, a mid ventral incision was made to expose the gravid uterus. Then, an
antimesometrial incision was made to open the uterus and expose the feto-placental units.
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Once exposed, umbilical cord arterial (A) and venous (V) blood samples were collected
using EDTA tubes. Then, two tags were attached to the umbilical cord of each fetoplacental unit. Each tag identified which uterine horn the fetus originated from (right or
left) and the location within that uterine horn (one being closet to the ovary). The
umbilical cord was then cut between the two tags to ensure one tag remained with the
placenta and one with the fetus. Next, each fetus was removed, and fetal weight, crownrump length (CRL), and girth were recorded before fetal necropsies were performed.
Once all fetuses were removed, the uterus was dissected from the dam and set aside for
further processing. Then, sodium pentobarbital (400 mg/mL, Sigma Aldrich, St. Louis,
MO) was used to euthanize the gilt.

Fetal Necropsies and Uterine Processing
Fetal necropsies were performed, as described by Wilmoth (2012), to obtain heart
weight, liver weight, brain weight, and semitendinosus (ST) weight. Then, the uterus was
processed; each uterus was opened along the antimesometrial side and placentas were
removed by carefully peeling each placenta away from the endometrium. During this
process, implantation site lengths (ISL) were measured, placentas were weighed, and
placental and adjacent endometrial samples were taken as described by Wilmoth (2012).
Placental and endometrial samples intended for RNA sequencing were placed in cyrovial
tubes, snap frozen in liquid nitrogen, and then stored at -80 °C. Placental efficiency for
each feto-placental unit was calculated by dividing fetal weight by placental weight.
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Vascular Density and Nutrient Concentrations
Placental and endometrial samples were prepared and evaluated to determine
vascular density (VD) as described by Wilmoth (2012). Vascular density, reported as a
percentage, was determined by dividing blood vessel area by the total area within a
selected viewing frame.
Arterial and venous umbilical cord blood samples were processed to obtain
plasma and used to determine nutrient concentrations as described by Wilmoth (2012).
Plasma glucose concentrations were determined using a glucose colorimetric assay kit
from Caymen Chemical (Ann Arbor, MI) and plasma non-esterified fatty acid (NEFA)
concentrations were determined using a NEFA-HR kit from Wako Chemicals
(Richmond, VA). In order to obtain the net direction (towards the fetus or the placenta) of
either nutrient measured, venous arterial (VA) concentration differences were calculated
by subtracting A concentrations from V concentrations.

RNA Extraction, Quality Validation, and Sequencing
Endometrial and placental samples from the most efficient and least efficient fetoplacental unit in each litter (n = 8) were processed at the Clemson University Genomics
& Computational Laboratory (CU-GCL). Total RNA was extracted from the endometrial
(n = 16) and placental (n = 16) samples in duplicate using a RNeasy Plus Universal Mini
Kit (Qiagen, Valencia, CA) and all extractions were performed according to the
manufacturer’s instructions. An aliquot of each sample was qualitatively assayed for
purity using UV spectroscopy via the Nanodrop8000 (ThermoFisher Scientific, Waltham,
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MA) to collect the 260/280 and 260/230 ratios, respectively. Total RNA was quantitated
with the Broad Range Assay in the Qubit (ThermoFisher Scientific, Waltham, MA). The
broad range kit contains a fluorescently labeled dye that is specific to dsRNA and can
accurately quantify RNA concentrations.
Each sample was normalized to a standard input concentration of 2 µg for
sequencing library preparation. Stranded mRNA sequencing libraries were prepared
manually at the CU-GCL with the TruSeq Stranded mRNA kit (Illumina, San Diego, CA)
following the manufacturer’s recommended procedures. Sequencing data was collected
on the HiSeq2500 (Illumina, San Diego, CA) using v4.0 chemistry and 2x125bp pairedend read module. Post sequencing, raw sequence reads were transferred to Clemson
University’s Palmetto Cluster for analysis.
Sequence reads were quality validated with the FastQC software, followed by
read preprocessing to remove adapter and primer sequences with the Trimmomatic
software (Bolger et al., 2014). Processed sequence reads were aligned to the v10.2 Sus
Scrofus reference genome assembly (Groenen et al., 2012) with the GMAP read
alignment tool in stranded mode (Wu and Watanabe, 2005). Indexed .BAM files were
prepared from the .SAM output of GMAP using Samtools (Li et al., 2009). Read
abundance per gene was determined with the featureCounts software (Liao et al., 2013),
and the count data per sample was output and transformed to tabular format with in-house
scripts.
Relative pairwise changes in gene level expression were determined with the
EdgeR software package (Robinson et al., 2010). Transcriptome comparisons were made
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using a GLM and classic pairwise comparisons were made to compare high efficiency
versus low efficiency conditions in a tissue specific manner. Differentially expressed
genes were determined and filtered for significance by the false discovery rate P-value
(FDR) of 0.01 (Benjamini and Hochberg, 1995). Gene level fold-change values were
output in tabular format and genes abounding thresholds were listed as candidate genes.
Candidate genes lists containing upregulated and downregulated genes in the
placenta were functionally classified using the Panther database version 12.0 (Mi et al.,
2013; Mi et al., 2017) and AmiGO 2 version 2.4.26 was utilized to search GO term
definitions (Ashburner et al., 2000; Carbon et al., 2008; The Gene Ontology Consortium,
2017). Functional classification of genes using the Panther database provides functional
insight by classifying genes according to the activity of the gene product (molecular
function), the pathway or processes the gene product functions in (biological process),
and the localization or location of the active gene product (cellular component)
(Ashburner et al., 2000; The Gene Ontology Consortium, 2017). Furthermore, GO slim
terms or broad parent terms are used providing a summary or general depiction of the
function of the input list. Percentages equal the number of genes within the input list with
that function, process, or component divided by the total number of functions, processes,
or component terms in the input list. (i.e. gene hits against total number of function hits,
gene hits against total number of process hits, and gene hits against total number of
component hits).
Candidate genes lists containing upregulated and downregulated genes in the
placenta were also independently tested for statistical enrichment with the GOSeq
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software tool (Young et al., 2010). Gene ontology terms can be described as hierarchal as
there are broad “parent” terms that encompass more specific specialized “child” terms,
but it is possible for a term to have more than one parent term (Ashburner et al., 2000;
The Gene Ontology Consortium, 2017). This analysis identified the more specific
specialized child terms and tested for enrichment.

Additional Statistical Analyses:
Placental/Fetal Measurements, Vascular Density, and Nutrient Concentrations
In order to make comparisons based on PE, the feto-placental unit with the
highest PE and the feto-placental unit with the lowest PE in each litter (n = 8) were
selected, creating the high PE group (n = 8, PE range 3.96 to 7.84) and the low PE group
(n = 8, PE range 1.92 to 3.19) used for analysis. Statistical analyses were conducted using
JMP Pro version 12.2.0 (SAS Institute Inc., Cary, NC 1989-2007). A linear mixed effects
model was used to analyze each dependent variable, with PE, sex, and PE*sex as fixed
effects, and a random effect to account for pigs nested within dam. A significance level
of 0.05 was used for all tests of significance.

Measurement by Gene Correlations
To identify relationships between the following measurements: fetal weight,
placental weight, PE, CRL, brain weight, ST weight, ISL, VA glucose, VA NEFA,
placental VD, and endometrial VD, and the 214 DEG in high PE versus low PE
placentas, Pearson’s correlation coefficient (r) was estimated using the cor function in R
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(R Core Development Team, 2017). A false discovery rate (FDR) adjustment was applied
to correct for multiple comparisons using the p.adjust function in R. A significance level
of 0.05 was used to identify significant correlations. The same method was used to
identify correlations between the above measurements and the 20,280 genes expressed in
the pig placenta at day 95 of gestation.

Results
Placental and Fetal Measurements
Descriptive statistics for the variables placental weight, ISL, fetal weight, CRL,
girth, heart weight, liver weight, brain weight, and ST weight are presented in Table 3.1.
For the variable placental weight, the effect sex was not significant. Mean placental
weight was higher in the low PE group compared to the high PE group and this difference
was significant (P = 0.0002, Figure 3.1). Moreover, there was a significant interaction
between PE and sex (P = 0.0479). Within the low PE group, males had higher weight
placentas than females, but within the high PE group, males had lower weight placentas
than females (Figure 3.2).
For the following variables: ISL, fetal weight, CRL, girth, heart weight, liver
weight, brain weight, and ST weight, there was not a significant effect of sex and there
were no significant interactions between PE and sex. Mean ISL was slightly higher in the
high PE group compared to the low PE group, but this difference was not significant.
Conversely, mean fetal weight was higher in the low PE group compared to the high PE
group, but again, this difference was not significant (Figure 3.1). Similarly, mean CRL
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was slightly higher in the low PE group than the high PE group, but this difference was
not significant. Mean girth was similar between the low PE group and the high PE group
(17.81 ± 3.61 and 17.86 ± 3.61 respectively), and therefore, was not significantly
different between low and high PE. All of the organ and muscle weights: heart, liver,
brain, and ST, were greater in the low PE group compared to the high PE group;
however, these differences were not significant.

Vascular Density and Nutrient Concentrations
Descriptive statistics for the variables placental VD, endometrial VD, A glucose,
V glucose, VA glucose, A NEFA, V NEFA, and VA NEFA are presented in Table 3.2.
For these variables of interest, there was not a significant effect of sex and there were no
significant interactions between PE and sex.
Mean placental VD was higher in the low PE group compared to the high PE
group, but this difference was not significant (Figure 3.3). Conversely, mean endometrial
VD was higher in the high PE group compared to the low PE group, but again, this
difference was not significant (Figure 3.3).
Mean A glucose was similar between low and high PE (28.69 ± 9.76 and 28.48 ±
11.62 respectively), and therefore, was not significantly different between the low PE
group and the high PE group. Mean V glucose was slightly higher in the low PE group
than the high PE group; however, this difference was not significant. Moreover, mean
VA glucose was positive in both the low PE group and the high PE group (2.13 ± 6.96
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and 1.50 ± 6.34 respectively) and was not significantly different between groups (Figure
3.4).
Mean A NEFA was similar between the low PE group and the high PE group
(0.071 ± 0.009 and 0.068 ± 0.002 respectively), and therefore, was not significantly
different between groups. Mean V NEFA was also similar between the low PE group and
the high PE group (0.075 ± 0.008 and 0.072 ± 0.004 respectively), and thus, was also not
significantly different between groups. Furthermore, mean VA NEFA was positive in
both the low PE group and the high PE group (0.004 ± 0.007 and 0.004 ± 0.004
respectively) and was not significantly different between groups (Figure 3.5).

RNA Sequencing Analysis
RNA sequencing samples clustered by tissue source, placenta or endometrium
(Figure 3.6). The number of genes expressed in the placenta and endometrium was
20,280. In total, 214 genes were differentially expressed (FDR < 0.10) in the placenta and
0 genes were differentially expressed (FDR < 0.10) in the endometrium (Figure 3.7, 3.9).
Of those differentially expressed in the placenta, 103 genes were upregulated (33 logFC ≥
1; 70 0 < logFC < 1.0) and 111 genes were downregulated (49 logFC ≤ -1.0; 62 -1.0 <
logFC < 0) (Figure 3.8). The ten most upregulated genes in high PE compared to low PE
placentas are listed in Table 3.9; logFC ranged from 1.90 to 4.89. The ten most
downregulated genes in high PE compared to low PE placentas are listed in Table 3.10;
logFC ranged from -1.88 to -2.99. Additional genes of relevance (related to the
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hypothesis) differentially expressed in high PE compared to low PE placentas are listed
in Table 3.11.

Gene Ontology Analyses:
Functional Classification
The Panther Database was used to determine the functional classification of the
upregulated and downregulated genes in high PE compared to low PE placentas. Of the
103 upregulated genes, 74 had known gene symbols and were used in the functional
classification analysis, classifying by molecular function, biological process, or cellular
component. Molecular function percentages are % of gene hit against total number of
function hits, biological process percentages are % of gene hit against total number of
process hits, and cellular component percentages are % of gene hit against total number
of component hits. Molecular function GO slim terms of upregulated genes in high PE
versus low PE placentas included catalytic activity (50.0%), binding (27.4%), transporter
activity (9.7%), receptor binding (4.8%), structural molecule activity (4.8%), antioxidant
activity (1.6%), and signal transducer activity (1.6%) (Figure 3.10). Biological Process
GO slim terms of upregulated genes in high PE versus low PE placentas included
metabolic process (28.6%), cellular process (25.6%), response to stimulus (11.3%),
biological regulation (10.5%), localization (8.3%), multicellular organismal process
(5.3%), cellular component organization or biogenesis (3.8%), developmental process
(3.0%), immune system process (1.5%), locomotion (0.8%), biological adhesion (0.8%),
and reproduction (0.8%) (Figure 3.11). Cellular component GO slim terms of upregulated
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genes in high PE versus low PE placentas included cell part (42.4%), organelle (25.8%),
membrane (12.1%), macrmolecular complex (10.6%), extracellular region (6.1%), cell
junction (1.5%), and synapse (1.5%) (Figure 3.12).
Of the 111 downregulated genes, 67 had known gene symbols and were used in
the functional classification analysis. Molecular function GO slim terms of
downregulated genes in high PE versus low PE placentas included binding (43.5%),
catalytic activity (34.8%), receptor activity (8.7%), transporter activity (6.5%), and
structural molecule activity (6.5%) (Figure 3.13). Biological process GO slim terms of
downregulated genes in high PE versus low PE placentas included cellular process
(28.3%), metabolic process (19.5%), developmental process (10.6%), response to
stimulus (9.7%), biological regulation (8.8%), mulicellular organismal process (8%),
localization (7.1%), cellular component organization or biogenesis (5.3%), reproduction
(0.9%), locomotion (0.9%), and immune system response (0.9%) (Figure 3.14). Cellular
component GO slim terms of downregulated genes in high PE versus low PE placentas
included cell part (51.2%), organelle (25.6%), membrane (11.6%), extracellular region
(7%), cell junction (2.3%), and extracellular matrix (2.3%) (Figure 3.15).

Gene Ontology Enrichment
Gene ontology enrichment analysis was performed on the upregulated and
downregulated genes in the placenta. The analysis revealed only 4 terms were
significantly (FDR < 0.05) enriched in the upregulated genes in high PE versus low PE
placentas and 0 terms were signficantly enriched in the downregulated genes in high PE
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versus low PE placentas. The significantly enriched molecular function GO terms were
sodium-dependent multivitamin transmembrane transporter activity and nucleobase
transmembrane transporter activity. The significantly enriched biological process GO
term was nucleobase transport and the significantly enriched cellular component GO term
was extracellular exosome.
Tables 3.3, 3.4, and 3.5 contain results of the enrichment analysis for molecular
function, biologial process, and cellular component GO terms, respectively, in the
upregulated genes in high PE versus low PE placentas. Molecular function GO terms
with the most number of DEG per category in the upregulated genes in high PE versus
low PE placentas included receptor binding, serine-type endopeptidase activity, and
growth factor activity (Table 3.3). Biological process GO terms with the most number of
DEG per category in the upreglated genes in high PE versus low PE placentas included
cellular calcium ion homeostasis, carbohydrate metabolic process, and chemical synaptic
transmission (Table 3.4). Cellular component GO terms with the most number of DEG
per category in the upregulated genes in high PE versus low PE placentas included
integral component of membrane, extracellular exosome, integral component of plasma
membrane, and membrane (Table 3.5).
Tables 3.6, 3.7, and 3.8 contain results of the enrichment analysis for molecular
function, biological process, and cellular component GO terms, respectively, in the
downregulated genes in high PE verus low PE placentas. Molecular function GO terms
with the most number of DEG per category in the downregulated genes in high PE versus
low PE placentas included transcription factor activity sequence specific DNA binding,
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sequence specific DNA binding, protein homodimerization, and Gtpase activator activity
(Table 3.6). Biological process GO terms with the most number of DEG genes per
category in the downreglated genes in high PE versus low PE placentas included positive
regulation of transcription DNA-templated, negative regulation of transcription from
RNA polymerase II promotor, activation of gtpase activity, and cilium morphogenesis
(Table 3.7). Cellular component GO terms with the most number of DEG per category in
the downregulated genes in high PE versus low PE placentas included integral
component of plasma membrane, endosome membrane, and endomembrane system
(Table 3.8).

Measurement by Gene Correlations
There were 8 significant correlations (P < 0.05) identified in the analysis between
measurements (fetal weight, placental weight, PE, CRL, brain weight, ST weight, ISL,
VA glucose, VA NEFA, placental VD, and endometrial VD) and the 214 DEG in high
PE versus low PE placentas (Table 3.12). Of the 8 significant correlations identified, 5
correlations included the measurement placental weight; 4 placental weight by gene
correlations were positive correlations with r ≥ 0.76, and 1 was negative with r = -0.76.
The other 3 significant correlations identified were positive PE by gene correlations with
r ≥ 0.76.
There were 41 significant correlations (P < 0.05) identified in the analysis
between measurements (fetal weight, placental weight, PE, CRL, brain weight, ST
weight, ISL, VA glucose, VA NEFA, placental VD, and endometrial VD) and the 20,280
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genes expressed in the pig placenta (Table 3.13). Of the 41 significant correlations
identified, 9 correlations were fetal weight by gene correlations with r ≥ -0.84, 1 was a
placental weight by gene correlation with r = 0.86, 15 were CRL by gene correlations
with r ≥ -0.84, 10 were ST weight by gene correlations with r ≥ -0.86, and 6 were VA
glucose by gene correlations with r ≥ -0.84. In terms of genes, 2 genes had 3 significant
correlations, 4 genes had 2 significant correlations, and 29 genes had 1 significant
correlation.
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Table 3.1 Descriptive statistics by placental efficiency (L or H) for the measurements
placental weight, implantation site length, fetal weight, crown-rump length, girth, heart
weight, liver weight, brain weight, and semitendinosus weight taken on day 95 of
gestation in pigs.
Measurement
Placental Wt, g
L
H
ISL, cm
L
H
Fetal Wt, g
L
H
CRL, cm
L
H
Girth, cm
L
H
Heart Wt, g
L
H
Liver Wt, g
L
H
Brain Wt, g
L
H
ST Wt, g
L
H

Mean

SD

330.09
161.24

83.09
60.25

21.38
22.89

9.58
5.30

857.24
789.60

278.16
256.42

26.19
25.38

3.60
3.45

17.81
17.86

3.61
3.61

7.51
6.39

3.42
1.86

22.03
19.18

9.85
5.70

19.91
19.46

1.55
2.21

1.60
1.53

PE
F
P-value
72.0698 0.0002*

Effects
Sex
PE*Sex
F
P-value
F
P-value
0.1335 0.7257 6.0239 0.0479*

0.0569

0.8208

0.1963

0.6657

0.0014

0.9710

0.3243

0.5914

0.9300

0.3647

0.6802

0.4386

0.7195

0.4338

1.7451

0.2303

0.1613

0.7022

0.1311

0.7310

0.0002

0.9900

0.8184

0.4043

2.0460

0.2071

0.0728

0.7930

0.8938

0.3736

2.2455

0.1925

0.5219

0.4927

0.4948

0.5075

0.0539

0.8254

0.3018

0.5937

0.1051

0.7535

0.1807

0.6886

0.2162

0.6552

0.0406

0.8463

0.65
0.48

ISL = Implantation Site Length, CRL = Crown-Rump Length,
ST = Semitendinosus
Means ± SD
Asterisk (*) indicates P < 0.05
PE denominator degrees of freedom between 4.95 and 5.60
Sex denominator degrees of freedom between 6.62 and 11.81
PE*Sex denominator degrees of freedom between 5.39 and 11.15
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Figure 3.1 Mean placental weight and fetal weight of pigs in the low placental efficiency
group and high placental efficiency group on day 95 of gestation. Mean ± SD, P < 0.05
indicated by an asterisk (*).
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Mean Placental Weight by Sex
Placental Weight (g)

400
350
300
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Male

200

Female

150
100

Low
High
Placental Ef9iciency
Figure 3.2 Mean placental weight associated with male or female fetal pigs in the low
placental efficiency group and high placental efficiency group on day 95 of gestation.
LSMeans ± SE

85

Table 3.2 Descriptive statistics by placental efficiency (L or H) for the measurements
placental vascular density, endometrial vascular density, arterial glucose, venous glucose,
venous arterial glucose difference, arterial non-esterified fatty acids, venous nonesterified fatty acids, and venous arterial non-esterified fatty acids difference in the
umbilical cord blood of pigs on day 95 of gestation.
Measurement
Placental VD, %
L
H
Endometrial VD, %
L
H
A Glucose, mg/dL
L
H
V Glucose, mg/dL
L
H
VA Glucose, mg/dL
L
H
A NEFA, mmol/L
L
H
V NEFA, mmol/L
L
H
VA NEFA, mmol/L
L
H

Mean

SD

8.28
6.72

2.82
4.29

6.49
7.03

3.66
4.96

28.69
28.48

9.76
11.62

30.82
29.99

12.24
13.97

2.13
1.50

6.96
6.34

0.071
0.068

0.009
0.002

0.075
0.072

0.008
0.004

0.004
0.004

0.007
0.004

PE
F
P-value
1.4559 0.2689

Effect
Sex
F
P-value
0.9425 0.3511

PE*Sex
F
P-value
0.4985 0.4941

0.4226

0.5463

0.0213

0.8872

0.7398

0.4179

0.0006

0.9812

0.2934

0.6070

0.1192

0.7422

0.2729

0.6217

0.3669

0.5647

0.6500

0.4505

0.0435

0.8414

0.3208

0.5816

0.0862

0.7745

1.6913

0.2363

2.7142

0.1256

0.8004

0.3910

1.5854

0.2543

0.3543

0.5661

0.1674

0.6936

0.0271

0.8737

1.6061

0.2300

0.1286

0.7261

VD = Vascular Density, A = Arterial, V = Venous, VA = Venous Arterial
difference, NEFA= Non-Esterified Fatty Acid
Means ± SD
PE denominator degrees of freedom between 4.666 and 7.455
Sex denominator degrees of freedom between 6.185 and 12.000
PE*Sex denominator degrees of freedom between 5.743 and 11.930
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Figure 3.3 Mean placental and endometrial vascular density in the low placental
efficiency group and high placental efficiency group on day 95 of gestation in pigs.
Mean ± SD
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Mean Venous Aterial Blood Glucose
Concentration
10

Glucose (mg/dL)

8
6
4
2

Low PE

0

High PE

-2
-4
-6

Placental Ef9iciency
Figure 3.4 Mean venous arterial umbilical cord blood glucose concentration difference in
the low placental efficiency group and high placental efficiency group on day 95 of
gestation in pigs. Mean ± SD
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Mean Venous Arterial Blood NEFA
Concentration
0.012

NEFA (mmol/L)

0.01
0.008
0.006
0.004

Low PE

0.002

High PE

0
-0.002
-0.004

Placental Ef9iciency
Figure 3.5 Mean venous arterial umbilical cord blood non-esterified fatty acids (NEFA)
difference in the low placental efficiency group and high placental efficiency group on
day 95 of gestation in pigs. Mean ± SD
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MDS Plot of Swine RNAseq Samples

Figure 3.6 MDS Plot of RNA sequencing samples. Light blue indicates placental
samples of low efficiency, dark blue indicates placental samples of high efficiency, light
red indicates endometrial samples of low efficiency, and dark red indicates endometrial
samples of high efficiency.
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Number of Upregulated and
Downregulated Genes in High PE
versus Low PE Placental and
Endometrial Tissues
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Figure 3.7 Number of upregulated and downregulated genes in high placental efficiency
versus low placental efficiency endometrial and placental tissues
at day 95 of gestation in pigs. FDR P-value < 0.10,
DEG = differentially expressed genes
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Volcano Plot of High Placental Efficiency versus
Low Placental Efficiency Placental Tissue

Figure 3.8 Volcano plot of differentially expressed genes in high placental efficiency
versus low placental efficiency placental tissue at day 95 of gestation in pigs. Colored
dots indicate differentially expressed genes (FDR < 0.10, |logFC| ≥ 1).
Dot colors indicate logFC range. FDR = False Discovery Rate
P-value, logFC = log fold change
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Volcano Plot of High Placental Efficiency versus
Low Placental Efficiency Endometrial Tissue

Figure 3.9 Volcano plot of differentially expressed genes in high placental efficiency
versus low placental efficiency endometrial tissues at day 95 of gestation in pigs.
Black dots indicate no differential gene expression (FDR > 0.10).
FDR = False Discovery Rate P-value
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GO Slim Molecular Func5ons of Upregulated
Genes in High PE vs Low PE Placentas
An5oxidant
Transporter
Ac5vity
Ac5vity 9.70%
1.60%

Binding 27.40%

Cataly5c
Ac5vity 50%

Receptor
Ac5vity
4.80%
Structural
Molecule
Ac5vity 4.80%
Signal
Transducer
Ac5vity 1.60%

Figure 3.10 Pie chart of GO Slim molecular functions of upregulated genes in high
placental efficiency versus low placental efficiency placentas at day 95 of gestation in
pigs. Made using Panther Database. % of gene hit against total number of function hits.
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Table 3.3 Gene Ontology Enrichment Analysis: Molecular function GO terms enriched in upregulated genes in high efficiency
versus low efficiency placentas at day 95 of gestation in pigs.
Category

Molecular Function GO Term

# in
Category
305

FDR

Gene IDs

Gene Symbols

Receptor binding

# DE in
Category
5

GO:0005102

0.8956

LOC100625283, LOC100625487,
CADM4, LOC100622354, GLA

GO:0004252

Serine-type endopeptidase activity

4

191

0.8956

GO:0008083

Growth factor activity

3

169

1

GO:0008523

Sodium-dependent multivitamin
transmembrane transporter activity
Nucleobase transmembrane
transporter activity
L-ascorbate:sodium symporter activity
L-ascorbic acid transporter activity
Sodium-dependent L-ascorbate
transmembrane transporter activity
Protein-disulfide reductase activity
ATP-dependent peptidase activity
N-acetylglucosamine 6-Osulfotransferase activity
Oxidoreductase activity, acting on a
sulfur group of donors, disulfide as
acceptor
Thioredoxin-disulfide reductase
activity
Aminopeptidase activity
Polypeptide N-acetylgalactosaminyl
transferase activity
Protease binding
Serine-type endopeptidase inhibitor
activity

2

3

0.0486*

13381, 13382,
13773, 29055,
38982
11434, 13381,
13382, 16987
29055, 29233,
33724
32427, 32428

2

3

0.0486*

32427, 32428

SLC23A2, LOC102159690

2
2
2

4
4
5

0.0517
0.0517
0.0819

32427, 32428
32427, 32428
32427, 32428

SLC23A2, LOC102159690
SLC23A2, LOC102159690
SLC23A2, LOC102159690

2
2
2

6
6
6

0.0996
0.1262
0.1443

2834, 2835
13381, 13382
13062, 28943

TXN, TXNDC8
LOC100625283, LOC100625487
LOC100522551, CHST3

2

8

0.1551

2834, 2835

TXN, TXNDC8

2

13

0.3735

2834, 2835

TXN, TXNDC8

2
2

25
30

0.8956
0.8956

16987, 19595
11440, 11442

CTSH, METAP1
LOC100519956, LOC100520836

2
2

85
112

1
1

13381, 13382
25961, 28246

LOC100625283, LOC100625487
ITIH3, PEBP1

GO:0015205
GO:0008520
GO:0015229
GO:0070890
GO:0047134
GO:0004176
GO:0001517
GO:0016671
GO:0004791
GO:0004177
GO:0004653
GO:0002020
GO:0004867

CELA1, LOC100625283,
LOC100625487, CTSH
LOC100622354, DKK1, LEP
SLC23A2, LOC102159690

DE = differentially expressed, Asterisk (*) indicates False Discovery Rate Adjusted P < 0.05
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GO Slim Biological Processes of Upregulated
Genes in High PE vs Low PE Placentas
Cellular
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Biogenesis
3.80%

Immune System
Process
1.50%
Metabolic
Process
28.60%

Cellular Process
25.60%

Locomo1on
0.80%
Biological
Adhesion
0.80%

Mul1cellular
Organismal
Process
5.30%

Response to
S1mulus
11.30%

Biological
Regula1on
10.50%

Localiza1on
8.30%

Reproduc1on
0.80%

Developmental
Process
3%

Figure 3.11 Pie chart of GO Slim biological processes of upregulated genes in high
placental efficiency versus low placental efficiency placentas at day 95 of gestation in
pigs. Made using Panther Database. % of gene hit against total number of process hits.
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Table 3.4 Gene Ontology Enrichment Analysis: Biological process GO terms enriched in upregulated genes in high efficiency
versus low efficiency placentas at day 95 of gestation in pigs.
Category

Biological Process GO Term

# in
Category
79

FDR

Gene IDs

Gene Symbols

Cellular calcium ion homeostasis

# DE in
Category
3

GO:0006874

0.8956

TMEM165, ATP13A3, KEL

GO:0005975

Carbohydrate metabolic process

3

126

0.9515

GO:0007268

Chemical synaptic transmission

3

189

1

GO:0015851
GO:0006662
GO:0015993
GO:0015882
GO:0070904

Nucleobase transport
Glycerol ether metabolic process
Molecular hydrogen transport
L-ascorbic acid transport
Transepithelial L-ascorbic acid
transport
Regulation of fatty acid beta-oxidation
L-ascorbic acid metabolic process
Positive regulation of fatty acid
biosynthetic process
Protein targeting to peroxisome
Sulfur compound metabolic process
Misfolded or incompletely
synthesized protein catabolic process
Nucleobase-containing compound
metabolic process
Acute-phase response
Tricarboxylic acid cycle
Positive regulation of tumor necrosis
factor production
Bone mineralization
Response to retinoic acid
Protein O-linked glycosylation
Sphingolipid biosynthetic process
Phagocytosis
Protein processing

2
2
2
2
2

3
4
4
4
4

0.0486*
0.0517
0.0517
0.0517
0.0517

18928, 26961,
33486
11741, 13062,
28943
6367, 30910,
34728
32427, 32428
2834, 2835
32427, 32428
32427, 32428
32427, 32428

2
2
2

5
7
8

0.0991
0.1262
0.2066

13381, 13382
32427, 32428
21107, 36691

LOC100625283, LOC100625487
SLC23A2, LOC102159690
SLC45A3, ELOVL5

2
2
2

10
10
12

0.3004
0.3499
0.4053

13381, 13382
13062, 28943
13381, 13382

LOC100625283, LOC100625487
LOC100522551, LOC100522551
LOC100625283, LOC100625487

2

16

0.5131

32427, 32428

SLC23A2, LOC102159690

2
2
2

33
37
35

0.8956
0.8956
0.8956

4566, 32934
11741, 26019
32934, 33724

SAA2, LBP
LOC100738034, PDHB
LBP, LEP

2
2
2
2
2
2

35
35
38
41
46
52

0.8956
0.8956
0.8956
0.8979
1
1

4490, 7688
16987, 29233
11440, 25687
2179, 36691
21619, 33724
13381, 13382

LGR4, VSIG10
CTSH, DKK1
LOC100519956, POMGNT2
SGPP1, ELOVL5
ADORA1, LEP
LOC100625283, LOC100625487

GO:0031998
GO:0019852
GO:0045723
GO:0006625
GO:0006790
GO:0006515
GO:0006139
GO:0006953
GO:0006099
GO:0032760
GO:0030282
GO:0032526
GO:0006493
GO:0030148
GO:0006909
GO:0016485
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LOC100738034, LOC100522551,
CHST3
PCDHB1, GPR1, DLG3
SLC23A2, LOC102159690
TXN, TXNDC8
SLC23A2, LOC102159690
SLC23A2, LOC102159690
SLC23A2, LOC102159690

Category

Biological Process GO Term

GO:0006006
GO:0045454
GO:0034599
GO:0070588
GO:0008203
GO:0006869
GO:0007218
GO:0006979
GO:0045766
GO:0001649
GO:0001501
GO:0006629
GO:0001666
GO:0055114

Glucose metabolic process
Cell redox homeostasis
Cellular response to oxidative stress
Calcium ion transmembrane transport
Cholesterol metabolic process
Lipid transport
Neuropeptide signaling pathway
Response to oxidative stress
Positive regulation of angiogenesis
Osteoblast differentiation
Skeletal system development
Lipid metabolic process
Response to hypoxia
Oxidation-reduction process

# DE in
Category
2
2
2
2
2
2
2
2
2
2
2
2
2
2

# in
Category
54
64
66
63
68
73
85
97
94
101
102
107
106
125

FDR

Gene IDs

Gene Symbols

1
1
1
1
1
1
1
1
1
1
1
1
1
1

26019, 33724
2834, 2835
2834, 2835
11421, 36436
33724, 34553
11299, 32934
28001, 30910
32427, 32428
11434, 16987
4490, 30801
29249, 34553
9974, 33724
321, 21619
2834, 10759

PDHB, LEP
TXN, TXNDC8
TXN, TXNDC8
ASIC1, MCOLN3
LEP, EBP
LOC100049666, LBP
GLRA3, GLRA3
SLC23A2, LOC102159690
CELA1, CTSH
LGR4, HSPE1
PAPSS2, EBP
MGST3, LEP
CITED2, ADORA1
TXN, LOC100624950

DE = differentially expressed, Asterisk (*) indicates False Discovery Rate Adjusted P < 0.05
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GO Slim Cellular Components of Upregulated
Genes in High PE vs Low PE Placentas
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Figure 3.12 Pie chart of GO Slim cellular components of upregulated genes in high
placental efficiency versus low placental efficiency placentas at day 95 of gestation in
pigs. Made using Panther Database. % of gene hit against total number of component
hits.
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Table 3.5 Gene Ontology Enrichment Analysis: Cellular component GO terms enriched in upregulated genes in high
efficiency versus low efficiency placentas at day 95 of gestation in pigs.
Category

Cellular
Component
GO Term
Integral
component of
membrane

# DE in
Category

# in
Category

FDR

Gene IDs

Gene Symbols

27

5493

0.8956

2179, 9974, 10759, 11440,
11442, 12506, 13061, 13062,
14459, 15891, 17365, 17670,
17716, 18928, 21107, 21425,
22155, 24847, 25687, 28943,
29039, 29055, 32427, 32428,
33486, 36436, 37947

GO:0070062

Extracellular
exosome

20

2283

0.0486*

GO:0005887

Integral
component of
plasma
membrane
Membrane

14

1328

0.0711

14

1835

0.7082

2834, 2835, 9974, 13773,
16722, 16987, 21425, 22411,
25487, 25961, 26019, 28246,
28918, 30442, 30801, 31181,
31252, 37947, 37983, 38982
4490, 6367, 11421, 13773,
21619, 25518, 26961, 28001,
30910, 32427, 32428, 32726,
33702, 34553
9974, 12506, 13381, 13382,
16513, 21425, 25487, 26961,
30801, 32427, 32428, 32934,
35283, 38641

SGPP1, MGST3, LOC100624950,
LOC100519956, LOC100520836,
LOC100154789, TMEM231,
LOC100522551, SLC25A33, ADTRP,
TM9SF1, EMC4, FAM174B, TMEM165,
SLC45A3, ABCB1, DEGS1, TMEM199,
POMGNT2, CHST3, TMEM254,
LOC100622354, SLC23A2, LOC102159690,
KEL, LOC100049666, ENTPD6
TXN, TXNDC8, MGST3, CADM4, PI16,
CTSH, ABCB1, FBP2, RPL15, ITIH3,
PDHB, PEBP1, PPA1, GCA, HSPE1,
SPHKAP, EFHD1, ENTPD6, AK2, GLA

GO:0005615

Extracellular
space

9

1380

1

GO:0005794

Golgi apparatus

8

856

0.8956

GO:0000139

Golgi
membrane

7

591

0.8956

GO:0016021

GO:0016020

11434, 13807, 16987, 29055,
29233, 32934, 33724, 34728,
37947
2835, 11421, 11440, 13062,
18928, 26368, 37947, 38982
11440, 11442, 13060, 13062,
26368, 28943, 37947
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LGR4, PCDHB1, ASIC1, CADM4,
ADORA1, SLC4A7, ATP13A3, GLRA3,
GPR1, SLC23A2, LOC102159690,
SLC52A3, TSPAN33, EBP
MGST3, LOC100154789, LOC100625283,
LOC100625487, NEU1, ABCB1, RPL15,
ATP13A3, HSPE1, SLC23A2,
LOC102159690, LBP, LOC102158723,
KPNA2
CELA1, CEACAM16, CTSH,
LOC100622354, DKK1, LBP, LEP, DLG3,
ENTPD6
TXNDC8, ASIC1, LOC100519956,
LOC100522551, TMEM165, RAB6B,
ENTPD6, GLA
LOC100520836, GABARAPL2,
LOC100522551, RAB6B, CHST3, ENTPD6

Category
GO:0005789
GO:0005739
GO:0031410
GO:0005743
GO:0016323
GO:0005764
GO:0005759
GO:0000421
GO:0005782
GO:0009925
GO:0043202
GO:0005758
GO:0042470
GO:0031090

Cellular
Component
GO Term
Endoplasmic
reticulum
membrane
Mitochondrion

# DE in
Category

# in
Category

FDR

Gene IDs

Gene Symbols

7

904

1

2179, 4901, 9974, 12506,
22155, 25687, 34553

SGPP1, LOC100620265, MGST3,
LOC100154789, DEGS1, POMGNT2, EBP

7

1124

1

Cytoplasmic
vesicle
Mitochondrial
inner membrane
Basolateral
plasma
membrane
Lysosome
Mitochondrial
matrix
Autophagosome
membrane
Peroxisomal
matrix
Basal plasma
membrane
Lysosomal
lumen
Mitochondrial
intermembrane
space
Melanosome
Organelle
membrane

5

259

0.7081

5

379

0.8956

4

215

0.8956

271, 2834, 17411, 22155,
30801, 31181, 37983
13060, 16513, 17365, 26368,
34553
1418, 14459, 31252, 34934,
37983
21619, 32427, 32428, 34728

RAB32, TXN, C7H14orf119, DEGS1,
HSPE1, SPHKAP, AK2
GABARAPL2, NEU1, TM9SF1, RAB6B,
EBP
LOC100519994, SLC25A33, EFHD1,
TIMM8A, AK2
ADORA1, SLC23A2, LOC102159690,
DLG3

3
3

231
269

1
1

16513, 16987, 38982
11741, 26019, 30801

NEU1, CTSH, GLA
LOC100738034, PDHB, HSPE1

2

24

0.8956

13060, 17365

GABARAPL2, TM9SF1

2

29

0.8956

13381, 13382

LOC100625283, LOC100625487

2

36

0.8956

32427, 32428

SLC23A2, LOC102159690

2

51

1

16513, 38982

NEU1, GLA

2

72

1

34934, 37983

TIMM8A, AK2

2
2

119
118

1
1

271, 32835
4901, 9974

RAB32, AHCY
LOC100620265, MGST3

DE = differentially expressed, Asterisk (*) indicates False Discovery Rate Adjusted P < 0.05
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Figure 3.13 Pie chart of GO Slim molecular functions of downregulated genes in high
placental efficiency versus low placental efficiency placentas at day 95 of gestation in
pigs. Made using Panther Database. % of gene hit against total number of function hits.
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Table 3.6 Gene Ontology Enrichment Analysis: Molecular function GO terms enriched in downregulated genes in high
efficiency versus low efficiency placentas at day 95 of gestation in pigs.
Category

Molecular Function GO Term

# DE in
Category
9

# in
Category
804

FDR

Gene IDs

Gene Symbols

GO:0003700

Transcription factor activity,
sequence-specific DNA binding

1

Sequence-specific DNA binding

7

424

1

6

732

1

GO:0005096

Protein homodimerization
activity
Gtpase activator activity

5

350

1

GO:0017137

Rab gtpase binding

4

156

1

GO:0000981

RNA polymerase II transcription
factor activity, sequence-specific
DNA binding
Transcription factor binding
Atpase activity, coupled to
transmembrane movement of
substances
Core promoter proximal region
sequence-specific DNA binding
Activating transcription factor
binding
Cell adhesion molecule binding
Oxidoreductase activity

4

187

1

1702, 1703, 2507, 2670,
13362, 14281, 20789,
23948, 24731
1702, 1703, 2507, 2670,
9462, 13362,14696
10045, 13353, 21340,
21361, 24731, 35165
3834, 11162, 19254,
23888, 28412
11162, 19254, 23888,
28412
2670, 14696, 21361,
23948

ZNF516, LOC100737102, RORB,
FOXE1, SALL1, ZNF135, TRIM29,
FOXJ1, HNF1B
ZNF516, LOC100737102, RORB,
FOXE1, OSR2, SALL1, GRHL3
LOC100737066, TOX3, AGR2,
TWIST1, HNF1B, TENM1
CDC42EP2, SGSM3, TBC1D9,
TBC1D16, SGSM1
SGSM3, TBC1D9, TBC1D16,
SGSM1
FOXE1, GRHL3, TWIST1, FOXJ1

GO:0043565
GO:0042803

4
3

301
88

1
1

39, 2507, 11147, 21361
19656, 19659, 23594

DACT2, RORB, CSDC2, TWIST1
LOC100739517, ABCG2,
LOC100153359

2

20

1

1702, 1703

ZNF516, LOC100737102

2

35

1

1702, 1703

ZNF516, LOC100737102

2
2

78
109

1
1

10045, 35165
21173, 38740

LOC100737066, TENM1
STEAP1, LOC100739711

GO:0008134
GO:0042626
GO:0000987
GO:0033613
GO:0050839
GO:0016491

DE = differentially expressed, FDR= False Discovery Rate Adjusted P-value
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GO Slim Biological Processes of
Downregulated Genes in High PE vs Low PE
Placentas
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0.90%
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Figure 3.14 Pie chart of GO Slim biological processes of downregulated genes in high
placental efficiency versus low placental efficiency placentas at day 95 of gestation in
pigs. Made using Panther Database. % of gene hit against total number of process hits.
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Table 3.7 Gene Ontology Enrichment Analysis: Biological process GO terms enriched in downregulated genes in high
efficiency versus low efficiency placentas at day 95 of gestation in pigs.
Category

Biological Process GO Term

# DE in
Category

# in
Category

FDR

Gene IDs

Gene Symbols

GO:0045893

Positive regulation of transcription,
DNA-templated

9

556

0.7877

GO:0000122

6

650

1

ZNF516, LOC100737102, RORB,
FOXE1, OSR2, TOX3, SALL1,
GRHL3, HNF1B
FOXE1, OSR2, SALL1, TRIM29,
TWIST1, FOXJ1

GO:0090630

Negative regulation of
transcription from RNA
polymerase II promoter
Activation of gtpase activity

1702, 1703, 2507,
2670, 9462, 13353,
13362, 14696, 24731
2670, 9462, 13362,
20789, 21361, 23948

5

101

0.3236

GO:0060271

Cilium morphogenesis

5

213

1

GO:0031338

Regulation of vesicle fusion

4

50

0.3236

GO:0006886

Intracellular protein transport

4

218

1

GO:0061029

Eyelid development in cameratype eye
Negative regulation of osteoblast
differentiation
Iron ion homeostasis
Embryonic digit morphogenesis
Heterophilic cell-cell adhesion via
plasma membrane cell adhesion
molecules
Ion transport
Actin cytoskeleton organization
Heart development
Homophilic cell adhesion via
plasma membrane adhesion
molecules
Outer ear morphogenesis
Negative regulation of cell
adhesion mediated by integrin

3

12

0.1495

11162, 19254, 23888,
23948, 28412
6482, 14629, 23594,
23948, 31503
11162, 19254, 23888,
28412
11162, 19254, 23888,
28412
9462, 14696, 21361

SGSM3, TBC1D9, TBC1D16,
FOXJ1, SGSM1
ABLIM3, UBXN10,
LOC100153359, FOXJ1, DNAH5
SGSM3, TBC1D9, TBC1D16,
SGSM1
SGSM3, TBC1D9, TBC1D16,
SGSM1
OSR2, GRHL3, TWIST1

3

38

0.7877

2507, 21361, 38912

RORB, TWIST1, LOC106508702

3
3
3

38
57
61

0.7877
1
1

21173, 21174, 38740
9462, 13362, 21361
10045, 19620, 35165

STEAP1, STEAP2, LOC100739711
OSR2, SALL1, TWIST1
LOC100737066, LOC102162554,
TENM1

3
3
3
3

70
155
173
176

1
1
1
1

21173, 24298, 38740
3834, 6482, 23948
13362, 23948, 31503
1762, 10045, 10081

STEAP1, WNK4, LOC100739711
CDC42EP2, ABLIM3, FOXJ1
SALL1, FOXJ1, DNAH5
CDH7, LOC100737066,
LOC102160717

2
2

9
8

0.7877
1

13362, 21361
2325, 36672

SALL1, TWIST1
ACER2, LOC100625479

GO:0045668
GO:0055072
GO:0042733
GO:0007157
GO:0006811
GO:0030036
GO:0007507
GO:0007156
GO:0042473
GO:0033629
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Category

Biological Process GO Term

# DE in
Category

# in
Category

FDR

Gene IDs

Gene Symbols

GO:0042476
GO:0006855
GO:0050873
GO:0035116

Odontogenesis
Drug transmembrane transport
Brown fat cell differentiation
Embryonic hindlimb
morphogenesis
Cholesterol efflux
Adipose tissue development
Response to cold
Embryonic forelimb
morphogenesis
Positive regulation of epithelial
cell proliferation
Pattern specification process
Positive regulation of actin
filament polymerization
Skin development
Positive regulation of bone
mineralization
Calcium-mediated signaling
Negative regulation of NF-kappab
transcription factor activity
Determination of left/right
symmetry
Rhythmic process
Neural tube closure
Positive regulation of angiogenesis

2
2
2
2

20
18
29
25

1
1
1
1

9462, 21361
19656, 19659
1702, 1703
9462, 21361

OSR2, TWIST1
LOC100739517, ABCG2
ZNF516, LOC100737102
OSR2, TWIST1

2
2
2
2

28
27
29
32

1
1
1
1

19656, 19659
1702, 1703
1702, 1703
9462, 21361

LOC100739517, ABCG2
ZNF516, LOC100737102
ZNF516, LOC100737102
OSR2, TWIST1

2

44

1

9462, 21361

OSR2, TWIST1

2
2

41
43

1
1

14696, 23948
3834, 35165

GRHL3, FOXJ1
CDC42EP2, TENM1

2
2

39
43

1
1

39, 23548
6706, 9462

DACT2, SLITRK5
LOC100737907, OSR2

2
2

50
69

1
1

9434, 38912
23948, 36672

NCALD, LOC106508702
LOC106508702, LOC100625479

2

66

1

23948, 31503

FOXJ1, DNAH5

2
2
2

71
74
94

1
1
1

2507, 21361
14696, 21361
21361, 36672

RORB, TWIST1
GRHL3, TWIST1
TWIST1, LOC100625479

GO:0033344
GO:0060612
GO:0009409
GO:0035115
GO:0050679
GO:0007389
GO:0030838
GO:0043588
GO:0030501
GO:0019722
GO:0032088
GO:0007368
GO:0048511
GO:0001843
GO:0045766

DE = differentially expressed, FDR = False Discovery Rate Adjusted P-value
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GO Slim Cellular Components of
Downregulated Genes in High PE vs Low PE
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Figure 3.15 Pie chart of GO Slim cellular components of downregulated genes in high
placental efficiency versus low placental efficiency placentas at day 95 of gestation in
pigs. Made using Panther Database. % of gene hit against total number of component
hits.
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Table 3.8 Gene Ontology Enrichment Analysis: Cellular component GO terms enriched in downregulated genes in high
efficiency versus low efficiency placentas at day 95 of gestation in pigs.
Category

Cellular Component GO
Term
Integral component of plasma
membrane

# DE in
Category
10

# in
Category
1328

FDR

Gene IDs

Gene Symbols

1

GO:0010008

Endosome membrane

5

185

1

GO:0012505

Endomembrane system

4

126

1

LOC100737066, LOC102162554,
STEAP1, STEAP2, LOC100153359,
EMB, TSPAN7, TENM1, KCNJ2,
LOC100739711
PARM1, STEAP1, STEAP2, TMEM175,
LOC100739711
CDC42EP2, SGSM3, TBC1D9, SGSM1

GO:0043235

Receptor complex

4

147

1

GO:0005769

Early endosome

4

251

1

GO:0005768

Endosome

4

259

1

GO:0031674
GO:0030173

I band
Integral component of Golgi
membrane
Mitochondrial membrane
Cell-cell adherens junction

2
2

21
37

1
1

10045, 19620, 21173,
21174, 23594, 31720,
34452, 35165, 35555,
38740
19064, 21173, 21174,
36628, 38740
3834, 11162, 19254,
28412
19656, 19659, 23548,
25920
2340, 19064, 21174,
23888
21173, 24792, 36628,
38740
1223, 35346
2325, 21174

2
2

79
73

1
1

19656, 19659
10045, 20789

LOC100739517, ABCG2
LOC100737066, TRIM29

GO:0005887

GO:0031966
GO:0005913

DE = differentially expressed, FDR = False Discovery Rate Adjusted P-value
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LOC100739517, ABCG2, SLITRK5,
GPR62
SH3GL2, PARM1, STEAP2, TBC1D1
STEAP1, MYO1D, TMEM175,
LOC100739711
GCOM1, MTM1
ACER2, STEAP2

Table 3.9 The ten most upregulated genes in high placental efficiency versus low
placental efficiency placental tissue at day 95 of gestation in pigs.
Gene Gene Symbol
Gene Name
Log
FDR
ID
FC
P-value
4566 SAA2
Serum Amyloid A2
4.89
0.00002
31181 SPHKAP
Sphingosine Kinase Type 1
2.88
0.00388
29233 DKK1
Dickkopf-1
2.80
0.00876
30175 LOC106508115 N/A
2.45
0.00835
4901 CYP4F22
Cytochrome P450 Family 4 Subfamily 2.44
0.05077
F Member 22
22411 FBP2
Fructose-1, 6-Biphosphatase
2.42
0.08290
Isoenzyme 2
6367 PCDHB1
Protocadherin Beta-1 Isoform X2
2.42
0.00302
36436 MCOLN3
Mucolipin 3 Isoform X2
2.12
0.03473
27528 KRTAP8-1
Keratin Associated Protein 8-1
2.03
0.05194
18448 LOC106504580 N/A
1.90
0.03175
LogFC = Log Fold Change, FDR P-value = False Discovery Rate Adjusted Pvalue
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Table 3.10 The ten most downregulated genes in high placental efficiency versus low
placental efficiency placental tissue at day 95 of gestation in pigs.
Gene Gene Symbol
Gene Name
Log
FDR
ID
FC
P-value
21340 AGR2
Anterior Gradient Protein 2 Homolog -2.99 0.00045
37409 COCH
Coagulation Factor C Homolog
-2.93 0.01159
2981 MORN5
MORN Repeat-containing Protein 5
-2.25 0.01159
Isoform X8
31720 EMB
Embigin
-2.06 0.01288
23548 SLITRK5
SLIT and NTRK-Like Protein 5
-2.06 0.01288
32569 LOC106506620 N/A
-2.06 0.07548
38740 STEAP1
Six-Transmembrane Epithelial
-1.98 0.05194
Antigen of Prostate 1
27550 C13H21orf62
N/A
-1.92 0.05118
3318 SARDH
Sarcosine Dehydrogenase
-1.89 0.02504
29192 TMEM72
Transmembrane Protein 72-Like
-1.88 0.06951
Isoform X2
LogFC = Log Fold Change, FDR P-value = False Discovery Rate Adjusted Pvalue
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Table 3.11 Additional genes of relevance differentially expressed in high placental
efficiency versus low placental efficiency placental tissues at day 95 of gestation in pigs.
Gene Gene Symbol
Gene Name
Log
FDR
ID
FC
P-value
21107 SLC45A3
Solute Carrier Family 45 Member 3
1.89
0.07267
11421 ASIC1
Acid Sensing Ion Channel 1 Isoform X2 1.81
0.05118
11434 CELA1
Chymotrypsin-like Elastase Family
1.55
0.04841
Member 1
33724 LEP
Leptin
1.01
0.05194
26961 ATP13A3
Probable Cation-Transporting ATPase
0.82
0.06425
13A3
25518 SLC4A7
Solute Carrier Family 4 Member 7
0.77
0.04207
16987 CTSH
Pro-cathepsin H
0.71
0.07854
32726 SLC52A3
Solute Carrier Family 52 Member 3
0.68
0.01438
32427 SLC23A2
Solute Carrier Family 23 Member 2
0.59
0.06802
35555 KCNJ2
Potassium Channel, Inwardly Rectifying -1.31 0.00875
Subfamily J, Member 2
23594 MRP4/ABCC4 Multidrug Resistance-Associated Protein -1.61 0.07267
4-like
21174 STEAP2
Six Transmembrane Epithelial Antigen
-1.72 0.07267
of the Prostate 2
LogFC = Log Fold Change, FDR P-value = False Discovery Rate Adjusted Pvalue
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Table 3.12 Statistically significant correlations between placental measurements and differentially expressed genes in high
placental efficiency compared to low placental efficiency placentas at day 95 of gestation in pigs.
Correlation Data
Measurement*
Gene
PW*gene1223
PE*gene12188
PE*gene24847
PW*gene19656

Correlation

RNA Sequencing Data
Gene Symbol
Protein

Molecular Function

GCOM1
LOC100156118
TMEM199
LOC100739517

N/A
N/A
N/A
N/A

0.82
0.81
0.81
0.78

FDR
P-value
0.0214
0.0214
0.0214
0.0257

PW*gene13353

0.77

0.0257

TOX3

PW*gene19659

0.76

0.0257

ABCG2

ATP-Binding Cassette Sub-Family G
Member 2

PE*gene6367
PW*gene26368

0.76
-0.76

0.0428
0.0257

PCDHB1
RAB6B

Protocadherin Beta-1 Isoform X2
Ras-Related Protein Rab-6B

Myocardial Zonula Adherens Protein
N/A
Transmembrane Protein 199
ATP-Binding Cassette Sub-Family G
Member 2
TOX High Mobility Group Box
Family Member 3

Chromatin binding,
Phosphoprotein binding,
Protein homodimerization
activity, Estrogen response
element binding
ATP binding, ATPase activity
coupled to transmembrane
movement of substance,
Cholesterol transporter activity
Calcium ion binding
GTP binding, GTPase activity,
Myosin V binding

log
FC
-0.43
0.63
0.29
-0.61

FDR
P- value
0.0769
0.0484
0.0421
0.0144

-1.41

0.0183

-0.77

0.0039

2.42
0.86

0.0030
0.0084

PW = placental weight, PE = placental efficiency, FDR P-value = False Discovery Rate Adjusted P-value, N/A = Not
Available, logFC = log fold change
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Table 3.13 Statistically significant correlations from an analysis of measurements and the
20,280 genes in the pig placenta at day 95 of gestation.
Measurement*Gene
FW*gene16622
FW*gene6318
FW*gene29460
FW*gene33443
FW*gene16008
FW*gene39086
FW*gene23336
FW*gene7837
FW*gene25954
PW*gene9806
CRL*gene16622
CRL*gene10643
CRL*gene8486
CRL*gene12791
CRL*gene11733
CRL*gene37194
CRL*gene28322
CRL*gene3506
CRL*gene19579
CRL*gene16008
CRL*gene24145
CRL*gene17880
CRL*gene8480
CRL*gene7778
CRL*gene31266
STwt*gene7837
STwt*gene16008
STwt*gene11733
STwt*gene15792
STwt*gene29460
STwt*gene33080
STwt*gene23889
STwt*gene16622
STwt*gene24416
STwt*gene28322
VAglucose*gene3887
VAglucose*gene35287
VAglucose*gene30344
VAglucose*gene23513
VAglucose*gene30345
VAglucose*gene25081

Correlation
-0.88
-0.87
-0.87
-0.87
-0.86
-0.85
-0.85
-0.84
-0.84
0.86
-0.89
-0.89
-0.89
-0.88
-0.88
-0.87
-0.86
-0.86
-0.86
-0.86
-0.85
-0.85
-0.85
-0.84
-0.84
-0.90
-0.89
-0.89
-0.89
-0.89
-0.88
-0.87
-0.87
-0.86
-0.86
-0.90
-0.89
-0.89
-0.88
-0.85
-0.84

FDR P-value
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Gene Symbol
RPS18
LOC100625643
DPCD
ABCB8
GMNN
LOC100627868
MED4
LOC100625214
GNL3
FAM110B
RPS18
BCAS2
GEMIN6
CCDC59
LOC106507495
RSL1D1
LOC102160475
LOC100512700
LAMTOR3
GMNN
FTSJ3
FCF1
MORN2
FAHD2A
LOC100526019
LOC100625214
GMNN
LOC106507495
LOC106504300
DPCD
ELMO2
CBX4
RPS18
PSMD3
LOC102160475
TRPT1
LOC100522722
LOC106506245
LOC100526183
LOC106506244
LOC106505509

FW = fetal weight (g), PW = placental weight (g), CRL = crown-rump
length (cm), STwt = semitendinosus weight (g), VAglucose = venous
arterial glucose difference (mg/dL)
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Discussion
Placental efficiency describes the relationship between placental and fetal weights
and is quantified by the ratio of fetal weight to placental weight. Within domestic pig
litters, PE can vary drastically, resulting in similarly sized pigs associated with very
different placenta, up to a 50% weight difference. However, the means enabling the
smaller placenta to grow a similarly sized littermate is unknown. We hypothesized that
high PE placentas would have differential gene expression that affects fetal growth via
growth factors and/or improved nutrient transport. Accordingly, the main objective of
this study was to determine the expression level of genes in placental and associated
endometrial tissues of high PE and low PE feto-placental units. Another objective of this
study was to obtain various measurements (placental, fetal, endometrial, and umbilical
blood) associated with each feto-placental unit in order to compare high PE feto-placental
units to low PE feto-placental units.
The highest and lowest PE values in each litter were used to create the high PE
and low PE groups used for comparisons. This method can be viewed as both
advantageous and limiting as it ensured comparisons were between the very most and
least efficient units but excluded feto-placental units that were more or less efficient than
the average. Therefore, it is suggested that future work evaluate the best method for
defining high and low PE.
Nevertheless, placental weight was lighter in the high PE group compared to the
low PE group, but fetal weight was not significantly different between the high PE group
and the low PE group. Therefore, in agreement with a previous study reporting fetuses
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within 4% body weight difference of each other were grown on different sized placentas,
with the placenta from the most efficient feto-placental unit being 50% lighter than the
placenta from the least efficient feto-placental unit (Wilmoth, 2009).
Implantation site length was not significantly different between the high PE group
and the low PE group. The lack of a difference was unexpected as the basis for high PE is
a smaller, but more efficient placenta that occupies less room within the uterus (Wilson et
al., 1998; Biensen et al., 1998). Moreover, Vonnahme and Ford (2004) reported the ISL
of a high PE group were shorter than those of a low PE group; however, the pigs used in
that study were selected for high or low PE for four generations before being bred, which
resulted in reduced placental size and fetal size in the high PE group on day 90 of
gestation (Vonnahme and Ford, 2004). Conversely, the pigs in this study were not
selected and bred for PE, instead natural variations in PE within litters were used to
create a high PE group and a low PE group. Therefore, the differing results of ISL in
terms of PE may partly be attributed to selection for PE versus natural separations in PE.
In addition to ISL, the fetal measurements CRL and girth were not significantly
different between the high PE group and the low PE group. Crown-rump length and girth
are highly correlated to fetal age (Ullrey et al., 1965) and weight (Groesbeck et al., 2010;
Jang et al., 2014) and can be used to predict neonatal survival (Baxter et al., 2008) and
post-natal growth performance (Douglas et al., 2016). Considering these fetal
measurements were not different by PE, the survivability and postnatal growth
performance of pigs grown on smaller but more efficient placentas (high PE) should not
be affected.
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Neonatal organ and tissue weights, including but not limited to heart weight, liver
weight, brain weight, and muscle weight, are linearly correlated with neonatal body
weights (Bauer et al., 1998a). Moreover, Leenhouwers (2002) reported fetal organ
weights of litters with low, average, or high estimated breeding values for piglet survival
(EBVps) differed near term. Litters with high EBVps tended to have lower absolute
organ weights but higher relative (per kg of body weight) liver and adrenal gland weights
(Leenhouwers et al., 2002). Similarly, naturally occurring intra-uterine growth restriction
in pigs is associated with asymmetrical growth retardation as reduced growth in organs
and tissues, like the liver and muscle, occurs, while at the same time a “brain sparing
effect” takes place (Bauer et al., 1998a). However, little has been reported regarding PE
and organ/tissue weights. In this study, heart weight, liver weight, brain weight, and ST
weight were not significantly different between the high PE group and the low PE group.
Given that placental weight was reduced in the high PE group, the absence of a
significant difference in fetal organ and tissue weights indicates that the reduction in
placental size observed in the high PE group did not adversely affect the fetus.
Furthermore, since fetal weight and organ/tissue weights are linearly correlated and piglet
size was reduced in both cases (EBVps and IUGR) mentioned earlier, it is likely that fetal
organ and tissue weights did not differ by PE in this study because fetal weight was not
different between the high PE group and the low PE group.
Several studies have reported that the highly prolific Chinese Meishan exhibits
high PE, as the placentas are small and highly vascularized, while Yorkshires exhibit low
PE, as the placentas are larger and less vascularized (Biensen et al., 1998; Wilson et al.,
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1998). Additionally, comparisons of the Meishan and the Yorkshire revealed near the end
of gestation, when an increase in fetal demand for nutrient uptake occurs, the smaller
Meishan placenta compensates by becoming more vascular, while the Yorkshire placenta
increases in size in order to maintain fetal growth (Biensen et al., 1998). Moreover, in
1999, Wilson and others confirmed variations in PE existed within Yorkshire litters and
then used those pigs to select and subsequently breed pigs associated with higher or lower
than average PE, resulting in an increase in litter size (Wilson et al., 1999). Then,
Vonnahme and Ford (2004) continued to select and breed those Yorkshires based on PE.
A comparison of pigs in the high PE group, low PE group, and unselected control group
revealed placental VD increased from day 70 to 90 in all groups, but there was no
additional increase in the VD of the placentas in the high PE group to account for the
increased efficiency of those placentas. Furthermore, endometrial VD was not different
by day of gestation or PE group (Vonnahme and Ford, 2004). Although the pigs in this
study were not selected and bred for PE, similar results were obtained; mean placental
VD and endometrial VD were not different between the high PE group and the low PE
group. The results indicate the increased efficiency of the smaller placentas in this study
were not the result of a greater increase in placental or endometrial VD in the high PE
group. Therefore, there must be another means enabling the smaller placenta to grow a
similarly sized littermate, such as an increase in nutrient transport.
To help elucidate the role nutrient transport has in PE, the concentration of
glucose, the main energy substrate of fetal pigs, and NEFA, a component of triglycerides
(fat) capable of crossing the placenta, were determined in A and V umbilical cord blood
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samples. Additionally, VA concentration differences were calculated to determine the net
direction of the concentrate. Mean A, V, and VA glucose concentrations were not
significantly different between the high PE group and the low PE group. Nonetheless, the
mean V glucose concentration of the high PE group (29.99 ± 13.97) and low PE group
(30.82 ± 12.24) in this study were similar to the mean V glucose concentration of the
high PE group (47.60 ± 29.69) and low PE group (38.91 ± 16.32) in chapter 2; however,
the slight variation in values may be due to day of gestation and/or plasma versus serum.
Mean A, V, and VA NEFA concentrations were not different by PE. However, the V
NEFA concentrations obtained in this study (0.075 ± 0.008 and 0.072 ± 0.004 mmol/L)
were similar to those reported by Père (2001) (114 ± 9 µmol/L); thus, providing more
evidence that fatty acid transport to the fetus is relatively low (Père, 2001). Furthermore,
both glucose and NEFA VA concentration differences were positive, indicating the net
direction of concentrates were toward the fetus. However, the standard deviations of VA
glucose and NEFA concentrations were large for both the high PE group and the low PE
group. Gilts in this study were taken off feed 12 h before surgery, but dams may have
consumed feed at varying time points before being taken off feed, potentially impacting
the availability of glucose and NEFA in the blood. Similarly, VA concentrations were
determined by subtracting A concentrations from V concentrations, which can vary by
gilt. Moreover, the PE values used to create the high PE and low PE groups were
calculated using the ratio fetal weight divided by placental weight, and thus, were another
source of variation. Although some of these effects are unavoidable, future work should
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evaluate dam feed consumption in relation to the concentration of metabolites in the
umbilical cord.
Even so, the lack of a difference in glucose and NEFA concentrations between the
high PE group and the low PE group is intriguing considering fetal weight was not
different by PE, but placental weight was reduced in the high PE group. The results
suggest that high PE placentas have another means enabling the smaller placenta to
transport similar nutrient quantities to grow a comparably sized littermate. Nutrients, like
carbohydrates, amino acids, and lipids, require nutrient transporters to cross the pig
placenta; therefore, since the concentration of glucose and NEFAs did not differ between
the high PE group and the low PE group it is plausible that the smaller more efficient
placenta (high PE) may transfer similar nutrient quantities to the fetus via an increase in
the number of nutrient transporters in the smaller placenta. However, Wilmoth (2009)
selected seven nutrient transporters and determined the expression of those transporters in
the pig placenta and adjacent endometrium and found no differences in expression
between high and low PE (Wilmoth, 2009). Nonetheless, other studies have indicated
gene expression in the pig placenta differs in association with litter size within Berkshires
(Kwon et al., 2016) and by PE between Erhualian and Large White gilts (Zhou et al.,
2009). Furthermore, the DEG in those studies, among other things, were involved in
nutrient transport; therefore, even though nutrient concentrations did not differ by PE,
nutrient transport could still be increased in high PE placentas enabling the transport of
similar nutrient quantities via a smaller placenta.
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Accordingly, the main objective of this study was to determine the expression
level of genes in placental and associated endometrial tissues of high PE and low PE fetoplacental units. RNA sequencing was used to identify DEG in high PE compared to low
PE placental and endometrial tissues. In total, 214 DEG (FDR < 0.1) were identified in
the placenta and zero DEG (FDR < 0.1) were identified in the endometrium. Of the DEG
in the placenta, 103 genes were upregulated (33 logFC ≥ 1; 70 0 < logFC < 1.0) and 111
genes were downregulated (49 logFC ≤ -1.0; 62 -1.0 < logFC < 0). It was anticipated a
greater number of genes would be differentially expressed in the placenta compared to
the endometrium. The endometrium is a maternal tissue, while the placenta originates
from the embryo; therefore, the presence of DEG in the placenta and absence of DEG in
the endometrium confirms the placenta changes in response to the requirements of the
fetus. Of the genes expressed in the placenta (20,280), only 214 were differentially
expressed. In other words, only 1.06% of the transcriptome was differentially expressed
in high PE compared to low PE placentas. The small percentage of DEG identified in this
study could be attributed to the comparison of two naturally occurring states as opposed
to two treatment groups. Moreover, this study only considered one time point during
gestation (day 95) and one level of expression (gene). Therefore, the small percentage of
DEG identified in this study could also be the result of the time point chosen and/or the
expression measured (gene expression versus protein expression).
Nonetheless, a gene ontology functional classification analysis was performed to
determine the function of the DEG in high PE versus low PE placentas. Among the
upregulated genes, the GO slim molecular function terms with the greatest percentages of
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gene hits against total number of function hits were catalytic activity (50%) and binding
(27.4%), respectively. The GO term catalytic activity is defined as the “catalysis of a
biochemical reaction at physiological temperatures.” The term binding is defined as “the
selective, non-covalent, often stoichiometric, interaction of a molecule with one or more
specific sites on another molecules (Carbon et al., 2008).” Likewise, binding (43.5%) and
catalytic activity (34.8%) had the greatest percentages of gene hits against total number
of function hits in the downregulated genes. The large percentage of DEG with catalytic
and binding activity in both the upregulated and downregulated genes suggests alterations
in these functions are central to PE. Even so, transporter activity, encompassing gene
products, like nutrient transporters, that “enable the directed movement of substances
(such as macromolecules, small molecules, and ions) into, out of or within a cell, or
between cells (Carbon et al., 2008),” were present in both the upregulated and
downregulated genes in high PE versus low PE placentas, but a greater percentage of
genes had transporter activity in the upregulated genes compared to the downregulated
genes (9.7% vs 6.5%), indicating the transport of substances also contributes to PE.
Additionally, the upregulated genes had antioxidant activity (1.6%) or “inhibition of the
reactions brought about by dioxygen (O2) or peroxides (Carbon et al., 2008)” and signal
transducer activity (1.6%) or “conveying a signal across a cell to trigger a change in cell
function or state (Carbon et al., 2008),” functions not present in the downregulated genes,
indicating the genes associated with these molecular functions may contribute to high PE.
Not surprisingly, the biological process GO slim terms metabolic process and
cellular process had the greatest percentage of gene hits against total number of process
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hits in both the upregulated (28.6% and 25.6%, respectively) and downregulated (19.5%
and 28.3%, respectively) genes in high PE compared to low PE placentas. The term
metabolic process includes gene products that are involved in “chemical reactions and
pathways, including anabolism and catabolism, by which living organisms transform
chemical substances (Carbon et al., 2008).” The term cellular process comprises gene
products that are involved in “any process that is carried out at the cellular level, but not
necessarily restricted to a single cell (Carbon et al., 2008).” The biological process GO
slim terms with the least percentage of gene hits against total number of process hits in
both upregulated and downregulated genes in high PE compared to low PE placentas
were locomotion (0.8% and 0.9%, respectively), reproduction (0.8% and 0.9%,
respectively), and immune system response (1.5% and 0.9%, respectively). These results
are in line with the biological processes one would predict to impact PE compared to
those less likely to impact PE. Biological adhesion was a GO slim biological process
term of the upregulated genes but not the downregulated genes, indicating this process
may be important to high PE; however, the percentage of gene hits against total number
of process hits was very low (0.8%), meaning only one gene had this function out of the
upregulated genes in high PE versus low PE placentas.
Cellular component GO slim terms with the greatest percentage of gene hits
against total number of components hits for the upregulated genes in high PE versus low
PE placentas were cell part (42.4%) or “any constituent part of a cell, the basic structural
and functional unit of all organisms (Carbon et al., 2008),” organelle (25.8%) or
“organized structure of distinctive morphology and function including the nucleus,
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mitochondria, plastids, vacuoles, vesicles, ribosomes, and the cytoskeleton (Carbon et al.,
2008),” and membrane or “a lipid bilayer along with all the proteins and protein
complexes embedded in it an attached to it (Carbon et al., 2008).” Similarly, the cellular
component GO slim terms with the greatest percentage of gene hits against total number
of component hits for the downregulated genes in high PE versus low PE placentas were
also cell part (51.2%), organelle (25.6%), and membrane (11.6%). Given the molecular
functions of the DEG, particularly catalytic activity, binding, and transporter activity, the
localization of the gene products is not unexpected. Moreover, the categorization of DEG
products into multiple cellular component categories (6 to 7) demonstrates the
complexity of PE.
A GO enrichment analysis was also performed on the upregulated and
downregulated genes in high PE versus low PE placentas to identify significantly
enriched GO terms. The GO enrichment analysis identified only 4 terms that were
significantly enriched in the upregulated genes in high PE versus low PE placentas and
zero terms that were significantly enriched in the downregulated genes in high PE versus
low PE placentas. Two of the terms enriched in the upregulated genes were the molecular
function terms sodium-dependent multivitamin transmembrane transporter activity and
nucleobase transmembrane transporter activity. One of the terms enriched in the
upregulated genes was the biological process GO term nucleobase transport. The
enrichment of these terms in the upregulated genes in high PE versus low PE placentas
indicates vitamin transport and/or the transport of nitrogenous bases from one side of the
membrane to the other are imperative to high PE. Moreover, it identifies solute carrier
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family 23 member 2 (SLC23A2) and gene 32428 (LOC102159690), likely a paralog of
SLC23A2, as relevant genes. The gene SLC23A2 encodes a sodium dependent ascorbate
(vitamin C) co-transporter (2Na+: ascorbate) and is required for placental transport of Lascorbic acid in mice (Takanaga et al., 2004).
The other significantly enriched term in the upregulated genes was the cellular
component term extracellular exosome. This term describes gene products that localize to
“vesicles that are released into the extracellular region by fusion of the limiting
endosomal membrane of a multivesicular body with the plasma membrane (Carbon et al.,
2008).” Exosomes are released by cells via exocytosis and are thought to be involved in
cell to cell communication. Exosomes have been shown to contain mRNA, miRNA,
proteins, and lipids and can impact the biological functions of adjacent or distant cells.
Exosomes have been identified at the maternal fetal interface in pigs and modulate
embryo uterine cross talk, especially during implantation. Recently, it has been shown
that exosomes derived from porcine trophectoderm cells can be taken up by porcine
endothelial cells and stimulate proliferation in vitro (Bidarimath et al., 2017). Thus, the
significant enrichment of the GO term extracellular exosome in the upregulated genes in
high PE versus low PE placentas is not surprising as previous reports indicate exosomes
modulate intercellular communication at the maternal fetal interface in pigs. Detailed
descriptions of 3 of the genes (CTSH, FBP2, SPHKAP) associated with the term
extracellular exosome are provided in later paragraphs describing the 10 most
upregulated genes in the high PE compared to low PE placentas.
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The lack of significantly enriched terms identified in the DEG of high PE
compared to low PE placentas is likely due to the limited number of DEG, only 1.06% of
the transcriptome, in the input list used in the analysis. Significantly enriched genes are
determined by comparing GO terms shared within the DEG input list to the GO terms in
background list (the transcriptome). Thus, a larger input list would increase the
probability of detecting enrichment. Since only 4 terms were identified as significantly
enriched, “the number of DEG in category,” in addition to genes with GO terms related
to nutrient transport, angiogenic activity, or growth factor activity, were used to identify
other potentially relevant genes not included in the 10 most upregulated or 10 most
downregulated list of genes in high PE versus low PE placentas.
A review of published information on the 10 most upregulated genes, 10 most
downregulated genes, and 12 other relevant DEG in high PE compared to low PE
placentas provided a better understanding of the role these genes may have in relation to
PE.

10 Most Upregulated Genes
The ten most upregulated genes in high PE compared to low PE placentas
included: serum amyloid A2 (SAA2), sphingosine kinase type 1 interacting protein
(SPHKAP or SKIP), dickkopf-1 (DKK1), gene 30175 (LOC106508115), cytochrome
P450 family 4 subfamily F member 22 (CYP4F22), fructose-1, 6-biphosphatase
isoenzyme 2 (FBP2), protocadherin beta-1 (PCDHB1), mucolipin 3 isoform X3
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(MCOLN3), keratin associated protein 8-1 (KRTAP8-1), and gene18448
(LOC106504580).
The most upregulated gene in the placentas of high efficiency versus low
efficiency feto-placental units was SAA2, one of four gene isoforms encoded by serum
amyloid A (SAA). The protein encoded by SAA2 is a major acute phase protein, which
increases in the blood in response to trauma, inflammation, infection, or neoplasia as part
of the innate immune response. Originally, hepatocytes were thought to be the primary
site of SAA synthesis; however, SAA can be produced in several extrahepatic tissues
such as adipocytes, synoviocytes, and human placental trophoblast cells (early and term).
Likewise, other biological roles have been described for SAA including functions in lipid
metabolism, cell proliferation, and cell invasion (Sandri et al., 2014).
For instance, during the acute phase reaction macrophages are recruited to the site
of inflammation and take up cholesterol. It has been shown that SAA2, expressed in
macrophages, promotes the transport of cholesterol back out of the cell (efflux) via the
ABCA1 transporter. Similarly, SAA1 expressed in human adipocytes, has also been
shown to promote cholesterol efflux via ABCA1 (Poitou et al., 2009). Moreover, acute
phase SAA (SAA1 and SAA2) have been shown to stimulate angiogenesis in relation to
rheumatoid arthritis (Mullan et al., 2006) and stimulate the proliferation of fibroblasts and
the production of reactive oxygen species (ROS) in relation to chronic diseases (Hatanaka
et al., 2011). Lastly, the presence of SAA (SAA1 and SAA2) during the first trimester of
pregnancy in humans is thought to promote human trophoblast invasion and maintain
maternal-fetal tolerance via regulation of pro and anti- inflammatory cytokines, while
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during the third trimester SAA may be indirectly related to the onset of labor (Sandri et
al., 2014).
The exact role of SAA2 in the swine placenta remains to be determined, but
several inferences can be made based on the roles of SAA2 in other tissues and species.
To address cholesterol efflux, ABCA1 was not differentially expressed between high and
low PE placentas in this study, suggesting SAA2 may have a different biological role in
the swine placenta. However, other members of the ATP-binding cassette family
functioning in the transmembrane transport of small molecules, ABCB1 (upregulated) and
ABCG2 (downregulated), were differentially expressed in the swine placenta, yet whether
a relationship exists between SAA2 and ABCB2 and/or ABCG2 remains to be determined.
In terms of cell proliferation, stimulation of cell proliferation, especially angiogenesis,
could provide a means by which the smaller placenta is capable of growing a similarly
sized littermate. Conversely, SAA2 functioning solely in immunomodulation or the
induction of parturition would be unexpected as SAA2 expression was increased in high
PE placentas compared to low PE placentas.
The gene SPHKAP or SKIP encodes an A-kinase-anchoring-protein (AKAP),
which functions to compartmentalize cAMP dependent protein kinase (PAK) to specific
subcellular positions. Many hormones elicit effects on cells by binding to a cell surface
receptor and activating second messenger intracellular signaling molecules like cyclic
AMP (cAMP). An intracellular target of cAMP is PAK, a holoenzyme. Binding of cAMP
to PAK results in the activation of PAK subunits that can phosphorylate substrates
nearby. A-kinase-anchoring-protein, which compartmentalizes PAK, therefore functions
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to regulate which substrates PAK can potentially phosphorylate (Kovanich et al., 2010).
To the author’s knowledge, the effect of overexpression or underexpression of SPHKAP
in the placenta of any species has not yet been reported. The biological function of the
protein encoded by SPHKAP suggests second messenger intracellular signaling is altered
in high PE placentas compared to low PE placentas in pigs; however, whether the
increased expression of SPHKAP positively or negatively impacts the placenta and in
turn fetus remains to be determined.
Dickkopf-1 encodes a secreted glycoprotein and is a known inhibitor of the
canonical Wnt signaling pathway (Peng et al., 2008). Wnt signaling is involved in the
control of embryonic development and adult tissue homeostasis. Wnt signaling pathways
are classified as either β-catenin dependent (canonical) or β-catenin independent, the
former being the classical signaling pathway. β-catenin dependent Wnt signaling occurs
when a Wnt protein binds to frizzled low-density lipoprotein receptor related proteins 5
and 6 receptors on a cells surface, resulting in an intracellular cascade of events enabling
the accumulation of cytosolic β-catenin. β-catenin is then translocated to the nucleus
where it transcriptionally co-activates target genes (Sethi and Vidal-Puig, 2010).
It has been established that DKK1 functions in vertebrate embryonic development
via inhibition of Wnt signaling. Specifically, DKK1 induces head formation, controls
digit patterning, and has regulatory roles in vertebral development, bone formation, and
eye development (Niehrs, 2006). Later in development and postnatally, DKK1 is
expressed in the retinal and aortic vasculature (Choi et al., 2012). Less is known about the
role of DKK1 in the placenta. In early gestation, DKK1 is known to promote trophoblast
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cell invasion in mice; however, this type of placentation does not occur in pigs. The role
of DKK1 in the placenta during late gestation in pigs remains to be determined.
Nonetheless, Stravosky and Pan (2011) reported DKK1, via the Wnt signaling
pathway, is involved in the regulation of lipid metabolism in the placenta of rats. In this
study, obesity prone and obesity resistant rats were used to investigate the effect of
maternal obesity on placental lipid metabolism. In obesity prone dams, maternal and
placental NEFA and triglycerides were elevated, placental DKK1 expression was lower,
β-catenin significantly increased, mRNA content of genes involved in fat transport and
triglyceride synthesis significantly increased, placental lipid accumulation occurred, and
decidual/junctional thickness was reduced. The authors concluded overexposure to NEFA
during gestation resulted in “fatty” placentas via DKK1/Wnt signaling and decreased PE
(Strakovsky and Pan, 2012). This study provides evidence that DKK1 is involved in the
regulation of placental lipid metabolism; however, further research is warranted to
determine if the upregulation of DKK1 in the high PE swine placentas in this study
negatively or positively impacts placental lipid metabolism and transport.
Dickkopf-1 also plays a role in angiogenesis via Wnt signaling; however, results
differ in whether the effect is anti-angiogenic or pro-angiogenic. Both inhibitory and
stimulatory effects of Wnt signaling on endothelial cell proliferation have been reported,
most likely due to differences in tissue source. In the human umbilical vein the Wnt
ligand Wnt-1 reportedly inhibits the proliferation of endothelial cells, while in the
microvasculature of the mouse brain it increases endothothelial cell proliferation (Cheng
et al., 2003). Moreover, the role of the Wnt antagonist, DKK1, in angiogenesis is unclear.

129

Reports indicate DKK1 increases endothelial progenitor cell angiogenic potential and is
pro-angiogenic in human breast tumors (Smadja et al., 2010). Conversely, DKK1 is antiangiogenic in diabetic retinopathy as it reduces overactivated retinal neovascularization
(Chen et al., 2009). Therefore, whether the increased expression of DKK1 in high PE
placentas results in anti-angiogenic or pro-angiogenic effects is unknown and remains to
be determined.
The gene 30175 (LOC106508115) encodes an uncharacterized protein in swine.
Characterization of this gene product is required to establish the biological significance of
increased expression in high PE placentas compared to low PE placentas.
Cytochrome P450 4F22 is a member of an enzyme superfamily, known as
cytochrome P450, encoding monooxygenases involved in the synthesis of cholesterol,
steroids, lipids and drug metabolism (GeneCards, 2017). Gene family, subfamily, and
member subdivide the cytochrome P450 superfamily. Cytochrome P450 family 4 is made
up of enzymes that catalyze the omega hydroxylation (addition of OH group on terminal
carbon) of fatty acids. Moreover, cytochrome P450 family 4 subfamily F (CYP4F)
preferentially omega hydroxylate long chain fatty acids and very long chain fatty acids.
Member 22 of the CYP4F family, a more recently identified member, is expressed in
various tissues including the liver, skeletal muscle, bone marrow, brain, kidney, testes,
keratinocytes, and the placenta (Hardwick, 2008). Since CYP4F22 was discovered more
recently, much remains to be determined about the function of CYP4F22; however,
research indicates CYP4F22 may omega hydroxylate acylceramides, a lipid essential to
skin permeability (Ohno et al., 2015). Likewise, CYP4F22 has been reported as a

130

causative gene in Ichthyosis Lamellar Type 3, a rare skin disease (GeneCards, 2017). To
the authors knowledge, the function of CYP4F22 in the placenta of any species has yet to
be determined, but given CYP4F22’s preference for very long chain fatty acids the
differential expression of this gene may indicate fatty acids metabolism is altered in high
PE placentas compared to low PE placentas.
The gene FBP2, encodes an enzyme involved in the regulation of
gluconeogenesis (endogenous glucose production). Fructose-1, 6-bisphosphatase 2
catalyzes the conversion of Fructose 1, 6-bisphosphate to Fructose 6-phosphate and
inorganic phosphate (Li et al., 2013). Fructose-1, 6-biphosphastase 2 has also been
suggested to be involved in the synthesis of glycogen from carbohydrate precursors like
lactate (glyconeogenesis) (Dzugaj, 2006). The presence of gluconeogenic enzymes, like
phosphoenolypyruvate carboxykinase (PCK1) and glucose-6-phosphate (G6P), in the
human placenta suggests the placenta is capable of gluconeogenesis. Furthermore, Kwon
and others (2016) and Hwang and others (2017) reported the presence of PCK1 and
FBP2 in the Berkshire pig placenta. Although, the authors reported FBP2 expression was
downregulated in Berkshire placentas from larger litter size groups compared to placentas
from smaller litter size groups. Conversely, in this study FBP2 expression was
upregulated in high PE placentas compared to low PE placentas on day 95 of gestation.
The difference in regulation direction (up or down) most likely arises from the grouping
method (PE versus litter size). Considering FBP2’s role in gluconeogenesis and possibly
glyconeogenesis, the increased expression of FBP2 in high PE placentas compared to low
PE placentas indicates the metabolic state of the placenta differs by PE.
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Protocadherin beta-1 belongs to the cadherin superfamily. Cadherins are
transmembrane glycoproteins characterized by cadherin ectodomains in the extracellular
portion of the molecule, a transmembrane segment, and a cytoplasmic domain (Wu and
Maniatis, 1999; Yagi and Takeichi, 2000). Conventionally, cadherins are described as
calcium dependent cell to cell adhesion molecules; however, as research has progressed
cadherins have been implemented in neural circuits, cell signaling during in-utero
development, and cell recognition (Morishita and Yagi, 2007). The cadherin superfamily
comprises classic cadherins, desmocollins, desmogleins, protocadherins, and cadherin
related proteins (Wu and Maniatis, 1999).
Protocadherins are the largest subclass of cadherins, primarily expressed in the
nervous system, and described as having 6 to 7 extracellular ectodomains with a unique
cytoplasmic domain. Protocadherins can be further subdivided into noncluster and
clustered protocadherins. Clustered protocadherins include the protocadherin alpha, beta,
and gamma families. In comparison to the protocadherins alpha and gamma, less is
known about the function of the protocadherin beta family (Morishita and Yagi, 2007).
The function of PCDHB1 is unknown, but PCDHB1 may be involved in neural cell to
cell connections (GeneCards, 2017). Although, PCDHB1 may have a different function
in the placenta, as studies indicate nerve fibers do not exist in the placenta (Walker and
McLean, 1971; Marzioni et al., 2004).
Nonetheless, the increased expression of PCDHB1 in high PE placentas compared
to low PE placentas could indicate cell to cell adhesion is altered. Interestingly, Kwon
and others (2016) reported protocadherin 1 (PCDH1), another member of the
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protocadherin family also thought to be involved in neural cell adhesion (GeneCards,
2017), was downregulated in the placentas of large litter groups compared to small litter
groups (Kwon et al., 2016). Thus, further research is warranted to determine the function
and effect of protocadherins on the efficiency of the pig placenta and reproduction.
The transient receptor potential (TRP) superfamily, encoding proteins that
function as membrane ion channels, comprises seven subfamilies. Among the seven
subfamilies is the mucolipin family, which is made up of three members, mucolipin-1,
mucolipin-2, and mucolipin-3 (Nilius and Owsianik, 2011). The gene MCOLN3 is
expressed in a variety of tissues but at varying levels. Mucolipin-3 is a Ca2+ permeable
cation channel that is inwardly rectifying and localizes to the plasma membrane,
endosomes, and lysozomes (Noben-Trauth, 2011). A MCOLN3 gain of function mutation
in mice results in pigmentation problems, vestibular dysfunction, and hearing loss, also
known as the Varitint-waddler phenotype. The phenotype is the result of a mutation that
causes the cation channel to remain open, allowing calcium to flood the cell and cause
cell death (Lelouvier and Puertollano, 2011). Moreover, MCOLN3 is proposed to play a
role in the endocytic pathway. This pathway occurs within eukaryotic cells and utilizes
endosomes and lysosome to “engulf, degrade, and recycle” molecules and/or fluid
(Noben-Trauth, 2011). Evidence utilizing human retinal pigmented epithelial cells
indicates MCOLN3 is required to maintain calcium homeostasis within the endocytic
pathway (Lelouvier and Puertollano, 2011); however, whether MCOLN3 serves the same
function within placental cells is unknown. Thus, further research into the function of
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MCOLN3 within the placenta is required to interpret the effect of increased MCOLN3
expression in high PE placentas compared to low PE placentas.
Keratin associated protein 8-1 belongs to the keratin associated protein (KAP)
family 8. Keratin associated proteins, along with hair keratins, make up the essential
components of a hair fiber. Hair keratins form keratin intermediate filaments, which are
surrounded by KAP. Keratin associated proteins provide the hair fiber rigidity via
disulfide bond cross-linking. Keratin associated proteins are further described as high
sulfur, ultrahigh sulfur, or high glycine/tyrosine based on amino acid composition.
Keratin associated protein family 8-1 is a high glycine/tyrosine KAP (Shimomura and
Ito, 2005). Given the role of KAP in hair fibers, the significance of the increased
expression of KRTAP8-1 in high PE placentas compared to low PE placentas is unclear.
The gene 18448 (LOC106504580) encodes an uncharacterized protein in swine.
Characterization of this gene product is required to establish the biological significance of
increased expression in high PE placentas compared to low PE placentas.

10 Most Downregulated Genes
The ten most downregulated genes in high PE compared to low PE placentas
included: anterior gradient protein 2 homolog (AGR2), coagulation factor C homolog
(COCH), membrane occupation and recognition nexus 5 (MORN5), embigin (EMB),
SLIT and NTRK-like protein 5 (SLITRK5), gene 32569 (LOC106506620), six
transmembrane epithelial antigen of prostate 1 (STEAP1), gene 27550 (C13H21orf62),
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sarcosine dehydrogenase (SARDH), and transmembrane protein 72-like isoform X2
(TMEM72).
The most downregulated gene in the placentas of high efficiency versus low
efficiency feto-placental units was AGR2. The gene AGR2 is a member of “the protein
disulfide isomerase (PDI) family of endoplasmic reticulum proteins,” which are essential
to the post-translational folding of proteins via disulfide bond formations (Galligan and
Petersen, 2012). Protein expression of AGR2 has been implemented in neoplastic
transformation, p53 tumor suppressor inhibitor and survival factor, and metastasis
(Brychtova et al., 2011). Most of the research on this gene focuses on AGR2’s role in
cancer as the gene is expressed in breast, prostate, colorectal, pancreatic, esophageal, and
other cancers. Possible biological roles of AGR2 include epithelial barrier function, cell
migration, cell differentiation, cell growth, and cell survival during physiological stress
(Del Curto, 2014).
In humans, AGR2 protein expression is strongly expressed in a variety of tissues
that have endocrine function and/or mucus secretory cells like the stomach, small
intestines, and colon. Accordingly, AGR2 is moderately expressed in the trophoblast cells
of the human placenta; however, AGR2’s role in the placenta of any species is largely
unknown (Brychtova et al., 2011). To the author’s knowledge, Del Curto (2014) is the
first and only author to propose a role for AGR2 in placental function. Using a sheep
IUGR model, Del Curto reported AGR2 expression was significantly downregulated in
the placentomes of nutrient restricted ewes that produced non-IUGR offspring compared
to nutrient restricted ewes that produced IUGR offspring. The author suggested a
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reduction in AGR2 expression in nutrient restricted ewes that produced non-IUGR
offspring (normal weight fetuses) could serve as an adaptive placental mechanism to
support fetal growth during stress by reducing the proliferative action of AGR2 (Del
Curto, 2014).
Interestingly, in this study AGR2 was downregulated in high PE placentas
compared to low PE placentas. Given that a high PE placenta is characterized as a smaller
placenta that is capable of growing a comparably sized littermate and AGR2 was
downregulated in high PE placentas, AGR2 may function as an adaptive placental
mechanism to support fetal growth as suggested by Del Curto (2014).
The gene COCH encodes the protein cochlin. The cochlea, eye, cerebellum, brain,
lung, spleen, and thymus express cochlin. In addition to a short predicted sequence
peptide, cochlin has thee domains: one N-terminal factor C homology domain (FCH or
LCCL) and two von Willebrand factor A-like domains. The main non-collagen
component of the inner ear extracellular matrix is cochlin. The function of cochlin is still
unclear; however, mutations in COCH are the cause of autosomal dominant
nonsyndromic sensorineural deafness 9 (DFNA9) in humans. The function of COCH in
the placenta remains to be elucidated (Bhattacharya, 2006). Thus, interpretation of
COCH’s downregulation in high PE placentas compared to low PE placentas cannot be
made at this time. Nonetheless, the gene ontology molecular function term associated
with COCH was collagen binding, while the gene ontology biological process terms
included defense response to bacterium, regulation of cell shape, sensory perception of
sound, and positive regulation of innate immune response (GeneCards, 2017).
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Membrane occupation and recognition nexus 5 is a protein coding gene. MORN5
is a cytoplasmic protein; however, the function of MORN5 is unknown. Reports on
MORN5 indicate this gene is involved in craniofacial development in humans and the
chick embryo (Cela et al., 2016). No gene ontology terms are available for MORN5
(GeneCards, 2017). Therefore, further research into the expression and function of
MORN5 is required to decipher the significance of MORN5 downregulation in high PE
placentas compared to low PE placentas.
Embigin, an immunoglobulin superfamily member, encodes a transmembrane
glycoprotein (Jung et al., 2016). Embigin acts as a chaperone protein for
monocarboxylate transporter 2 (MCT2), without this association MCT2 localization to
and function in the plasma membrane is disturbed. Monocarboxylate transporter 2 is a
proton coupled transporter and predominantly transports pyruvate, lactate, and ketone
bodies across the plasma membrane of cells (Halestrap, 2013). The decreased expression
of EMB in high PE placentas compared to low PE placentas is surprising given EMBs
function in localizing MCT2 to the plasma membrane.
SLIT and NTRK-like protein 5 codes for an integral membrane protein belonging
to the SLITRK family. Six members make up the SLITRK family, named so because of
the two leucine rich repeats in the extracellular domain that resemble those found in the
SLIT family and the c-terminal domain present that shares sequence homology with
neurotrophin receptors. The expression of SLITRK is primarily found in neural tissues
and SLITRK5 suppresses neurite outgrowth. Nonetheless, SLITRK, including SLITRK5,
are expressed in embryonic stem cells, endothelial cells, and leukemias, indicating further
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biological functions have yet to be elucidated (Milde et al., 2007). Given the lack of
information on the biological function of SLITRK5 in non-neural tissues, like the
placenta, the significance of the downregulation of SLITRK5 in high PE placentas
compared to low PE placentas cannot be determined.
The gene 32569 (LOC106506620) encodes an uncharacterized protein in swine.
Characterization of this gene product is required to establish the biological significance of
increased expression in high PE placentas compared to low PE placentas.
Six-transmembrane epithelial antigen of prostate 1 was originally identified as a
cell surface antigen in prostate tissue and as the name indicates is a six-transmembrane
protein. The gene is overexpressed in prostate cancer, as well as several other cancers in
humans. Inhibiting the expression of STEAP1 results in decreased rates of cell
proliferation in tumors. More recently, STEAP1 has been identified as a metal reductase
and superoxide synthase capable of reducing Fe3+, Cu2+, and O2, enabling transport of
these essential micronutrients across the plasma membrane (Kim et al., 2016). The
reduced expression of STEAP1 in high PE placentas compared to low PE placentas could
inhibit cell proliferation, as in tumors, potentially attributing to the smaller size of high
PE placentas. Alternatively, if STEAP1 functions as a metal reductase in the placenta
then the reduced expression of STEAP1 in high PE placentas would indicate the transport
of iron and copper, essential to various enzymatic processes, is altered.
The gene 27550 (C13H21orf62) encodes an uncharacterized protein in swine.
Characterization of this gene product is required to interpret the downregulation of this
gene in high PE placentas compared to low PE placentas.

138

Sarcosine dehydrogenase encodes a mitochondrial enzyme that catalyzes the
conversion of sarcosine to glycine (Porter et al., 1985). The down regulation of SARDH
indicates the conversion of sarcosine to glycine is reduced in high PE placentas compared
to low PE placentas. Glycine is a major amino acid involved in an array of biological
processes, including but not limited to, protein synthesis and glycine utilization to
produce uric acid, nucleic acids, glutathione, creatine, bilirubin, and heme (Wang et al.,
2013). Thus, the biological significance of a reduction in the conversion of sarcosine to
glycine within the placenta remains to be determined.
Transmembrane protein 72-like encodes a transmembrane protein. The biological
function of TMEM72 is unknown. Recently, TMEM72 was localized to the mitochondria
in human clear cell renal cell carcinoma and is associated with metastasis (Wrzesiński et
al., 2015). Further research is required to elucidate the function of TMEM72 in the
placenta and the significance of the downregulation of TMEM72 in high PE placentas
compared to low PE placentas.

Twelve Other Relevant DEG
Twelve genes were included in the other relevant DEG list, including the
upregulated genes solute carrier family 45 member 3 (SLC45A3), acid sensing ion
channel 1 isoform X2 (ASIC1), chymotrypsin-like elastase family member 1 (CELA1),
leptin (LEP), probable cation-transporting ATPase 13A3 (ATP13A3), solute carrier
family 4 member 7 (SLC4A7), pro-cathepsin H (CTSH), solute carrier family 52 member
3 (SLC52A3), solute carrier family 23 member 2 (SLC23A2), and the downregulated
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genes potassium channel, inwardly rectifying subfamily J, member 2 (KCNJ2), multidrug
resistance-associated protein 4-like (Like MRP4/ABCC4), and six transmembrane
epithelial antigen of the prostate 2 (STEAP2).
The solute carrier family 45 is a mammalian sucrose transporter family with four
members, SLC45A1-A4. An analysis of SLC45A3 expressed in Saccharomyces
cerevisiae confirmed this protein functions as a H+ sucrose symporter. Conventionally,
the transport of sugars across the cell membranes of mammals occurs exclusively as
monosaccharides via facilitative glucose transporters (GLUTs) and/or sodium-dependent
glucose transporters (SGLTs). Conversely, the transport of disaccharides, like sucrose,
across mammalian cell membranes was previously unheard of. In addition to transporting
diassacharides, this novel mammalian sugar transporter functions in a proton-dependent
manner; again challenging the traditional concept of mammalian sugar transport across
cell membranes (Bartolke et al., 2014).
Recently, SLC45A3 was identified as a novel H+ sucrose symporter expressed in
the kidney (mice and rat) (Vitavska et al., 2016). It has also been suggested that
SLC45A3 can transports other sugars like fructose and glucose (Bartolke et al., 2014;
Vitavska et al., 2016). Solute carrier family 45 member 3 was identified as a glucose
transporter in oligodendrocytes essential to myelin production via regulation of glucose
and lipid metabolism (Shin et al., 2012). The function of SLC45A3 as a H+ sucrose
transporter has not been verified in the pig placenta; however, the expression of SLC45A3
in the pig placenta has previously been reported.

140

Kwon and others (2016) and Hwang and others (2017) reported SLC45A3 was
downregulated in Berkshire placentas from larger litter size groups compared to placentas
from smaller litter size groups (Kwon et al., 2016; Hwang et al., 2017). In this study,
SLC45A3 was significantly upregulated in high PE placentas compared to low PE
placentas on day 95 of gestation in pigs. The discrepancy in the regulation of SLC45A3 in
the pig placenta is likely due to grouping (PE vs litter size). Nonetheless, the
identification of SLC45A3 as a DEG in separate but similar studies, both aimed at
improving pig reproduction, suggests SLC45A3 is an important gene in the placenta.
Given SLC45A3’s proposed function as a novel H+ sucrose symporter with the potential
to transport fructose and glucose, SLC45A3 may provide a mechanism for the smaller but
more efficient placenta (high PE) to grow a comparably sized littermate by increasing
sugar transport across the placenta. In support of this concept, glucose is the primary
carbohydrate transported across the placenta and utilized by the fetus (Hay Jr, 1994).
Moreover, the placenta produces fructose and quantitatively fructose is the main
carbohydrate in the fetal pig (Père, 1995). Conversely, little is known about placental
transport of sucrose or sucrose concentrations in the fetal pig. Thus, future research
should assess sucrose transport and utilization in the feto-maternal unit.
Acid sensing ion channel 1 encodes ASIC1, which has three known isoforms.
Acid sensing ion channel 1 isoform 2 is a proton-gated sodium channel activated by
extracellular drops in pH and localized to mainly the plasma membrane and golgi
apparatus. Expression of ASIC1 is most common in neurons of the central and peripheral
nervous system (Wemmie et al., 2006). To the author’s knowledge, ASIC1 expression in
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the pig placenta has not been reported. Assuming ASIC1 has a similar biological function
in placental tissues, the increased expression of ASIC1 in high PE placentas compared to
low PE placentas would indicate sodium ion transmembrane transport is altered by PE.
Chymotrypsin-like elastase family member 1 encodes an enzyme that degrades
the protein elastin, a component of the vascular matrix. One of the gene ontology
enrichment terms for CELA1 is positive regulation of angiogenesis (GeneCards, 2017).
Data from mesenteric angiogenesis, chick embryo angiogenesis, and tumor angiogenesis
suggests that elastin and products of elastin degradation have a role in vascular
morphogenesis. Moreover, CELA1 is expressed during murine fetal lung development in
vascular cells (Varisco and Liu, 2013) and CELA1 silencing impairs angiogenesis in vitro
(Liu et al., 2014), demonstrating an associating between CELA1 and angiogenesis. Thus,
the increased expression of CELA1 in high PE placentas compared to low PE placentas
may correspond with increased angiogenesis in high PE placentas.
The gene LEP encodes the protein leptin, a well-known protein hormone
originally characterized as a satiety factor derived from adipocytes and involved in
energy homeostasis. Leptin is primarily produced in white adipose tissue, but the
synthesis of leptin also occurs in other tissues such as brown adipose tissue, the gastrointestinal tract, bone, cartilage, the brain, and the placenta (Bajoria et al., 2002). In terms
of immunoreactivity, charge, and size, human placental leptin is identical to adipose
tissue leptin; however, LEP in the human placenta contains an upstream enhancer not
present in adipose tissue indicating placental LEP is regulated differently (Ashworth et
al., 2000; Bajoria et al., 2002). Even so, an analysis of leptin showed high sequence
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homology among species. For instance, human and pig leptin share 85% sequence
identity, suggesting leptin has a common function irrespective of species (Máčajová et
al., 2004).
Circulating concentrations of leptin rise as gestation progresses, which poses a
conceptual problem. As gestation progresses, especially during the last third of gestation,
nutrient requirements increase in order to maintain pregnancy and fetal growth; yet
leptin, a satiety factor, also increases. Thus, researchers have proposed placental leptin
has an alternative function and/or leptin resistance occurs in the mother (Ashworth et al.,
2000; Henson and Castracane, 2006). Transmembrane leptin receptors mediate the effects
of leptin. Several isoforms of the leptin receptor gene exist and are categorized as either
short form or long form receptors. The soluble leptin receptor is thought to promote
maternal leptin resistance by binding to circulating leptin, and thus, preventing leptin
from binding receptors in the hypothalamus and inducing satiety (Henson and
Castracane, 2006).
Proposed functions of placental leptin include both autocrine and paracrine
actions. In terms of autocrine actions, human umbilical cord leptin concentrations were
correlated with placental size, suggesting leptin may have a role in placental growth.
Leptin may also stimulate placental angiogenesis as seen in endothelial cell human
cultures (Ashworth et al., 2000) and in umbilical vein endothelial cells inducing vascular
endothelial growth factor receptor 2 phosphorylation (Tessier et al., 2013). Additionally,
leptin has an immunomodulatory role at the maternal fetal interface (Ashworth et al.,
2000). In terms of paracrine actions, leptin enters both the maternal and fetal circulations.
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In humans, 95% of placental leptin enters maternal circulation while 5% enters fetal
circulation. Within the maternal body, leptin may mobilize energy stores via leptin
resistance. Within the fetus, leptin may modulate fetal growth as leptin concentrations in
the umbilical cord are positively correlated with birth weight, fetal length, head
circumference, and ponderal index (birth weight/ CRL3) (Ashworth et al., 2000; Bajoria
et al., 2002; Henson and Castracane, 2006).
Although most of the information on placental leptin is from murine and human
studies, leptin and leptin receptors have been identified in the pig placenta. Moreover, the
function of placental leptin in pigs is thought to be similar to human placental leptin
(Ashworth et al., 2000). In this study, LEP was upregulated in high PE placentas
compared to low PE placentas. Considering the above data on placental leptin, the
increased expression of LEP in high PE placentas may modulate increased placental
function and fetal growth, enabling the efficiency of a smaller placenta and growth of a
comparably sized littermate. In this study, no significant correlations were identified
between LEP and placental weight, placental VD, fetal weight, or CRL; however, leptin
concentrations in the umbilical cord blood were not evaluated. Thus, future research
should evaluate leptin (localization, concentration, receptors, ect.) in the dam, placenta,
and fetus of pigs in relation to PE to elucidate the role of placental leptin during
pregnancy in a livestock animal.
Probable cation-transporting ATPase 13A3 belongs to the P type ATPase family.
The P type ATPase family comprises membrane proteins that function to transport ions
across the cell membrane and against the concentration gradient by using the energy

144

stored in ATP (active transport). The family is subdivided into five types, Type I-V, also
known as P1-P5, based on sequence homology (Kühlbrandt, 2004). Type V (P5)
ATPases comprise the newest subfamily, and thus, the least characterized subfamily.
More recently it has been suggested that Type V (P5) ATPases should be subdivided into
P5A and P5B based on a phylogenetic analysis. Thus, ATP13A3 belongs to the P5A
subfamily (Sørensen et al., 2010).
Gene ontology enrichment terms for ATP13A3 indicate the product of this gene is
involved in calcium ion transmembrane transport and calcium ion homeostasis.
Intriguingly, ATP13A3 has been shown to play a role in polyamine transport. In 2010, the
worm homologue of human ATP13A3, CATP-5, localized to the plasma membrane, was
suggested to either transport polyamines or positively regulate polyamine transport
(Heinick et al., 2010). In 2016, ATP13A3 was shown to play a role in polyamine transport
in human pancreatic cancer (Madan et al., 2016). Polyamines (putrescine, spermidine,
and spermine) perform numerous essential functions in mammalian physiology, including
but not limited to, cell proliferation and differentiation, DNA and protein synthesis,
regulating gene expression, signal transduction, ion-channel function, and protection
from oxidative damage. Moreover, polyamines are known regulators of placental growth
and angiogenesis (Wu et al., 2005). Thus, the increased expression of ATP13A3 in high
PE placentas compared to low PE placentas is interesting and implies active transport of a
molecule is increased in high PE placentas; what molecule (potentially calcium,
polyamines, or other ions) remains to be elucidated in the pig.
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Solute carrier family 4 member 7 encodes a sodium bicarbonate cotransporter
protein. This transmembrane protein is an electroneutral cotransporter, transporting one
Na+ for one HCO3-. This gene is reportedly expressed in various tissues such as the
kidney, liver, lung, heart, brain, spleen, and testes. Additionally, SLC4A7 is expressed in
trohphoblast epithelial cells of day 85 pig placentas (Vallet et al., 2014). The gene
SLC4A7 has been implemented in pathologies like drug addiction, breast cancer,
blindness and auditory impairment, and hypertension (Romero et al., 2013). Interestingly,
a Slc4a7 knockout model in mice “inhibited nitric oxide mediated vasorelaxation” in
arteries (Boedtkjer et al., 2011). Moreover, vasodilation increases blood flow, and an
increase in blood flow increases nutrient and oxygen transport.
Although the protein encoded by SLC4A7’s molecular function is a sodium
bicarbonate transporter, the biological process this protein is involved in within the
placenta needs to be determined. It is possible that the increased expression of SLC4A7 in
high PE placentas compared to low PE placentas increases vasodilation, and thus, blood
flow within those placentas. Nonetheless, further research is required to determine if
sodium bicarbonate transport is increased in high PE placentas and the physiological
significance of that increase.
Pro-cathepsin H encodes a lysosomal cysteine proteinase, cathepsin H, that can
act as both an endopeptidase and aminopeptidase (Brix et al., 2008). Cathespsin H is 1 of
11 members in the cysteine cathepsin family. Cysteine cathepsins function in apoptosis,
cellular migration, keratinocyte differentiation, bone remodeling, and protein turnover
(Sulpizio et al., 2012). Moreover, cysteine cathepsins, especially cathepsin B and L, have
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been extensively studied in relation to cancer. Cathepsin H is elevated in breast cancer,
colorectal carcinoma, gliomas, and prostate cancer, but in comparison to cathepsin B and
L, less is known regarding the function of cathepsin H. In a pancreatic cancer mouse
model, Ctsh knockout resulted in a reduction in premalignant hyperplastic islet
angiogenic switching, tumor vascularization, and tumor growth, suggesting Ctsh is
proangiogenic and essential for vascular development in tumors (Gocheva et al., 2010).
Given the proangiogenic role of CTSH in tumors, the increased expression of CTSH in
high PE placentas compared to low PE placentas may indicate angiogenesis is enhanced
in high PE placentas; however, further research is required to determine if CTSH has a
proangiogenic function in the pig placenta.
Solute carrier family 52 member 3 encodes a recently discovered riboflavin
transporter protein. Riboflavin, also known as vitamin B2, is an essential (mammals can
not synthesize riboflavin) water-soluble vitamin required for normal cellular function
(Yonezawa and Inui, 2013). Riboflavin has two important biologically active forms,
flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), that act as enzyme
cofactors in oxidation-reduction reactions (Yonezawa and Inui, 2013; Ashoori and
Saedisomeolia, 2014). Riboflavin is suggested to protect the body from oxidative stress
(an increase in reactive oxygen species), which is associated with diseases like cancer,
via antioxidant properties (Ashoori and Saedisomeolia, 2014).
Riboflavin deficiencies are associated with retarded growth, neurodegeneration,
and anemia. Moreover, riboflavin is considered necessary for normal fetal growth, as
reductions in maternal riboflavin intake during pregnancy have been shown to contribute

147

to disorders in offspring. Moreover, Yoshimatsu and others (2016) demonstrated the
protein encoded by SLC52A3 facilitates placental transport of riboflavin. Knockout of
Slc52a3 in mice resulted in reduced riboflavin concentrations in the plasma and tissue of
knockout mice, and mice died within 48 h of birth with hyperlipidemia and
hypoglycemia. Concentrations of FAD, an active form of riboflavin, were also decreased
in knockout mice. Therefore, the authors suggested the state of hyperlipidemia was the
result of decreased FAD, which is required for the first step of fatty acid beta-oxidation.
Hypoglycemia is also associated with impaired fatty acid oxidation. Notably, the neonatal
death observed in this study verifies riboflavin is required for normal fetal growth and
development (Yoshimatsu et al., 2016).
In high PE placentas, SLC52A3 expression was upregulated compared to low PE
placentas indicating placental transport of riboflavin is increased. The increase in
riboflavin transport may serve to protect the placenta and/or fetus from oxidative stress.
Conversely, riboflavin may be converted to the biologically active forms (FMN and
FAD) within the fetus, which are involved in oxidation-reduction reactions that are
essential to the production of ATP via cellular respiration.
Solute carrier family 23 member 2 encodes a sodium dependent ascorbate
(vitamin C) co-transporter (2Na+: ascorbate). In humans, SLC23A2 is expressed in a
number of tissues, including the retina, brain, spleen, prostate, testis, ovary, and placenta.
Moreover, knockout of Slc23a2 in mice confirmed Slc23a2 is required for placental
transfer of L-ascorbic acid (Takanaga et al., 2004). During gestation, fetal pigs cannot
synthesize vitamin C, but ascorbate concentrations in the plasma of fetal pigs continues to
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rise throughout gestation, peaking between 80 and 100 d. Therefore, placental transport
of ascorbate from dam to fetus must occur in pigs (Mahan and Vallet, 1997) and is likely
mediated by placental SLC23A2.
The gene 32428, encoding a solute carrier family 23 member 2-like protein, was
upregulated in high PE placentas compared to low PE placentas. Likewise, the expression
of SLC23A2 was also upregulated in high PE placentas compared to low PE placentas,
suggesting increased vitamin C transport in these placentas. Vitamin C is involved in a
number of biological functions, but is widely recognized as an antioxidant and for
vitamin C’s role in collagen synthesis (Du et al., 2012).
In a hypoxic pregnancy rat model, maternal vitamin C supplementation was
shown to prevent oxidative stress and vitamin C supplementation increased birth weight
irrespective of hypoxic or normoxic pregnancy conditions. The authors suggested the
increase in birth weight following supplementation with the antioxidant, vitamin C, likely
resulted from increased umbilical/placental blood flow improving oxygen and nutrient
transport to the fetus, as vascular endothelial cells produce reactive oxygen species, like
superoxide, and changes in nitric oxide to superoxide ratios (regulating bioavailability)
alter vascular tone (Richter et al., 2012).
Further research is required to determine if the up regulation of SLC23A2 in the
pig placenta and potential subsequent increase in vitamin C transport effects placental
vascular tone, and in turn, fetal growth. Early studies indicated maternal vitamin C
supplementation had no beneficial effect on developing fetuses; however, it was reported
vitamin C inclusion into sow diets did not alter fetal ascorbate concentrations (Mahan and
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Vallet, 1997). Thus, maternal vitamin C supplementation may benefit fetuses in
conditions where the placental transporter is abundant.
Potassium channel, inwardly rectifying subfamily J, member 2 encodes an
inwardly rectifying potassium channel membrane protein. Among ion channels,
potassium channels comprise the largest most diverse group. The family of potassium
channels is sub grouped according to structure (based on alpha subunit transmembrane
domains). Potassium channels with 6 to 7 transmembrane domains are voltage gated
potassium channels (KV) or calcium activated potassium channels (KCa), those with 4
transmembrane domains are leak potassium channels (KL), and those with 2
transmembrane domains are inward rectifier potassium channels (KIR) (Wareing and
Greenwood, 2011). These subfamilies are further sub grouped, with each resulting group
often containing more than one member. The KIR subfamily includes seven subgroups,
KIR1 through KIR7. KIR2 has five members: KIR2.1, KIR2.2, KIR2.3, KIR2.4, and KIR2.6.
The gene KCNJ2 encodes the inwardly rectifying potassium channel protein KIR2.1. The
term inwardly rectifying denotes the flow of potassium ions into the cells opposed to out
of the cell (De Boer et al., 2010).
In general potassium channels, distributed widely throughout the body, are
essential for cell membrane potential and cell survival (Wareing and Greenwood, 2011).
Maintenance of resting membrane potential and prevention of hyperpolarization of cells
is mediated by KIR (Mylona et al., 1998). Moreover, members of the KIR family have
been implemented is vasodilation (Wareing and Greenwood, 2011). KIR2.1 is expressed
in the human placenta (Mylona et al., 1998) and various other potassium channels are
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expressed in human placental arteries and veins (Wareing et al., 2006). The presence of
potassium channels in the placental vasculature of humans has been suggested to play a
role in placental vascular tone (i.e. blood flow) as potassium channels are involved in the
release of vasoactive factors, which modify smooth muscle tone, from vascular
endothelial cells. Moreover, local regulation of vascular tone is especially important in
the placenta given the lack of innervation in this tissue (Wareing and Greenwood, 2011).
The expression of KCNJ2 was significantly downregulated in high PE placentas
compared to low PE placentas, suggesting the presence of fewer potassium channel
proteins in high PE placentas. Given the potential role of KIR2.1 in the regulation of
placental vascular tone in conjunction with the differential expression of KCNJ2, further
research is warranted. Future research should determine KIR2.1 localization within the pig
placenta (diffuse epitheliochorial as opposed to discoid hemochorial) and conduct a
functional analysis of KIR2.1 in the placenta.
Sus Scrofus gene 23594 encodes a protein like multidrug resistance-associated
protein 4. The gene MRP4/ABC4 belongs to the MRP/ABCC subfamily of ATP binding
cassette transporter family. Members of the ABCC subfamily hydrolyze ATP to transport
a substance across a membrane and against the concentration gradient. Members of the C
subfamily are known to transport a wide variety of organic anions (both endogenous and
xenobiotic); MRP4/ABCC4 can transport numerous endogenous substrates, such as
steroid hormones, urate, eicosanoids, ADP, cyclic nucleotides, glutathione, bile acids,
and folate, and is also a drug transporter with broad substrate specificity (Russel et al.,
2008). Gene ontology terms associated with MRP4-like included ATPase activity,
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coupled to transmembrane movement of substances, transmembrane transport, and
chloride transmembrane transport. Multidrug Resistance-Associated Protein 4-like was
downregulated in high PE placentas compared to low PE placentas, but further
characterization of this transporter in the pig placenta is required to interpret the
significance of that downregulation.
Six Transmembrane epithelial antigen of the prostate 2 is another member (1 of 4)
of the STEAP family. The proteins encoded by the STEAP family are found in mammals
and function as metalloreductases. Like STEAP1, STEAP2 was identified in malignant
prostate cells localizing to the plasma membrane and golgi complex of epithelial cells.
Expression of STEAP2 has also been identified in various normal human tissues and in
mouse embryos (Gomes et al., 2012). Ohgami and others (2006) identified STEAP2 as a
ferrireductase (Ferric (Fe3+) to Ferrous (Fe2+)) and cupric reductase (Cupric (Cu2+) to
Cuprous (Cu1+)), functioning to stimulate iron and copper uptake in cells.
Iron, a component of the oxygen transport protein hemoglobin, is required to
maintain blood hemoglobin levels (Ohgami et al., 2006). The uptake of iron in animal
cells can occur two ways, either non-transferrin bound or transferrin bound. Either way,
ferric iron must be reduced to ferrous iron as the main iron transporter, DMT1, only
transports ferrous iron (McKie, 2005). In mice, increased placental expression of another
ferrireductase in the same family, STEAP4, has been suggested to prevent neonatal iron
deficiency (Ohgami et al., 2006).
Thus, the decreased expression of STEAP2 in high PE placentas compared to low
PE placentas may indicate a decrease in iron reduction, and thus, ferric transport across
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the placenta of high PE placentas at day 95 of gestation. It is well known that
confinement pigs are born with low iron stores and will develop a deficiency during the
first week of life (Kegley et al., 2002), thus the differential expression of STEAP2, a gene
involved in the reduction of iron to facilitate iron transport, in the placenta near term is
intriguing. Whether differential expression of STEAP2 is associated with differential iron
concentration in the fetuses of high and low PE placentas should be determined.

Lastly, correlation analyses were conducted. The first correlation analysis was
performed to identify any significant correlations between the following measurements:
fetal weight, placental weight, PE, CRL, brain weight, ST weight, ISL, VA glucose, VA
NEFA, placental VD, and endometrial VD, and the 214 DEG in high PE versus low PE
placentas. Eight significant correlations were identified, including 5 placental weight
correlations and 3 PE correlations. Combining the results of the correlation analysis with
the RNA sequencing results enabled directional (upregulated or downregulated)
interpretation of the results.
The following genes were correlated with placental weight: GRINL1A complex
locus 1 (GCOM1), gene19656, ATP-binding cassette sub-family G member 2 (ABCG2),
TOX high mobility group box family member 3 (TOX3), and Ras-related protein rab-6B
(RAB6B). The gene GCOM1 was very strongly positively correlated with placental
weight, but GCOM1 was downregulated in high PE versus low PE placentas, indicating a
reduction in GCOM1 is correlated with a reduction in placental weight. The molecular
function of GCOM1 in pigs is unknown and requires further research. Gene19656
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encodes an ABCG2 like protein. Similarly, the gene19659 encodes ABCG2. These genes
were strongly correlated with placental weight and downregulated in high PE compared
to low PE placentas, indicating a decrease in ABCG2 expression is correlated with a
decrease in placental weight. The gene ABCG2 belongs to the ATP binding cassette
transporter family, which transports substances across membranes using ATP. Moreover,
ABCG2 is significantly expressed in the human placenta and transports xenobiotic
compounds (Gedeon et al., 2008; GeneCards, 2017). Gene ontology molecular functions
of ABCG2 included ATP binding, ATPase activity coupled to transmembrane movement
of substances, and cholesterol transporter activity, but further research is required to
elucidate the role of ABCG2 in the pig placenta. The gene TOX3 was also strongly
positively correlated with placental weight, but TOX3 was downregulated in high PE
compared to low PE placentas. Therefore, a decrease in TOX3 expression is correlated
with a decrease in placental weight. The protein product of TOX3 may be involved in
chromatin remodeling, and the bending and unwinding of DNA (GeneCards, 2017),
suggesting TOX3 may regulate the characteristically smaller size of high PE placentas.
Conversely, RAB6B was strongly negatively correlated with placental weight, but RAB6B
was upregulated in high PE compared to low PE placentas. Thus, an increase in RAB6B
expression is correlated with a decrease in placental weight. The gene RAB6B is a
member of the RAB subfamily, functioning in the regulation of intracellular transport.
Rab6B localizes to the golgi apparatus and may function in retrograde membrane traffic
(Opdam et al., 2000). Given the strong negative correlation between RAB6B and
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placental weight, further research into the function of Rab6b in the pig placenta is
warranted.
Gene 12188, transmembrane protein 199 (TMEM199), and proto-cadherin beta 1
(PCDHB1) were correlated with PE. Gene 12188 encodes an uncharacterized protein in
swine. The expression of this gene was very strongly positively correlated with PE and
was upregulated in high PE compared to low PE placentas. Thus, an increase in
gene12188 is correlated with an increase in PE, but characterization of this gene is
required to further explain this correlation. Transmembrane protein 199 was very strongly
positively correlated with PE. The gene TMEM199 was upregulated in high PE versus
low PE placentas, and therefore, an increase in TMEM199 expression is correlated with
an increase in PE. The molecular function of TMEM199 in pigs in unknown; however,
the protein encoded by this gene in humans may be involved in golgi homeostasis
(GeneCards, 2017). Lastly, PCDHB1 was strongly positively correlated with PE. The
gene PCDHB1 was also among the 10 most upregulated genes in high PE compared to
low PE placentas, indicating increased expression of PCDHB1 is correlated with an
increase in PE. Moreover, the strong positive correlation of PCDHB1 with PE supports
the RNA sequencing results identifying PCDHB1 as a candidate gene for PE. The
specific function of the protein PCDHB1 is unknown, but PCDHB1 may be a calcium
dependent cell to cell adhesion protein (GeneCards, 2017). Given the strong positive
correlations of gene12188, TMEM199, and PCDHB1 with PE further research is
warranted to determine the specific functions these genes may have within the pig
placenta.
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A second correlation analysis was performed to identify correlations between the
following measurements: fetal weight, placental weight, PE, CRL, brain weight, ST
weight, ISL, VA glucose, VA NEFA, placental VD, and endometrial VD, and the 20,280
genes in the pig placenta on day 95 of gestation. The analysis identified 41 significant
correlations between 33 genes and fetal weight, placental weight, CRL, ST weight, or VA
glucose. The genes identified in this correlation analysis were not DEG identified by
RNA sequencing. Nonetheless, these genes may still contribute to PE and should be
considered candidate genes for PE, especially given the very strong correlations
identified. Of particular interest are the 6 genes identified with more than one correlation;
however, 3 of these genes (gene7837, gene11733, gene28322) are uncharacterized in
swine. Nevertheless, ribosomal protein S18 (RPS18) was very strongly negatively
correlated with fetal weight, CRL, and ST weight, all measures of the fetus. The protein
encoded by RPS18 is a component of the small 40S subunit of ribosomes, the machinery
involved in protein synthesis (translation). The ortholog of RPS18 in Escherichia coli is
involved in translation initiation (GeneCards, 2017). Likewise, geminin DNA replication
inhibitor (GMNN) was also very strongly negatively correlated with fetal weight, CRL,
and ST weight. The gene GMNN inhibits DNA replication, thus playing a crucial role in
the regulation of the cell cycle (GeneCards, 2017). Lastly, deleted in primary ciliary
dyskinesia homolog (DPCD) was very strongly negatively correlated with fetal weight
and ST weight. In mice, Dpcd plays a role in the differentiation and maintenance of
ciliated cells (GeneCards, 2017). Although not significantly differentially expressed in
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the placenta, RPS18, GMNN, and DPCD all have regulatory roles and may be critical to
PE. Thus, further research into these genes is justified.
In conclusion, the results of this study were obtained by comparing a high PE
group to a low PE group. These groups were created using the highest and lowest PE
values in each litter. This method can be viewed as both advantageous and limiting as it
ensured comparisons were only between the very most and least efficient units but
excluded feto-placental units that were more or less efficient than the average. Therefore,
it is suggested that future work evaluate the best method for defining high and low PE.
Regardless, the basis of high PE, a similarly sized pig grown on a smaller placenta, was
confirmed in this study. Likewise, the reduction in placental size, characteristic of high
PE placentas, did not adversely affect the fetus. The lack of a difference in placental VD,
and glucose and NEFA concentrations in the umbilical blood of high PE and low PE fetoplacental units confirmed previous data indicating high PE placentas have some other
means, such as an increase in nutrient transporters, enabling the smaller placenta to grow
a similarly sized littermate. However, it is recommended that future studies account for
the effect of dam feed intake on the concentration of metabolites in the umbilical blood of
high PE and low PE feto-placental units. The identification of DEG genes in the placenta,
but absence of DEG in the endometrium confirmed the placenta responds to the
requirements of the fetus. Furthermore, the identification of DEG in high PE compared to
low PE pig placentas, and further analysis of those genes, confirmed a portion of the
DEG in the pig placenta encode nutrient transporters and gene products with growth
factor or angiogenic activity; however, DEG with alternative functions were also
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identified, indicating the complexity of the relationship between placental and fetal
weights. The results of this study demonstrate PE is not controlled by one or even a few
genes, but rather multiple genes and the interaction of those genes. Therefore, future
work should attempt to make associations between the phenotype high PE and genetic
variations within the genome that could be used to select for high PE, potentially making
PE production applicable. Moreover, to what extent environmental effects impact PE is
unknown and should also be evaluated in future studies.
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CHAPTER FOUR
CONCLUSION

Currently the world population is around 7.3 billion people, but by 2050 it is
estimated to reach a staggering 9.7 billion people (Zeigler and Steensland, 2016). The rise
in population will result in a substantial increase in food demand; however, the resources
required to sustain such food production, like land mass, are limited (Handelsman and
Stulberg, 2016). Consequently, it is imperative that efforts are made to increase the
efficiency of food production. Moreover, the high meat consumption practices of the
industrialized world will presumably be adopted by the developing world as the
population rises and these areas become industrialized and prosperous (Foley, 2014;
Spiess, 2016). Given that pigs are litter-bearing species, have a relatively short gestation
length (114 d), and a shorter grow-finish period (∼ 6 mo) than that of larger meat
producing animals, increases in the reproductive efficiency of pigs would provide
sustainable and efficient increases in meat production.
Although litter size has continued to increase over time and the average litter size
of U.S. production pigs is currently 10.50 (NASS, 2017), ovulation rates and teat
numbers indicate the maximum potential of commercial production breed litter sizes has
not been reached. Likewise, more prolific breeds farrow 3 to 4 more pigs per litter than
U.S. and European counterparts (Wilson et al., 1998). The discovery of the smaller more
vascular placentas of more prolific breeds (Biensen et al., 1998; Wilson et al., 1998) lead
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to PE, a measure of the efficiency of the placenta quantified by the ratio of fetal weight to
placental weight (Christenson et al., 1987).
Placental efficiency varies not only between, but also within breeds, and even
within litters (Wilson et al., 1999). In fact, within a single litter PE can vary drastically,
resulting in similarly sized pigs associated with very different placenta, up to a 50%
weight difference (Wilmoth, 2009). Thus, high PE placentas take up less room in the
uterus while still growing a comparably sized littermate. However, the means enabling
the smaller placenta to grow a similarly sized littermate is unknown.
The results of this study have confirmed the basis of high PE, a smaller more
efficient placenta capable of growing a similarly sized littermate. Likewise, growth
measurements taken at birth demonstrated the reduction in placental size, characteristic of
high PE placentas, did not adversely affect the fetus. Moreover, growth measurements,
predictive of survivability and postnatal growth performance, in combination with body
weights up to day 21, indicated the survival and postnatal growth performance of pigs
grown of high PE placentas should not be reduced. Although, it is recommended that
future studies follow body weight to slaughter weight to ensure the postnatal growth
performance of pigs is not affected by PE. The lack of concentration differences in the
umbilical blood of high PE compared to low PE feto-placental units suggested that high
PE placentas have some other means enabling the smaller placenta to transport
comparable nutrient/hormone quantities and grow a similarly sized littermate. However,
future work should evaluate if the timing of feed consumption by dams significantly
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effects the concentration of metabolites in the umbilical blood of high PE and low PE
feto-placental units.
Gene expression was determined in placental and associated endometrial tissues
of high PE and low PE feto-placental units in an effort to elucidate potential mechanisms.
The identification of DEG genes in the placenta, but absence of DEG in the endometrium
confirmed the placenta responds to the requirements of the fetus. Furthermore, the
identification of DEG in high PE compared to low PE pig placentas, and further analysis
of those genes, confirmed a portion of the DEG in the pig placenta encode nutrient
transporters and gene products with growth factor or angiogenic activity; however, DEG
with alternative functions were also identified, indicating the complexity of the
relationship between placental and fetal weights.
The results of this study provide new insights into the regulation of PE; however,
further research is required to make PE production applicable. Future work should
identifying associations between high PE and genetic variations within the genome in an
effort to make high PE selectable. Moreover, two different methods, the highest and
lowest PE value within a litter and the 25th and 75th quartiles of all PE values, were used
to define high and low PE within these studies due to sampling time points (95 d versus
∼114 d). This called attention to the values used as cutoffs for high and low PE.
Therefore, conducting a meta-analysis of PE values from different pig studies to
determine the most appropriate method for defining high and low PE is also suggested.
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